p.value	odds_ratio	overlap	adj_p.value	genes
Eukaryotic Translation Elongation R-HSA-156842	6.47941719678145e-89	202.791835222915	71/83	1.7196373240258e-85	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;EEF1A2
Peptide chain elongation R-HSA-156902	2.92651722400601e-88	215.924049167112	70/81	3.88348835625597e-85	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Eukaryotic Translation Termination R-HSA-72764	5.7683932698632e-86	193.704660986648	69/81	3.82732893455423e-83	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Viral mRNA Translation R-HSA-192823	5.7683932698632e-86	193.704660986648	69/81	3.82732893455423e-83	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Translation R-HSA-72766	1.94567979428964e-85	44.1983750007707	93/181	1.03276683480894e-82	UBA52;EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;SEC11A;EEF1A2;SRP14;MRPL27;MRPL28;MRPL12;MRPL58;MRPS11;MRPL23;MRPL40;SSR2;MRPL22;MRPL43;MRPL51;AURKAIP1;MRPL47;MRPS24;MRPL41;MRPL46;MRPL11
Formation of a pool of free 40S subunits R-HSA-72689	3.56100217195297e-85	142.176037473183	71/88	1.5751499607272e-82	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Selenocysteine synthesis R-HSA-2408557	2.03652803396005e-84	165.120974168074	69/83	7.72135057447139e-82	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) R-HSA-975956	1.10810596581737e-83	154.064136939971	69/84	3.67614154159913e-81	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
SRP-dependent cotranslational protein targeting to membrane R-HSA-1799339	2.25699593675378e-83	112.503887235343	72/94	6.65563024016059e-81	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;SEC11A;SRP14;SSR2
GTP hydrolysis and joining of the 60S ribosomal subunit R-HSA-72706	9.06404342745753e-83	107.37794752588	72/95	2.40559712564723e-80	UBA52;EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Response of EIF2AK4 (GCN2) to amino acid deficiency R-HSA-9633012	1.48442869023908e-82	115.219584236219	71/92	3.58152158535865e-80	UBA52;EIF2S2;ATF2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
L13a-mediated translational silencing of Ceruloplasmin expression R-HSA-156827	3.52512383458469e-82	102.910302367501	72/96	7.79639888082314e-80	UBA52;EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Cap-dependent Translation Initiation R-HSA-72737	1.32982804937325e-81	98.8036328758204	72/97	2.52097403074043e-79	UBA52;EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Eukaryotic Translation Initiation R-HSA-72613	1.32982804937325e-81	98.8036328758204	72/97	2.52097403074043e-79	UBA52;EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Selenoamino acid metabolism R-HSA-2408522	8.99733470274628e-79	94.3754982411887	70/95	1.59192842007258e-76	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;INMT
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) R-HSA-975957	1.67062730919032e-78	100.219116741922	69/92	2.60814404623006e-76	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Nonsense-Mediated Decay (NMD) R-HSA-927802	1.67062730919032e-78	100.219116741922	69/92	2.60814404623006e-76	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Influenza Viral RNA Transcription and Replication R-HSA-168273	3.03785710053391e-73	65.479730164159	70/106	4.47915152489833e-71	UBA52;POLR2F;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Cellular response to starvation R-HSA-9711097	2.57098363770007e-68	42.5868173627221	73/132	3.49722923772559e-66	UBA52;EIF2S2;ATF2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;ATP6V1F;ATP6V0E1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Major pathway of rRNA processing in the nucleolus and cytosol R-HSA-6791226	2.63544026957467e-68	48.9853329962015	70/118	3.49722923772559e-66	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;RPP30
Influenza Infection R-HSA-168255	6.21881525926037e-68	47.9955114072814	70/119	7.85939795146525e-66	UBA52;POLR2F;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
rRNA processing in the nucleus and cytosol R-HSA-8868773	8.64422677186669e-68	45.3631762939219	71/124	1.0428080842061e-65	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;NOP10;RPP30
rRNA processing R-HSA-72312	1.9446296476574e-67	44.511844012836	71/125	2.24393351516641e-65	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;NOP10;RPP30
Regulation of expression of SLITs and ROBOs R-HSA-9010553	2.92675519006148e-60	32.0230484205481	70/143	3.23650344767632e-58	UBA52;PSMC5;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Signaling by ROBO receptors R-HSA-376176	1.20479593375964e-53	23.2392622759589	70/170	1.27901136327923e-51	UBA52;PSMC5;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Metabolism of amino acids and derivatives R-HSA-71291	2.14075819278084e-46	16.2150095032554	71/216	2.18522009370783e-44	UBA52;PSMC5;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;INMT
Metabolism of RNA R-HSA-8953854	2.47031454288297e-37	9.31470301600618	81/384	2.42822770252274e-35	UBA52;PSMC5;POLR2F;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;NOP10;LSM3;LSM4;LSM5;SNRPE;SNRPG;LSM10;RPP30;SF3B5;SNRNP27
Cellular responses to stimuli R-HSA-8953897	5.38347547487792e-36	7.54893896180133	99/620	4.92680824494e-34	UBA52;PSMC5;EIF2S2;CDC26;SKP1;CCNA2;CXCL8;DYNLL1;TFDP1;E2F1;H2AX;H2BC8;H2BC3;RPA3;TP53;JUN;NFKB1;RELA;CYCS;SP1;FOS;ATF2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;COX5A;COX4I1;COX16;COX7A2L;HSF1;ATP6V1F;ATP6V0E1;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;MYC
Cellular responses to stress R-HSA-2262752	5.38347547487792e-36	7.54893896180133	99/620	4.92680824494e-34	UBA52;PSMC5;EIF2S2;CDC26;SKP1;CCNA2;CXCL8;DYNLL1;TFDP1;E2F1;H2AX;H2BC8;H2BC3;RPA3;TP53;JUN;NFKB1;RELA;CYCS;SP1;FOS;ATF2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;COX5A;COX4I1;COX16;COX7A2L;HSF1;ATP6V1F;ATP6V0E1;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;MYC
Metabolism of proteins R-HSA-392499	2.87574561138383e-32	6.30422271039057	119/998	2.54407628420423e-30	DERL2;UBA52;RNF5;PSMC5;EIF2S2;SKP1;CCNA2;DYNLL1;H2AX;H2BC8;H2BC3;TP53;RELA;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M;UBE2A;UBE2L3;UBE2F;COX5A;UQCRQ;COX4I1;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;PCNA;MYC;TOP2A;PFDN1;PFDN5;VBP1;TAF10;UCHL3;SEC11A;EEF1A2;SRP14;MRPL27;MRPL28;MRPL12;COMMD6;MRPL58;MRPS11;MRPL23;MRPL40;SSR2;MRPL22;MRPL43;MRPL51;AURKAIP1;MRPL47;MRPS24;MRPL41;MRPL46;MRPL11
SARS-CoV-1 modulates host translation machinery R-HSA-9735869	6.43478190321847e-32	110.338387883786	27/33	5.50900360359414e-30	RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1
Axon guidance R-HSA-422475	1.64154039523013e-31	8.35586446197589	71/343	1.36145256529399e-29	UBA52;PSMC5;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;ARPC1A;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Nervous system development R-HSA-9675108	2.11187784602385e-30	7.94606956484983	71/356	1.69846175859009e-28	UBA52;PSMC5;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;ARPC1A;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34
Formation of the ternary complex, and subsequently, the 43S complex R-HSA-72695	5.05363220056237e-30	51.5811292878208	29/43	3.94480584126251e-28	EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M
SARS-CoV-2 modulates host translation machinery R-HSA-9754678	8.80678979470871e-29	49.4885699310593	28/42	6.67806289004483e-27	RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;SNRPE;SNRPG
Viral Infection Pathways R-HSA-9824446	2.11787213371174e-28	6.22553888810462	86/567	1.56134240079749e-26	UBA52;PSMC5;SKP1;DYNLL1;POLR2F;SUPT4H1;H2BC8;H2BC3;NFKB1;RELA;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;TBP;BRMS1;TAF10;SNRPE;SEC11A;SNRPG
Ribosomal scanning and start codon recognition R-HSA-72702	2.5313493086166e-28	40.0540743774521	29/47	1.81573001758607e-26	EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M
Translation initiation complex formation R-HSA-72649	6.15703370942487e-28	37.9830779564491	29/48	4.30020196442463e-26	EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S R-HSA-72662	1.45233276841428e-27	36.0506110165053	29/49	9.88331068556795e-26	EIF2S2;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;EIF3L;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EIF3M
Infectious disease R-HSA-5663205	3.15045306388799e-24	5.18430645554983	88/673	2.09032560788968e-22	UBA52;PSMC5;SKP1;DYNLL1;POLR2F;SUPT4H1;H2BC8;H2BC3;JUN;NFKB1;RELA;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;ARPC1A;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;TBP;BRMS1;TAF10;SNRPE;SEC11A;SNRPG
Metabolism R-HSA-1430728	1.41249750696702e-22	4.60764094232118	100/900	9.14333752070847e-21	UBA52;PSMC5;CYCS;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;COA1;NDUFA8;COX5A;UQCRFS1;UQCR11;UQCRQ;ATP5MF;COX4I1;COX16;COX7A2L;NDUFS5;NDUFB2;NDUFB1;NDUFA6;UQCRB;ATP5F1D;UQCRH;NDUFB4;NDUFA3;NDUFAF1;NDUFA1;NDUFAF4;NDUFB10;NDUFB5;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;GUK1;NME4;INMT;COQ3
SARS-CoV-1-host interactions R-HSA-9692914	4.69918778353906e-21	14.090363111379	31/86	2.96943913750302e-19	UBA52;NFKB1;RELA;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1
Developmental Biology R-HSA-1266738	5.86163811436007e-21	4.58445609524662	85/699	3.61785757104922e-19	UBA52;PSMC5;TFDP1;E2F1;POLR2F;H2AX;H2BC8;H2BC3;TP53;JUN;DPY30;NFKB1;RELA;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;ATP6V1F;ATP6V0E1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;ARPC1A;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;MYC
SARS-CoV-1 Infection R-HSA-9678108	1.31340271749169e-17	9.87703485678291	31/109	7.92220639141578e-16	UBA52;NFKB1;RELA;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1
Respiratory electron transport R-HSA-611105	8.64627418698729e-15	11.6434317190775	23/70	5.09938037605873e-13	CYCS;COA1;NDUFA8;COX5A;UQCRFS1;UQCR11;UQCRQ;COX4I1;COX16;COX7A2L;NDUFS5;NDUFB2;NDUFB1;NDUFA6;UQCRB;UQCRH;NDUFB4;NDUFA3;NDUFAF1;NDUFA1;NDUFAF4;NDUFB10;NDUFB5
Disease R-HSA-1643685	9.16164672786732e-15	3.30558490737467	97/1079	5.28587182951301e-13	DERL2;UBA52;RNF5;PSMC5;CDC26;SKP1;DYNLL1;TFDP1;E2F1;POLR2F;SUPT4H1;H2AX;H2BC8;H2BC3;RPA3;TP53;JUN;NFKB1;RELA;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1;RPL28;RPL23A;RPL37;RPLP1;RPL32;RPL22;RPL15;RPL26L1;RPLP2;RPL19;RPL10;RPL13A;RPL31;RPL27;RPL26;RPL13;RPL3;RPL7A;RPLP0;RPL27A;RPL17;RPL38;RPL24;RPL8;RPL18A;RPL18;RPL12;RPL30;RPL41;RPL23;RPL29;RPL10A;RPL36;ARPC1A;RPL22L1;RPL6;RPL35;RPL4;RPL11;RPL35A;RPL7;RPL37A;RPL34;TBP;MYC;BRMS1;TAF10;SNRPE;SEC11A;SNRPG
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. R-HSA-163200	1.01559628401428e-14	10.008721072099	25/85	5.73487773994447e-13	CYCS;COA1;NDUFA8;COX5A;UQCRFS1;UQCR11;UQCRQ;ATP5MF;COX4I1;COX16;COX7A2L;NDUFS5;NDUFB2;NDUFB1;NDUFA6;UQCRB;ATP5F1D;UQCRH;NDUFB4;NDUFA3;NDUFAF1;NDUFA1;NDUFAF4;NDUFB10;NDUFB5
Aerobic respiration and respiratory electron transport R-HSA-1428517	6.86314426755549e-13	7.5304300861781	26/109	3.79474685126922e-11	UBA52;CYCS;COA1;NDUFA8;COX5A;UQCRFS1;UQCR11;UQCRQ;ATP5MF;COX4I1;COX16;COX7A2L;NDUFS5;NDUFB2;NDUFB1;NDUFA6;UQCRB;ATP5F1D;UQCRH;NDUFB4;NDUFA3;NDUFAF1;NDUFA1;NDUFAF4;NDUFB10;NDUFB5
SARS-CoV-2-host interactions R-HSA-9705683	9.2366207772892e-13	6.47682304994675	29/138	5.00285541692358e-11	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;SNRPE;SNRPG
Mitochondrial translation termination R-HSA-5419276	5.50738848999811e-10	9.8869637947738	16/53	2.923321810491e-08	MRPL27;MRPL28;MRPL12;MRPL58;MRPS11;MRPL23;MRPL40;MRPL22;MRPL43;MRPL51;AURKAIP1;MRPL47;MRPS24;MRPL41;MRPL46;MRPL11
Mitochondrial translation elongation R-HSA-5389840	7.5199924796973e-10	9.62464355114783	16/54	3.83808846944551e-08	MRPL27;MRPL28;MRPL12;MRPL58;MRPS11;MRPL23;MRPL40;MRPL22;MRPL43;MRPL51;AURKAIP1;MRPL47;MRPS24;MRPL41;MRPL46;MRPL11
Mitochondrial translation initiation R-HSA-5368286	7.5199924796973e-10	9.62464355114783	16/54	3.83808846944551e-08	MRPL27;MRPL28;MRPL12;MRPL58;MRPS11;MRPL23;MRPL40;MRPL22;MRPL43;MRPL51;AURKAIP1;MRPL47;MRPS24;MRPL41;MRPL46;MRPL11
SARS-CoV-2 Infection R-HSA-9694516	8.8195525613442e-10	4.62294497150694	29/180	4.41643254675613e-08	UBA52;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;SNRPE;SNRPG
Mitochondrial translation R-HSA-5368287	1.01900393458467e-09	9.37578609239258	16/55	5.00821563405132e-08	MRPL27;MRPL28;MRPL12;MRPL58;MRPS11;MRPL23;MRPL40;MRPL22;MRPL43;MRPL51;AURKAIP1;MRPL47;MRPS24;MRPL41;MRPL46;MRPL11
SARS-CoV Infections R-HSA-9679506	7.84219316580124e-09	3.66789715959538	34/260	3.78421466582482e-07	UBA52;NFKB1;RELA;SP1;RPS16;RPS15;RPS24;RPS15A;RPS18;RPS23;RPS7;RPS8;RPS27L;RPS25;RPSA;RPS19;RPS10;RPS11;RPS6;RPS3A;RPS21;RPS9;RPS27;RPS29;RPS5;RPS12;RPS13;RPS2;RPS20;RPS17;EEF1A1;BRMS1;SNRPE;SNRPG
Complex I biogenesis R-HSA-6799198	1.26585059791362e-08	10.451557716669	13/41	5.99922765511205e-07	COA1;NDUFA8;NDUFS5;NDUFB2;NDUFB1;NDUFA6;NDUFB4;NDUFA3;NDUFAF1;NDUFA1;NDUFAF4;NDUFB10;NDUFB5
Transcription of E2F targets under negative control by DREAM complex R-HSA-1362277	1.755028672444e-05	16.2942872446687	6/14	0.000817165981871294	TFDP1;E2F1;PCNA;MYC;TOP2A;E2F4
G0 and Early G1 R-HSA-1538133	3.31547866294032e-05	10.1816290929728	7/22	0.00151711730542131	CCNA2;TFDP1;E2F1;PCNA;MYC;TOP2A;E2F4
Protein hydroxylation R-HSA-9629569	0.000127639631938452	28.65015925664	4/7	0.00574162005363816	RPS23;RPS6;RPL27A;RPL8
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest R-HSA-6804114	0.00037245659148212	10.7994057587538	5/15	0.0164749965632258	TFDP1;TP53;BAX;PCNA;E2F4
Activation of NOXA and translocation to mitochondria R-HSA-111448	0.000852330988665254	32.0554409485992	3/5	0.0370833843265178	TFDP1;E2F1;TP53
TP53 Regulates Transcription of Cell Cycle Genes R-HSA-6791312	0.00112367962596109	5.07550675213308	7/37	0.0481007375371086	CCNA2;TFDP1;E2F1;TP53;BAX;PCNA;E2F4
Transcriptional Regulation by TP53 R-HSA-3700989	0.0012523335625596	2.28759259339704	21/228	0.0527570361116378	UBA52;CCNA2;TFDP1;E2F1;POLR2F;SUPT4H1;RPA3;TP53;JUN;CYCS;FOS;ATF2;BAX;COX5A;COX4I1;COX16;COX7A2L;TBP;PCNA;E2F4;TAF10
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 R-HSA-1362300	0.00150902915828819	10.7446944720974	4/12	0.0625775529077634	CCNA2;TFDP1;E2F1;E2F4
rRNA modification in the nucleus and cytosol R-HSA-6790901	0.00252174520859924	6.34428860451106	5/22	0.102964796671114	RPS7;RPS6;RPS9;RPS2;NOP10
Activation of PUMA and translocation to mitochondria R-HSA-139915	0.00278819085267853	16.0424673517658	3/7	0.110445649597147	TFDP1;E2F1;TP53
SLBP independent Processing of Histone Pre-mRNAs R-HSA-111367	0.00278819085267853	16.0424673517658	3/7	0.110445649597147	SNRPE;SNRPG;LSM10
Regulation of NFE2L2 gene expression R-HSA-9818749	0.00431334508479067	12.8305264744229	3/8	0.165907505145427	NFKB1;RELA;MYC
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs R-HSA-77588	0.00431334508479067	12.8305264744229	3/8	0.165907505145427	SNRPE;SNRPG;LSM10
G1/S-Specific Transcription R-HSA-69205	0.00481183760444164	7.15945774109881	4/16	0.182437385745544	TFDP1;E2F1;PCNA;E2F4
Oncogene Induced Senescence R-HSA-2559585	0.00543825966334049	5.13255060547436	5/26	0.203283678119798	UBA52;TFDP1;E2F1;TP53;SP1
Protein ubiquitination R-HSA-8852135	0.00592920744278546	3.61433782067564	7/49	0.215563240454145	UBA52;H2BC8;H2BC3;UBE2A;UBE2L3;PCNA;UCHL3
Release of apoptotic factors from the mitochondria R-HSA-111457	0.00592879311770193	42.4996328593167	2/3	0.215563240454145	CYCS;BAX
Extension of Telomeres R-HSA-180786	0.00607311803270443	6.60837021041069	4/17	0.217811557551318	CCNA2;RPA3;PCNA;NOP10
Intrinsic Pathway for Apoptosis R-HSA-109606	0.00651507803871063	4.05361665849823	6/38	0.227513383088658	DYNLL1;TFDP1;E2F1;TP53;CYCS;BAX
TP53 Regulates Transcription of DNA Repair Genes R-HSA-6796648	0.00651507803871063	4.05361665849823	6/38	0.227513383088658	POLR2F;SUPT4H1;TP53;JUN;FOS;ATF2
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582	0.00782026130018059	2.53431690806849	11/106	0.269545110268562	UBA52;CDC26;CCNA2;CXCL8;H2AX;H2BC8;H2BC3;JUN;NFKB1;RELA;FOS
Activation of the AP-1 family of transcription factors R-HSA-450341	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	JUN;FOS;ATF2
E3 ubiquitin ligases ubiquitinate target proteins R-HSA-8866654	0.00840567569593141	3.81361732724354	6/40	0.269855702778874	UBA52;H2BC8;H2BC3;UBE2A;UBE2L3;PCNA
ER Quality Control Compartment (ERQC) R-HSA-901032	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	DERL2;UBA52;RNF5
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest R-HSA-6804116	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	CCNA2;E2F1;TP53
Translesion Synthesis by POLH R-HSA-110320	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	UBA52;RPA3;PCNA
Translesion synthesis by POLI R-HSA-5656121	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	UBA52;RPA3;PCNA
Translesion synthesis by POLK R-HSA-5655862	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	UBA52;RPA3;PCNA
Translesion synthesis by REV1 R-HSA-110312	0.00864270336707019	9.16318574776365	3/10	0.269855702778874	UBA52;RPA3;PCNA
Synthesis of active ubiquitin: roles of E1 and E2 enzymes R-HSA-8866652	0.00921468678579011	5.72411162608318	4/19	0.284369520110313	UBA52;UBE2A;UBE2L3;UCHL3
Cellular Senescence R-HSA-2559583	0.0107755877034499	2.09204322312151	15/173	0.324981929147228	UBA52;CDC26;CCNA2;CXCL8;TFDP1;E2F1;H2AX;H2BC8;H2BC3;TP53;JUN;NFKB1;RELA;SP1;FOS
G1/S Transition R-HSA-69206	0.0107527469265918	2.53636195591998	10/96	0.324981929147228	UBA52;PSMC5;SKP1;CCNA2;TFDP1;E2F1;RPA3;PCNA;MYC;E2F4
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) R-HSA-5358606	0.0115048961631908	21.2647976784668	2/4	0.339266604634538	RPA3;PCNA
mRNA decay by 5' to 3' exoribonuclease R-HSA-430039	0.0114927338865542	8.01793796792812	3/11	0.339266604634538	LSM3;LSM4;LSM5
Mitotic G1 phase and G1/S transition R-HSA-453279	0.0124290433916261	2.35603238002218	11/113	0.362491001773359	UBA52;PSMC5;SKP1;CCNA2;TFDP1;E2F1;RPA3;PCNA;MYC;TOP2A;E2F4
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation R-HSA-163841	0.0132592840452557	5.0480743432241	4/21	0.382501520175094	RPS23;RPS6;RPL27A;RPL8
Gap-filling DNA repair synthesis and ligation in GG-NER R-HSA-5696397	0.0148206354626428	7.12523413393325	3/12	0.418446452317596	UBA52;RPA3;PCNA
NF-kB is activated and signals survival R-HSA-209560	0.0148206354626428	7.12523413393325	3/12	0.418446452317596	UBA52;NFKB1;RELA
Cyclin E associated events during G1/S transition  R-HSA-69202	0.0151073901223589	2.71109802517588	8/72	0.422052772470953	UBA52;PSMC5;SKP1;CCNA2;TFDP1;E2F1;MYC;E2F4
Telomere Maintenance R-HSA-157579	0.0163302949225246	2.66875923102139	8/73	0.451464611712295	CCNA2;POLR2F;H2AX;H2BC8;H2BC3;RPA3;PCNA;NOP10
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656	0.0176232930352215	2.62779426352007	8/74	0.482187832118328	UBA52;PSMC5;SKP1;CCNA2;TFDP1;E2F1;MYC;E2F4
G2 Phase R-HSA-68911	0.0186066062795412	14.1795152295651	2/5	0.484570115480409	CCNA2;E2F1
MAP3K8 (TPL2)-dependent MAPK1/3 activation R-HSA-5684264	0.0186358369123731	6.4106787194246	3/13	0.484570115480409	UBA52;SKP1;NFKB1
Mismatch Repair R-HSA-5358508	0.0186066062795412	14.1795152295651	2/5	0.484570115480409	RPA3;PCNA
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) R-HSA-5358565	0.0186066062795412	14.1795152295651	2/5	0.484570115480409	RPA3;PCNA
MyD88 cascade initiated on plasma membrane R-HSA-975871	0.0189884295440703	2.58758987616685	8/75	0.484570115480409	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toll Like Receptor 10 (TLR10) Cascade R-HSA-168142	0.0189884295440703	2.58758987616685	8/75	0.484570115480409	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toll Like Receptor 5 (TLR5) Cascade R-HSA-168176	0.0189884295440703	2.58758987616685	8/75	0.484570115480409	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-2173796	0.0216484502863893	3.46856336040122	5/36	0.547190352953116	UBA52;TFDP1;SP1;MYC;E2F4
S Phase R-HSA-69242	0.0222849104405537	2.14016051171529	11/123	0.557963701030467	UBA52;PSMC5;CDC26;SKP1;CCNA2;TFDP1;E2F1;RPA3;PCNA;MYC;E2F4
Calnexin/calreticulin cycle R-HSA-901042	0.0229433723801759	5.82759437674182	3/14	0.563812132379508	DERL2;UBA52;RNF5
Pyroptosis R-HSA-5620971	0.0229433723801759	5.82759437674182	3/14	0.563812132379508	TP53;CYCS;BAX
Activation of BH3-only proteins R-HSA-114452	0.0243536015896565	4.08359532401425	4/25	0.592976684577508	DYNLL1;TFDP1;E2F1;TP53
CLEC7A/inflammasome pathway R-HSA-5660668	0.0270859321117026	10.6370880762724	2/6	0.629346610385208	NFKB1;RELA
Processing of Capped Intronless Pre-mRNA R-HSA-75067	0.0277443682799809	5.34107372885187	3/15	0.629346610385208	SNRPE;SNRPG;LSM10
Processive synthesis on the lagging strand R-HSA-69183	0.0270859321117026	10.6370880762724	2/6	0.629346610385208	RPA3;PCNA
Recognition of DNA damage by PCNA-containing replication complex R-HSA-110314	0.0277443682799809	5.34107372885187	3/15	0.629346610385208	UBA52;RPA3;PCNA
Removal of the Flap Intermediate R-HSA-69166	0.0270859321117026	10.6370880762724	2/6	0.629346610385208	RPA3;PCNA
Removal of the Flap Intermediate from the C-strand R-HSA-174437	0.0270859321117026	10.6370880762724	2/6	0.629346610385208	RPA3;PCNA
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation R-HSA-975138	0.0269645743746023	2.40493781736342	8/80	0.629346610385208	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
p75NTR signals via NF-kB R-HSA-193639	0.0277443682799809	5.34107372885187	3/15	0.629346610385208	UBA52;NFKB1;RELA
Chromosome Maintenance R-HSA-73886	0.028802826945163	2.37133940195023	8/81	0.637022522603855	CCNA2;POLR2F;H2AX;H2BC8;H2BC3;RPA3;PCNA;NOP10
MyD88 dependent cascade initiated on endosome R-HSA-975155	0.028802826945163	2.37133940195023	8/81	0.637022522603855	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181	0.028802826945163	2.37133940195023	8/81	0.637022522603855	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Regulated Necrosis R-HSA-5218859	0.0296638423415753	3.16022512757782	5/39	0.650643285740007	UBA52;TP53;CYCS;BAX;UBE2L3
Interleukin-17 signaling R-HSA-448424	0.0310233866528093	2.74972122702049	6/53	0.664000549810934	UBA52;SKP1;JUN;NFKB1;FOS;ATF2
MAP kinase activation R-HSA-450294	0.0310233866528093	2.74972122702049	6/53	0.664000549810934	UBA52;SKP1;JUN;NFKB1;FOS;ATF2
Regulation of TP53 Activity through Phosphorylation R-HSA-6804756	0.0310233866528093	2.74972122702049	6/53	0.664000549810934	UBA52;CCNA2;RPA3;TP53;TBP;TAF10
Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138	0.0327360307105287	2.30705914100044	8/83	0.695051404045945	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
DEx/H-box helicases activate type I IFN and inflammatory cytokines production  R-HSA-3134963	0.0368050286153122	8.51071573416495	2/7	0.74565302248121	NFKB1;RELA
DNA Double-Strand Break Repair R-HSA-5693532	0.0357409906083747	2.14228359942027	9/100	0.74565302248121	UBA52;CCNA2;H2AX;H2BC8;H2BC3;RPA3;TP53;PCNA;EYA4
IkBA variant leads to EDA-ID R-HSA-5603029	0.0368050286153122	8.51071573416495	2/7	0.74565302248121	NFKB1;RELA
Lagging Strand Synthesis R-HSA-69186	0.0368050286153122	8.51071573416495	2/7	0.74565302248121	RPA3;PCNA
Processive synthesis on the C-strand of the telomere R-HSA-174414	0.0368050286153122	8.51071573416495	2/7	0.74565302248121	RPA3;PCNA
Telomere Extension By Telomerase R-HSA-171319	0.0368050286153122	8.51071573416495	2/7	0.74565302248121	CCNA2;NOP10
Dual Incision in GG-NER R-HSA-5696400	0.038814356324466	4.57579053420684	3/17	0.774536102895735	UBA52;RPA3;PCNA
Termination of translesion DNA synthesis R-HSA-5656169	0.038814356324466	4.57579053420684	3/17	0.774536102895735	UBA52;RPA3;PCNA
Cyclin D associated events in G1 R-HSA-69231	0.0429445760339333	2.82481758280348	5/43	0.844258554030066	UBA52;SKP1;TFDP1;E2F1;E2F4
G1 Phase R-HSA-69236	0.0429445760339333	2.82481758280348	5/43	0.844258554030066	UBA52;SKP1;TFDP1;E2F1;E2F4
Loss of Function of TP53 in Cancer R-HSA-9723907	0.0452522255192876	Inf	1/1	0.851768840625456	TP53
Loss of function of TP53 in cancer due to loss of tetramerization ability R-HSA-9723905	0.0452522255192876	Inf	1/1	0.851768840625456	TP53
Methylation of MeSeH for excretion R-HSA-2408552	0.0452522255192876	Inf	1/1	0.851768840625456	INMT
NTRK3 as a dependence receptor R-HSA-9603505	0.0452522255192876	Inf	1/1	0.851768840625456	BAX
Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164	0.044135403207007	2.15996712888506	8/88	0.851768840625456	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Ubiquinol biosynthesis R-HSA-2142789	0.0452522255192876	Inf	1/1	0.851768840625456	COQ3
Interleukin-1 processing R-HSA-448706	0.0476355897921528	7.09139216316751	2/8	0.854221995326848	NFKB1;RELA
MyD88:MAL(TIRAP) cascade initiated on plasma membrane R-HSA-166058	0.0466941774834934	2.13277050434953	8/89	0.854221995326848	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801	0.0476355897921528	7.09139216316751	2/8	0.854221995326848	RPA3;PCNA
Protein methylation R-HSA-8876725	0.0476355897921528	7.09139216316751	2/8	0.854221995326848	RPS2;EEF1A1
Toll Like Receptor 2 (TLR2) Cascade R-HSA-181438	0.0466941774834934	2.13277050434953	8/89	0.854221995326848	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toll Like Receptor TLR1:TLR2 Cascade R-HSA-168179	0.0466941774834934	2.13277050434953	8/89	0.854221995326848	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toll Like Receptor TLR6:TLR2 Cascade R-HSA-168188	0.0466941774834934	2.13277050434953	8/89	0.854221995326848	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Iron uptake and transport R-HSA-917937	0.0491586213212674	3.17162663846939	4/31	0.861650756339581	UBA52;SKP1;ATP6V1F;ATP6V0E1
MyD88-independent TLR4 cascade  R-HSA-166166	0.049348498479132	2.10618403800946	8/90	0.861650756339581	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
TP53 Regulates Metabolic Genes R-HSA-5628897	0.0488286156701807	2.43474984432416	6/59	0.861650756339581	TP53;CYCS;COX5A;COX4I1;COX16;COX7A2L
TRIF (TICAM1)-mediated TLR4 signaling  R-HSA-937061	0.049348498479132	2.10618403800946	8/90	0.861650756339581	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
N-glycan trimming in the ER and Calnexin/Calreticulin cycle R-HSA-532668	0.0517927626099869	4.00278822181239	3/19	0.898418248149707	DERL2;UBA52;RNF5
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks R-HSA-5693565	0.0523016093890071	2.38906492868628	6/60	0.901353709859902	UBA52;H2AX;H2BC8;H2BC3;TP53;EYA4
Transcriptional Regulation by VENTX R-HSA-8853884	0.0542710442990252	3.05762964787587	4/32	0.92926033270718	CDC26;TP53;NFKB1;RELA
DNA Double Strand Break Response R-HSA-5693606	0.0559220056342352	2.34489448096322	6/61	0.951391044572181	UBA52;H2AX;H2BC8;H2BC3;TP53;EYA4
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal R-HSA-141444	0.0596606457770039	2.95149144207468	4/33	0.960111046358603	DYNLL1;RPS27;ZWINT;BUB1
Amplification of signal from the kinetochores R-HSA-141424	0.0596606457770039	2.95149144207468	4/33	0.960111046358603	DYNLL1;RPS27;ZWINT;BUB1
Apoptotic factor-mediated response R-HSA-111471	0.0594582751487208	6.07726705722446	2/9	0.960111046358603	CYCS;BAX
HSF1 activation R-HSA-3371511	0.0589705208070218	3.76598074574327	3/20	0.960111046358603	RPA3;HSF1;EEF1A1
Oxidative Stress Induced Senescence R-HSA-2559580	0.0595397286970518	1.92517938196527	9/110	0.960111046358603	UBA52;TFDP1;E2F1;H2AX;H2BC8;H2BC3;TP53;JUN;FOS
Processing of DNA double-strand break ends R-HSA-5693607	0.0596904003953163	2.30266400067476	6/62	0.960111046358603	UBA52;CCNA2;H2AX;H2BC8;H2BC3;RPA3
Regulated proteolysis of p75NTR R-HSA-193692	0.0594582751487208	6.07726705722446	2/9	0.960111046358603	NFKB1;RELA
Regulation of BACH1 activity R-HSA-9708530	0.0594582751487208	6.07726705722446	2/9	0.960111046358603	UBA52;SKP1
Resolution of AP sites via the multiple-nucleotide patch replacement pathway R-HSA-110373	0.0594582751487208	6.07726705722446	2/9	0.960111046358603	RPA3;PCNA
Cell Cycle Checkpoints R-HSA-69620	0.0620530582583788	1.69123295499274	13/180	0.992101304926128	UBA52;PSMC5;CDC26;CCNA2;DYNLL1;H2AX;H2BC8;H2BC3;RPA3;TP53;RPS27;ZWINT;BUB1
2-LTR circle formation R-HSA-164843	1	0	0/5	1	
5-Phosphoribose 1-diphosphate biosynthesis R-HSA-73843	1	0	0/0	1	
A tetrasaccharide linker sequence is required for GAG synthesis R-HSA-1971475	1	0	0/10	1	
ABC transporter disorders R-HSA-5619084	0.318228079983844	1.43984505169485	4/63	1	DERL2;UBA52;RNF5;PSMC5
ABC transporters in lipid homeostasis R-HSA-1369062	1	0	0/10	1	
ABC-family proteins mediated transport R-HSA-382556	0.26825921345093	1.47804197964337	5/77	1	DERL2;UBA52;RNF5;PSMC5;EIF2S2
ABO blood group biosynthesis R-HSA-9033807	1	0	0/2	1	
ADORA2B mediated anti-inflammatory cytokines production R-HSA-9660821	1	0	0/21	1	
ADP signalling through P2Y purinoceptor 1 R-HSA-418592	1	0	0/14	1	
ADP signalling through P2Y purinoceptor 12 R-HSA-392170	1	0	0/11	1	
AKT phosphorylates targets in the cytosol R-HSA-198323	1	0	0/12	1	
AKT phosphorylates targets in the nucleus R-HSA-198693	1	0	0/10	1	
AKT-mediated inactivation of FOXO1A R-HSA-211163	1	0	0/4	1	
ALK mutants bind TKIs R-HSA-9700645	1	0	0/3	1	
ALKBH2 mediated reversal of alkylation damage R-HSA-112122	1	0	0/0	1	
ALKBH3 mediated reversal of alkylation damage R-HSA-112126	1	0	0/0	1	
AMPK inhibits chREBP transcriptional activation activity R-HSA-163680	1	0	0/6	1	
APC truncation mutants are not K63 polyubiquitinated R-HSA-5467333	1	0	0/1	1	
APC truncation mutants have impaired AXIN binding R-HSA-5467337	1	0	0/10	1	
APC-Cdc20 mediated degradation of Nek2A R-HSA-179409	0.262447347130839	2.12165544098413	2/22	1	UBA52;CDC26
APC/C-mediated degradation of cell cycle proteins R-HSA-174143	0.294840926222009	1.41781952428007	5/80	1	UBA52;PSMC5;CDC26;SKP1;CCNA2
APC/C:Cdc20 mediated degradation of Cyclin B R-HSA-174048	0.27952948330592	2.02003720593716	2/23	1	UBA52;CDC26
APC/C:Cdc20 mediated degradation of Securin R-HSA-174154	0.580744230375476	1.00476095404346	3/66	1	UBA52;PSMC5;CDC26
APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176409	0.401759187481922	1.26532142135965	4/71	1	UBA52;PSMC5;CDC26;CCNA2
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 R-HSA-174178	0.630816115142367	0.929672288614347	3/71	1	UBA52;PSMC5;CDC26
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint R-HSA-179419	0.380919275721042	1.30492962087669	4/69	1	UBA52;PSMC5;CDC26;CCNA2
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway R-HSA-5649702	1	0	0/2	1	
APOBEC3G mediated resistance to HIV-1 infection R-HSA-180689	1	0	0/5	1	
ARL13B-mediated ciliary trafficking of INPP5E R-HSA-5624958	1	0	0/0	1	
ARMS-mediated activation R-HSA-170984	1	0	0/4	1	
ASP-3026-resistant ALK mutants R-HSA-9717264	1	0	0/0	1	
ATF4 activates genes in response to endoplasmic reticulum  stress R-HSA-380994	0.671967212159988	0.916883980868546	1/24	1	CXCL8
ATF6 (ATF6-alpha) activates chaperone genes R-HSA-381183	1	0	0/9	1	
ATF6 (ATF6-alpha) activates chaperones R-HSA-381033	1	0	0/11	1	
ATF6B (ATF6-beta) activates chaperones R-HSA-8874177	1	0	0/4	1	
ATP sensitive Potassium channels R-HSA-1296025	1	0	0/1	1	
AUF1 (hnRNP D0) binds and destabilizes mRNA R-HSA-450408	0.700220534921121	0.825511968611909	2/53	1	UBA52;PSMC5
AURKA Activation by TPX2 R-HSA-8854518	0.821158128973633	0.58384413554016	1/37	1	DYNLL1
AXIN missense mutants destabilize the destruction complex R-HSA-5467340	1	0	0/10	1	
Abacavir ADME R-HSA-2161522	1	0	0/3	1	
Abacavir metabolism R-HSA-2161541	1	0	0/1	1	
Abacavir transmembrane transport R-HSA-2161517	1	0	0/2	1	
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway R-HSA-73930	1	0	0/1	1	
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787	0.177991752687346	2.83195799693249	2/17	1	TFDP1;E2F1
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139	0.209377839062297	1.99380895946531	3/35	1	CDC26;TFDP1;E2F1
Aberrant regulation of mitotic exit in cancer due to RB1 defects R-HSA-9687136	0.585989544514493	1.17302584275925	1/19	1	CDC26
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate R-HSA-2978092	1	0	0/0	1	
Abortive elongation of HIV-1 transcript in the absence of Tat R-HSA-167242	0.211408656218083	2.49763475961611	2/19	1	POLR2F;SUPT4H1
Acetylation R-HSA-156582	1	0	0/2	1	
Acetylcholine Neurotransmitter Release Cycle R-HSA-264642	1	0	0/5	1	
Acetylcholine binding and downstream events R-HSA-181431	1	0	0/5	1	
Acetylcholine inhibits contraction of outer hair cells R-HSA-9667769	1	0	0/1	1	
Acetylcholine regulates insulin secretion R-HSA-399997	1	0	0/4	1	
Acrosome Reaction and Sperm:Oocyte Membrane Binding R-HSA-1300645	1	0	0/1	1	
Activated NOTCH1 Transmits Signal to the Nucleus R-HSA-2122948	0.501352035090244	1.50960242203817	1/15	1	UBA52
Activated NTRK2 signals through CDK5 R-HSA-9032845	1	0	0/5	1	
Activated NTRK2 signals through FRS2 and FRS3 R-HSA-9028731	1	0	0/7	1	
Activated NTRK2 signals through FYN R-HSA-9032500	1	0	0/4	1	
Activated NTRK2 signals through PI3K R-HSA-9028335	1	0	0/5	1	
Activated NTRK2 signals through PLCG1 R-HSA-9026527	1	0	0/2	1	
Activated NTRK2 signals through RAS R-HSA-9026519	1	0	0/6	1	
Activated NTRK3 signals through PI3K R-HSA-9603381	1	0	0/4	1	
Activated NTRK3 signals through PLCG1 R-HSA-9034793	1	0	0/1	1	
Activated NTRK3 signals through RAS R-HSA-9034864	1	0	0/5	1	
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 R-HSA-5625886	0.515370223918295	1.11224773379227	3/60	1	H2AX;H2BC8;H2BC3
Activated point mutants of FGFR2 R-HSA-2033519	1	0	0/4	1	
Activation and oligomerization of BAK protein R-HSA-111452	1	0	0/1	1	
Activation of AKT2 R-HSA-165158	1	0	0/3	1	
Activation of AMPA receptors R-HSA-399710	1	0	0/0	1	
Activation of AMPK downstream of NMDARs R-HSA-9619483	1	0	0/26	1	
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176814	0.412136798098303	1.24639083314126	4/72	1	UBA52;PSMC5;CDC26;CCNA2
Activation of ATR in response to replication stress R-HSA-176187	0.426772182116293	1.92268712388978	1/12	1	RPA3
Activation of BAD and translocation to mitochondria  R-HSA-111447	1	0	0/14	1	
Activation of BIM and translocation to mitochondria  R-HSA-111446	0.129736663484848	10.5841732097137	1/3	1	DYNLL1
Activation of BMF and translocation to mitochondria R-HSA-139910	1	0	0/1	1	
Activation of C3 and C5 R-HSA-174577	1	0	0/5	1	
Activation of Ca-permeable Kainate Receptor R-HSA-451308	1	0	0/4	1	
Activation of G protein gated Potassium channels R-HSA-1296041	1	0	0/11	1	
Activation of GABAB receptors R-HSA-991365	1	0	0/18	1	
Activation of HOX genes during differentiation R-HSA-5619507	0.258887798531979	1.43651225816609	6/95	1	POLR2F;H2AX;H2BC8;H2BC3;JUN;DPY30
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) R-HSA-936964	0.477631583419205	1.62611481395553	1/14	1	UBA52
Activation of Matrix Metalloproteinases R-HSA-1592389	1	0	0/12	1	
Activation of NF-kappaB in B cells R-HSA-1169091	0.0762477948480304	2.14687398920647	6/66	1	UBA52;PSMC5;SKP1;REL;NFKB1;RELA
Activation of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767	1	0	0/4	1	
Activation of NMDA receptors and postsynaptic events R-HSA-442755	1	0	0/59	1	
Activation of Na-permeable kainate receptors R-HSA-451307	1	0	0/0	1	
Activation of PPARGC1A (PGC-1alpha) by phosphorylation R-HSA-2151209	1	0	0/7	1	
Activation of RAC1 R-HSA-428540	1	0	0/10	1	
Activation of RAC1 downstream of NMDARs R-HSA-9619229	1	0	0/5	1	
Activation of RAS in B cells R-HSA-1169092	1	0	0/5	1	
Activation of SMO R-HSA-5635838	1	0	0/7	1	
Activation of TRKA receptors R-HSA-187015	1	0	0/3	1	
Activation of anterior HOX genes in hindbrain development during early embryogenesis R-HSA-5617472	0.258887798531979	1.43651225816609	6/95	1	POLR2F;H2AX;H2BC8;H2BC3;JUN;DPY30
Activation of caspases through apoptosome-mediated cleavage R-HSA-111459	0.0884673733624665	21.1535855938183	1/2	1	CYCS
Activation of gene expression by SREBF (SREBP) R-HSA-2426168	0.671967212159988	0.916883980868546	1/24	1	SP1
Activation of kainate receptors upon glutamate binding R-HSA-451326	1	0	0/12	1	
Activation of the TFAP2 (AP-2) family of transcription factors R-HSA-8866907	1	0	0/6	1	
Activation of the phototransduction cascade R-HSA-2485179	1	0	0/6	1	
Activation of the pre-replicative complex R-HSA-68962	0.477631583419205	1.62611481395553	1/14	1	RPA3
Activation, myristolyation of BID and translocation to mitochondria R-HSA-75108	1	0	0/3	1	
Activation, translocation and oligomerization of BAX R-HSA-114294	0.0884673733624665	21.1535855938183	1/2	1	BAX
Acyl chain remodeling of CL R-HSA-1482798	1	0	0/4	1	
Acyl chain remodeling of DAG and TAG R-HSA-1482883	1	0	0/3	1	
Acyl chain remodelling of PC R-HSA-1482788	1	0	0/10	1	
Acyl chain remodelling of PE R-HSA-1482839	1	0	0/9	1	
Acyl chain remodelling of PG R-HSA-1482925	1	0	0/6	1	
Acyl chain remodelling of PI R-HSA-1482922	1	0	0/7	1	
Acyl chain remodelling of PS R-HSA-1482801	1	0	0/6	1	
Adaptive Immune System R-HSA-1280218	0.952184838301525	0.641032977780174	12/393	1	UBA52;PSMC5;CDC26;SKP1;DYNLL1;REL;NFKB1;RELA;UBE2A;UBE2L3;UBE2F;VAMP8
Adenosine P1 receptors R-HSA-417973	1	0	0/2	1	
Adenylate cyclase activating pathway R-HSA-170660	1	0	0/5	1	
Adenylate cyclase inhibitory pathway R-HSA-170670	1	0	0/7	1	
Adherens junctions interactions R-HSA-418990	0.656326253281738	0.958800817046349	1/23	1	SP1
Adipogenesis R-HSA-9843745	0.821295811551947	0.635407089763104	2/68	1	NFKB1;RELA
Adrenaline signalling through Alpha-2 adrenergic receptor R-HSA-392023	1	0	0/2	1	
Adrenaline,noradrenaline inhibits insulin secretion R-HSA-400042	1	0	0/13	1	
Adrenoceptors R-HSA-390696	1	0	0/3	1	
Advanced glycosylation endproduct receptor signaling R-HSA-879415	1	0	0/11	1	
Aflatoxin activation and detoxification R-HSA-5423646	1	0	0/6	1	
Aggrephagy R-HSA-9646399	0.185873135499092	2.12777881148111	3/33	1	UBA52;DYNLL1;HSF1
Agmatine biosynthesis R-HSA-351143	1	0	0/0	1	
Alanine metabolism R-HSA-8964540	1	0	0/0	1	
Alpha-defensins R-HSA-1462054	1	0	0/3	1	
Alpha-oxidation of phytanate R-HSA-389599	1	0	0/3	1	
Alpha-protein kinase 1 signaling pathway R-HSA-9645460	0.341107769845094	2.6453817850105	1/9	1	UBA52
Alternative Lengthening of Telomeres (ALT) R-HSA-9006821	1	0	0/1	1	
Alternative complement activation R-HSA-173736	1	0	0/2	1	
Amine Oxidase reactions R-HSA-140179	1	0	0/1	1	
Amine ligand-binding receptors R-HSA-375280	1	0	0/3	1	
Amino Acid conjugation R-HSA-156587	1	0	0/4	1	
Amino acid transport across the plasma membrane R-HSA-352230	1	0	0/10	1	
Amino acids regulate mTORC1 R-HSA-9639288	0.546871130387055	1.11162888632792	2/40	1	ATP6V1F;ATP6V0E1
Amyloid fiber formation R-HSA-977225	0.541711649671137	1.04283462418044	4/85	1	UBA52;H2AX;H2BC8;H2BC3
Anchoring fibril formation R-HSA-2214320	1	0	0/13	1	
Anchoring of the basal body to the plasma membrane R-HSA-5620912	0.876998015498509	0.476711887904323	1/45	1	DYNLL1
Androgen biosynthesis R-HSA-193048	1	0	0/2	1	
Antagonism of Activin by Follistatin R-HSA-2473224	1	0	0/2	1	
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851	1	0	0/42	1	
Antigen Presentation: Folding, assembly and peptide loading of class I MHC R-HSA-983170	1	0	0/20	1	
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers R-HSA-983695	1	0	0/16	1	
Antigen processing-Cross presentation R-HSA-1236975	0.755444853755168	0.7586728237689	3/86	1	UBA52;PSMC5;VAMP8
Antigen processing: Ubiquitination & Proteasome degradation R-HSA-983168	0.537575368703137	1.01927733759846	7/152	1	UBA52;PSMC5;CDC26;SKP1;UBE2A;UBE2L3;UBE2F
Antimicrobial peptides R-HSA-6803157	1	0	0/16	1	
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410	0.878848544897769	0.590452780357597	3/109	1	UBA52;EIF2S2;TP53
Apoptosis R-HSA-109581	0.233869857970124	1.40088329573641	8/130	1	UBA52;PSMC5;DYNLL1;TFDP1;E2F1;TP53;CYCS;BAX
Apoptosis induced DNA fragmentation R-HSA-140342	1	0	0/10	1	
Apoptotic cleavage of cell adhesion  proteins R-HSA-351906	1	0	0/4	1	
Apoptotic cleavage of cellular proteins R-HSA-111465	1	0	0/20	1	
Apoptotic execution phase R-HSA-75153	1	0	0/31	1	
Aquaporin-mediated transport R-HSA-445717	1	0	0/21	1	
Arachidonate production from DAG R-HSA-426048	1	0	0/4	1	
Arachidonic acid metabolism R-HSA-2142753	1	0	0/21	1	
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 R-HSA-211957	1	0	0/0	1	
Aryl hydrocarbon receptor signalling R-HSA-8937144	1	0	0/6	1	
Asparagine N-linked glycosylation R-HSA-446203	0.898954816575277	0.593971911906185	4/144	1	DERL2;UBA52;RNF5;DYNLL1
Aspartate and asparagine metabolism R-HSA-8963693	1	0	0/4	1	
Aspirin ADME R-HSA-9749641	1	0	0/12	1	
Assembly Of The HIV Virion R-HSA-175474	0.341107769845094	2.6453817850105	1/9	1	UBA52
Assembly and cell surface presentation of NMDA receptors R-HSA-9609736	1	0	0/31	1	
Assembly and release of respiratory syncytial virus (RSV) virions R-HSA-9820962	1	0	0/2	1	
Assembly of Viral Components at the Budding Site R-HSA-168316	1	0	0/2	1	
Assembly of active LPL and LIPC lipase complexes R-HSA-8963889	1	0	0/9	1	
Assembly of collagen fibrils and other multimeric structures R-HSA-2022090	1	0	0/38	1	
Assembly of the ORC complex at the origin of replication R-HSA-68616	0.492415282671302	1.15328898052379	3/58	1	H2AX;H2BC8;H2BC3
Assembly of the pre-replicative complex R-HSA-68867	0.517684458289803	1.04777086018474	6/127	1	UBA52;PSMC5;CDC26;H2AX;H2BC8;H2BC3
Association of TriC/CCT with target proteins during biosynthesis R-HSA-390471	0.63994378502192	1.00470864523097	1/22	1	TP53
Astrocytic Glutamate-Glutamine Uptake And Metabolism R-HSA-210455	1	0	0/2	1	
Asymmetric localization of PCP proteins R-HSA-4608870	0.74665634099698	0.750830125560174	2/58	1	UBA52;PSMC5
Atorvastatin ADME R-HSA-9754706	1	0	0/3	1	
Attachment and Entry R-HSA-9678110	1	0	0/1	1	
Attachment and Entry R-HSA-9694614	1	0	0/7	1	
Attachment of GPI anchor to uPAR R-HSA-162791	1	0	0/2	1	
Attenuation phase R-HSA-3371568	0.585989544514493	1.17302584275925	1/19	1	HSF1
Autodegradation of Cdh1 by Cdh1:APC/C R-HSA-174084	0.548743152711061	1.05584339321167	3/63	1	UBA52;PSMC5;CDC26
Autodegradation of the E3 ubiquitin ligase COP1 R-HSA-349425	0.40836414679745	1.3238525111593	3/51	1	UBA52;PSMC5;TP53
Autointegration results in viral DNA circles R-HSA-177539	1	0	0/3	1	
Autophagy R-HSA-9612973	0.605259975903222	0.958110139156748	4/92	1	UBA52;DYNLL1;HSF1;EEF1A1
Axonal growth inhibition (RHOA activation) R-HSA-193634	1	0	0/2	1	
Axonal growth stimulation R-HSA-209563	1	0	0/2	1	
Azathioprine ADME R-HSA-9748787	0.399525249474029	2.11529879670146	1/11	1	GUK1
B-WICH complex positively regulates rRNA expression R-HSA-5250924	0.250854557781074	1.52105443539661	5/75	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
BBSome-mediated cargo-targeting to cilium R-HSA-5620922	1	0	0/11	1	
BDNF activates NTRK2 (TRKB) signaling R-HSA-9024909	1	0	0/1	1	
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members R-HSA-111453	1	0	0/8	1	
BMAL1:CLOCK,NPAS2 activates circadian gene expression R-HSA-1368108	1	0	0/20	1	
Bacterial Infection Pathways R-HSA-9824439	0.851668895633996	0.52491646278713	1/41	1	UBA52
Base Excision Repair R-HSA-73884	0.0896355866691805	2.2307860775924	5/53	1	H2AX;H2BC8;H2BC3;RPA3;PCNA
Base-Excision Repair, AP Site Formation R-HSA-73929	0.308126600339051	1.59184051160436	3/43	1	H2AX;H2BC8;H2BC3
Basigin interactions R-HSA-210991	1	0	0/11	1	
Beta defensins R-HSA-1461957	1	0	0/6	1	
Beta oxidation of butanoyl-CoA to acetyl-CoA R-HSA-77352	1	0	0/5	1	
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA R-HSA-77346	1	0	0/2	1	
Beta oxidation of hexanoyl-CoA to butanoyl-CoA R-HSA-77350	1	0	0/3	1	
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA R-HSA-77310	1	0	0/3	1	
Beta oxidation of myristoyl-CoA to lauroyl-CoA R-HSA-77285	1	0	0/1	1	
Beta oxidation of octanoyl-CoA to hexanoyl-CoA R-HSA-77348	1	0	0/2	1	
Beta oxidation of palmitoyl-CoA to myristoyl-CoA R-HSA-77305	1	0	0/0	1	
Beta-catenin independent WNT signaling R-HSA-3858494	0.862391733248523	0.614259744283096	3/105	1	UBA52;PSMC5;MYC
Beta-catenin phosphorylation cascade R-HSA-196299	1	0	0/11	1	
Beta-oxidation of pristanoyl-CoA R-HSA-389887	1	0	0/3	1	
Beta-oxidation of very long chain fatty acids R-HSA-390247	1	0	0/4	1	
Bicarbonate transporters R-HSA-425381	1	0	0/3	1	
Bile acid and bile salt metabolism R-HSA-194068	1	0	0/13	1	
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782	1	0	0/20	1	
Binding and entry of HIV virion R-HSA-173107	1	0	0/4	1	
Binding of TCF/LEF:CTNNB1 to target gene promoters R-HSA-4411364	0.309813381545497	3.02371343760045	1/8	1	MYC
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB R-HSA-141333	1	0	0/1	1	
Biological oxidations R-HSA-211859	1	0	0/74	1	
Biosynthesis of A2E, implicated in retinal degradation R-HSA-2466712	1	0	0/0	1	
Biosynthesis of D-series resolvins R-HSA-9018676	1	0	0/2	1	
Biosynthesis of DHA-derived SPMs R-HSA-9018677	1	0	0/5	1	
Biosynthesis of DHA-derived sulfido conjugates R-HSA-9026395	1	0	0/0	1	
Biosynthesis of DPA-derived SPMs R-HSA-9018683	1	0	0/3	1	
Biosynthesis of DPAn-3 SPMs R-HSA-9025094	1	0	0/3	1	
Biosynthesis of DPAn-3-derived 13-series resolvins R-HSA-9026403	1	0	0/1	1	
Biosynthesis of DPAn-3-derived maresins R-HSA-9026290	1	0	0/1	1	
Biosynthesis of DPAn-3-derived protectins and resolvins R-HSA-9026286	1	0	0/2	1	
Biosynthesis of DPAn-6 SPMs R-HSA-9025106	1	0	0/1	1	
Biosynthesis of E-series 18(R)-resolvins R-HSA-9023661	1	0	0/3	1	
Biosynthesis of E-series 18(S)-resolvins R-HSA-9018896	1	0	0/3	1	
Biosynthesis of EPA-derived SPMs R-HSA-9018679	1	0	0/4	1	
Biosynthesis of aspirin-triggered D-series resolvins R-HSA-9020265	1	0	0/2	1	
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives R-HSA-9027604	1	0	0/2	1	
Biosynthesis of maresin conjugates in tissue regeneration (MCTR) R-HSA-9026762	1	0	0/0	1	
Biosynthesis of maresin-like SPMs R-HSA-9027307	1	0	0/0	1	
Biosynthesis of maresins R-HSA-9018682	1	0	0/2	1	
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) R-HSA-9026766	1	0	0/0	1	
Biosynthesis of protectins R-HSA-9018681	1	0	0/1	1	
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678	1	0	0/6	1	
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein R-HSA-446193	1	0	0/21	1	
Biotin transport and metabolism R-HSA-196780	1	0	0/6	1	
Blockage of phagosome acidification R-HSA-9636467	1	0	0/0	1	
Blood group systems biosynthesis R-HSA-9033658	1	0	0/4	1	
Branched-chain amino acid catabolism R-HSA-70895	1	0	0/10	1	
Breakdown of the nuclear lamina R-HSA-352238	1	0	0/1	1	
Budding and maturation of HIV virion R-HSA-162588	0.524000974672891	1.40863417894967	1/16	1	UBA52
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA R-HSA-450385	1	0	0/15	1	
Butyrophilin (BTN) family interactions R-HSA-8851680	1	0	0/4	1	
C-type lectin receptors (CLRs) R-HSA-5621481	0.625214707316925	0.931703980740188	5/118	1	UBA52;PSMC5;SKP1;NFKB1;RELA
C6 deamination of adenosine R-HSA-75102	1	0	0/0	1	
CASP8 activity is inhibited R-HSA-5218900	1	0	0/10	1	
CD163 mediating an anti-inflammatory response R-HSA-9662834	1	0	0/6	1	
CD209 (DC-SIGN) signaling R-HSA-5621575	0.24537329698268	2.23374304689324	2/21	1	NFKB1;RELA
CD22 mediated BCR regulation R-HSA-5690714	1	0	0/4	1	
CD28 co-stimulation R-HSA-389356	1	0	0/26	1	
CD28 dependent PI3K/Akt signaling R-HSA-389357	1	0	0/17	1	
CD28 dependent Vav1 pathway R-HSA-389359	1	0	0/9	1	
CDC42 GTPase cycle R-HSA-9013148	1	0	0/70	1	
CDC6 association with the ORC:origin complex R-HSA-68689	1	0	0/3	1	
CDH11 homotypic and heterotypic interactions R-HSA-9833576	1	0	0/5	1	
CDK-mediated phosphorylation and removal of Cdc6 R-HSA-69017	0.412136798098303	1.24639083314126	4/72	1	UBA52;PSMC5;CDC26;CCNA2
CHL1 interactions R-HSA-447041	1	0	0/5	1	
CLEC7A (Dectin-1) induces NFAT activation R-HSA-5607763	1	0	0/9	1	
CLEC7A (Dectin-1) signaling R-HSA-5607764	0.39485740116261	1.2329439150261	5/91	1	UBA52;PSMC5;SKP1;NFKB1;RELA
COPI-dependent Golgi-to-ER retrograde traffic R-HSA-6811434	1	0	0/55	1	
COPI-independent Golgi-to-ER retrograde traffic R-HSA-6811436	0.812601772791195	0.600680353804841	1/36	1	DYNLL1
COPI-mediated anterograde transport R-HSA-6807878	0.960167644618536	0.306535194429365	1/69	1	DYNLL1
COPII-mediated vesicle transport R-HSA-204005	1	0	0/32	1	
COX reactions R-HSA-140180	1	0	0/1	1	
CREB phosphorylation R-HSA-199920	1	0	0/7	1	
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling R-HSA-442742	1	0	0/21	1	
CREB1 phosphorylation through the activation of Adenylate Cyclase R-HSA-442720	1	0	0/7	1	
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde R-HSA-442729	1	0	0/6	1	
CREB3 factors activate genes R-HSA-8874211	1	0	0/4	1	
CRMPs in Sema3A signaling R-HSA-399956	1	0	0/8	1	
CS/DS degradation R-HSA-2024101	1	0	0/6	1	
CTLA4 inhibitory signaling R-HSA-389513	1	0	0/15	1	
CTNNB1 S33 mutants aren't phosphorylated R-HSA-5358747	1	0	0/11	1	
CTNNB1 S37 mutants aren't phosphorylated R-HSA-5358749	1	0	0/11	1	
CTNNB1 S45 mutants aren't phosphorylated R-HSA-5358751	1	0	0/11	1	
CTNNB1 T41 mutants aren't phosphorylated R-HSA-5358752	1	0	0/11	1	
CYP2E1 reactions R-HSA-211999	1	0	0/3	1	
Ca-dependent events R-HSA-111996	1	0	0/23	1	
Ca2+ activated K+ channels R-HSA-1296052	1	0	0/2	1	
Ca2+ pathway R-HSA-4086398	0.784412680894045	0.657501709845148	1/33	1	MYC
CaM pathway R-HSA-111997	1	0	0/21	1	
CaMK IV-mediated phosphorylation of CREB R-HSA-111932	1	0	0/8	1	
Calcineurin activates NFAT R-HSA-2025928	1	0	0/9	1	
Calcitonin-like ligand receptors R-HSA-419812	1	0	0/5	1	
Calmodulin induced events R-HSA-111933	1	0	0/21	1	
Cam-PDE 1 activation R-HSA-111957	1	0	0/2	1	
Carboxyterminal post-translational modifications of tubulin R-HSA-8955332	1	0	0/23	1	
Cardiac conduction R-HSA-5576891	1	0	0/51	1	
Cardiogenesis R-HSA-9733709	1	0	0/18	1	
Cargo concentration in the ER R-HSA-5694530	1	0	0/17	1	
Cargo recognition for clathrin-mediated endocytosis R-HSA-8856825	0.755171998666624	0.737465689905408	2/59	1	UBA52;VAMP8
Cargo trafficking to the periciliary membrane R-HSA-5620920	1	0	0/21	1	
Carnitine metabolism R-HSA-200425	1	0	0/8	1	
Carnitine synthesis R-HSA-71262	1	0	0/1	1	
Caspase activation via Death Receptors in the presence of ligand R-HSA-140534	1	0	0/13	1	
Caspase activation via Dependence Receptors in the absence of ligand R-HSA-418889	1	0	0/3	1	
Caspase activation via extrinsic apoptotic signalling pathway R-HSA-5357769	1	0	0/16	1	
Caspase-mediated cleavage of cytoskeletal proteins R-HSA-264870	1	0	0/7	1	
Catecholamine biosynthesis R-HSA-209905	1	0	0/1	1	
Cation-coupled Chloride cotransporters R-HSA-426117	1	0	0/4	1	
Cdc20:Phospho-APC/C mediated degradation of Cyclin A R-HSA-174184	0.380919275721042	1.30492962087669	4/69	1	UBA52;PSMC5;CDC26;CCNA2
Cell Cycle R-HSA-1640170	0.192154220275625	1.25901616280929	22/400	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;DYNLL1;TFDP1;E2F1;POLR2F;H2AX;H2BC8;H2BC3;RPA3;TP53;RPS27;ZWINT;BUB1;PCNA;MYC;NOP10;TOP2A;E2F4
Cell Cycle, Mitotic R-HSA-69278	0.135083641149728	1.35301564954501	20/341	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;DYNLL1;TFDP1;E2F1;H2AX;H2BC8;H2BC3;RPA3;TP53;RPS27;ZWINT;BUB1;PCNA;MYC;TOP2A;E2F4
Cell death signalling via NRAGE, NRIF and NADE R-HSA-204998	0.851668895633996	0.52491646278713	1/41	1	UBA52
Cell junction organization R-HSA-446728	0.882626763476446	0.465997493441312	1/46	1	SP1
Cell recruitment (pro-inflammatory response) R-HSA-9664424	0.296584199081995	1.92778058369726	2/24	1	NFKB1;RELA
Cell surface interactions at the vascular wall R-HSA-202733	1	0	0/66	1	
Cell-Cell communication R-HSA-1500931	0.962001436073833	0.302013389101634	1/70	1	SP1
Cell-cell junction organization R-HSA-421270	0.740166932123927	0.752200778598454	1/29	1	SP1
Cell-extracellular matrix interactions R-HSA-446353	1	0	0/13	1	
Cellular hexose transport R-HSA-189200	1	0	0/5	1	
Cellular response to chemical stress R-HSA-9711123	0.0789003865042479	1.65534216328118	12/169	1	UBA52;PSMC5;SKP1;NFKB1;RELA;CYCS;SP1;COX5A;COX4I1;COX16;COX7A2L;MYC
Cellular response to heat stress R-HSA-3371556	0.457031266610523	1.22076592574228	3/55	1	RPA3;HSF1;EEF1A1
Cellular response to hypoxia R-HSA-1234174	0.808145956733675	0.655606580232416	2/66	1	UBA52;PSMC5
Cellular response to mitochondrial stress R-HSA-9840373	0.27704115757633	3.52822750116427	1/7	1	EIF2S2
Centrosome maturation R-HSA-380287	0.851668895633996	0.52491646278713	1/41	1	DYNLL1
Ceramide signalling R-HSA-193681	1	0	0/2	1	
ChREBP activates metabolic gene expression R-HSA-163765	1	0	0/3	1	
Chaperone Mediated Autophagy R-HSA-9613829	0.145545260024666	3.26902954467283	2/15	1	UBA52;EEF1A1
Chaperonin-mediated protein folding R-HSA-390466	0.287167693795017	1.51814634498572	4/60	1	TP53;PFDN1;PFDN5;VBP1
Chemokine receptors bind chemokines R-HSA-380108	0.763315860802052	0.701695123324785	1/31	1	CXCL8
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex R-HSA-75035	1	0	0/11	1	
Cholesterol biosynthesis R-HSA-191273	1	0	0/6	1	
Cholesterol biosynthesis via desmosterol R-HSA-6807047	1	0	0/0	1	
Cholesterol biosynthesis via lathosterol R-HSA-6807062	1	0	0/0	1	
Choline catabolism R-HSA-6798163	1	0	0/2	1	
Chondroitin sulfate biosynthesis R-HSA-2022870	1	0	0/10	1	
Chondroitin sulfate/dermatan sulfate metabolism R-HSA-1793185	1	0	0/21	1	
Chromatin modifications during the maternal to zygotic transition (MZT) R-HSA-9821002	0.515370223918295	1.11224773379227	3/60	1	H2AX;H2BC8;H2BC3
Chromatin modifying enzymes R-HSA-3247509	0.296340578159824	1.25493651547344	10/180	1	H2AX;H2BC8;H2BC3;DPY30;NFKB1;RELA;ATF2;RPS2;BRMS1;TAF10
Chromatin organization R-HSA-4839726	0.296340578159824	1.25493651547344	10/180	1	H2AX;H2BC8;H2BC3;DPY30;NFKB1;RELA;ATF2;RPS2;BRMS1;TAF10
Chylomicron assembly R-HSA-8963888	1	0	0/5	1	
Chylomicron clearance R-HSA-8964026	1	0	0/1	1	
Chylomicron remodeling R-HSA-8963901	1	0	0/6	1	
Cilium Assembly R-HSA-5617833	0.937062270041483	0.44287519941792	2/96	1	DYNLL1;IFT43
Ciprofloxacin ADME R-HSA-9793528	1	0	0/2	1	
Circadian Clock R-HSA-400253	0.420666715016203	1.29650338349409	3/52	1	UBA52;SKP1;ATF2
Citric acid cycle (TCA cycle) R-HSA-71403	1	0	0/12	1	
Class A/1 (Rhodopsin-like receptors) R-HSA-373076	0.976297802097955	0.263091082999315	1/80	1	CXCL8
Class B/2 (Secretin family receptors) R-HSA-373080	1	0	0/38	1	
Class C/3 (Metabotropic glutamate/pheromone receptors) R-HSA-420499	1	0	0/1	1	
Class I MHC mediated antigen processing & presentation R-HSA-983169	0.682567296455288	0.883267558970158	8/198	1	UBA52;PSMC5;CDC26;SKP1;UBE2A;UBE2L3;UBE2F;VAMP8
Class I peroxisomal membrane protein import R-HSA-9603798	1	0	0/8	1	
Classical Kir channels R-HSA-1296053	1	0	0/1	1	
Classical antibody-mediated complement activation R-HSA-173623	1	0	0/3	1	
Clathrin-mediated endocytosis R-HSA-8856828	0.725943426153848	0.797924997226097	3/82	1	UBA52;VAMP8;ARPC1A
Cleavage of the damaged purine R-HSA-110331	0.283006250373054	1.6764752847409	3/41	1	H2AX;H2BC8;H2BC3
Cleavage of the damaged pyrimidine  R-HSA-110329	0.308126600339051	1.59184051160436	3/43	1	H2AX;H2BC8;H2BC3
Cobalamin (Cbl) metabolism R-HSA-9759218	1	0	0/4	1	
Cobalamin (Cbl, vitamin B12) transport and metabolism R-HSA-196741	1	0	0/7	1	
Coenzyme A biosynthesis R-HSA-196783	1	0	0/1	1	
Cohesin Loading onto Chromatin R-HSA-2470946	1	0	0/10	1	
Collagen biosynthesis and modifying enzymes R-HSA-1650814	1	0	0/31	1	
Collagen chain trimerization R-HSA-8948216	1	0	0/22	1	
Collagen degradation R-HSA-1442490	1	0	0/34	1	
Collagen formation R-HSA-1474290	1	0	0/45	1	
Common Pathway of Fibrin Clot Formation R-HSA-140875	1	0	0/11	1	
Competing endogenous RNAs (ceRNAs) regulate PTEN translation R-HSA-8948700	1	0	0/1	1	
Complement cascade R-HSA-166658	1	0	0/25	1	
Condensation of Prometaphase Chromosomes R-HSA-2514853	1	0	0/6	1	
Condensation of Prophase Chromosomes R-HSA-2299718	0.548743152711061	1.05584339321167	3/63	1	H2AX;H2BC8;H2BC3
Conjugation of benzoate with glycine R-HSA-177135	1	0	0/2	1	
Conjugation of carboxylic acids R-HSA-159424	1	0	0/4	1	
Conjugation of phenylacetate with glutamine R-HSA-177162	1	0	0/1	1	
Conjugation of salicylate with glycine R-HSA-177128	1	0	0/4	1	
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400	1	0	0/25	1	
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530	1	0	0/43	1	
Constitutive Signaling by EGFRvIII R-HSA-5637810	1	0	0/13	1	
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382	0.545626551046988	1.32029355805218	1/17	1	UBA52
Constitutive Signaling by NOTCH1 HD Domain Mutants R-HSA-2691232	0.341107769845094	2.6453817850105	1/9	1	UBA52
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants R-HSA-2894862	0.395986040988239	1.35235537341895	3/50	1	UBA52;SKP1;MYC
Constitutive Signaling by NOTCH1 PEST Domain Mutants R-HSA-2644606	0.395986040988239	1.35235537341895	3/50	1	UBA52;SKP1;MYC
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660826	1	0	0/4	1	
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285	1	0	0/7	1	
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase R-HSA-176407	0.566274760919946	1.24232925880823	1/18	1	CDC26
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding R-HSA-6814122	1	0	0/23	1	
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding R-HSA-389958	0.185873135499092	2.12777881148111	3/33	1	PFDN1;PFDN5;VBP1
Costimulation by the CD28 family R-HSA-388841	1	0	0/51	1	
Creatine metabolism R-HSA-71288	1	0	0/1	1	
Creation of C4 and C2 activators R-HSA-166786	1	0	0/7	1	
Cristae formation R-HSA-8949613	0.313579151415377	1.84339522129094	2/25	1	ATP5MF;ATP5F1D
Cross-presentation of particulate exogenous antigens (phagosomes) R-HSA-1236973	1	0	0/5	1	
Cross-presentation of soluble exogenous antigens (endosomes) R-HSA-1236978	0.876998015498509	0.476711887904323	1/45	1	PSMC5
Crosslinking of collagen fibrils R-HSA-2243919	1	0	0/14	1	
Cyclin A/B1/B2 associated events during G2/M transition R-HSA-69273	0.501352035090244	1.50960242203817	1/15	1	CCNA2
Cysteine formation from homocysteine R-HSA-1614603	1	0	0/1	1	
Cytochrome P450 - arranged by substrate type R-HSA-211897	1	0	0/16	1	
Cytochrome c-mediated apoptotic response R-HSA-111461	0.206782414170199	5.2933772792375	1/5	1	CYCS
Cytokine Signaling in Immune system R-HSA-1280215	0.997837530205721	0.483852770836403	13/540	1	UBA52;PSMC5;EIF2S2;SKP1;CXCL8;TP53;JUN;NFKB1;RELA;FOS;ATF2;RPLP0;MYC
Cytoprotection by HMOX1 R-HSA-9707564	0.0736107877385553	2.38126209931747	5/50	1	CYCS;COX5A;COX4I1;COX16;COX7A2L
Cytosolic iron-sulfur cluster assembly R-HSA-2564830	1	0	0/2	1	
Cytosolic sensors of pathogen-associated DNA  R-HSA-1834949	0.127848105694057	2.18925495846266	4/43	1	UBA52;POLR2F;NFKB1;RELA
Cytosolic sulfonation of small molecules R-HSA-156584	1	0	0/11	1	
Cytosolic tRNA aminoacylation R-HSA-379716	1	0	0/7	1	
DAG and IP3 signaling R-HSA-1489509	1	0	0/25	1	
DAP12 interactions R-HSA-2172127	1	0	0/23	1	
DAP12 signaling R-HSA-2424491	1	0	0/21	1	
DARPP-32 events R-HSA-180024	1	0	0/14	1	
DCC mediated attractive signaling R-HSA-418885	1	0	0/9	1	
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928	0.601273556404463	0.973339638566097	3/68	1	UBA52;NFKB1;RELA
DNA Damage Bypass R-HSA-73893	0.101142247248105	2.90706588742707	3/25	1	UBA52;RPA3;PCNA
DNA Damage Recognition in GG-NER R-HSA-5696394	0.566274760919946	1.24232925880823	1/18	1	UBA52
DNA Damage Reversal R-HSA-73942	1	0	0/0	1	
DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586	0.184785702193428	1.72088612765521	5/67	1	CCNA2;H2AX;H2BC8;H2BC3;TP53
DNA Repair R-HSA-73894	0.284537613089158	1.27055961352302	10/178	1	UBA52;CCNA2;POLR2F;H2AX;H2BC8;H2BC3;RPA3;TP53;PCNA;EYA4
DNA Replication Pre-Initiation R-HSA-69002	0.404192891397191	1.16933144740595	7/134	1	UBA52;PSMC5;CDC26;H2AX;H2BC8;H2BC3;RPA3
DNA Replication R-HSA-69306	0.139673592809613	1.5361201964496	10/150	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;H2AX;H2BC8;H2BC3;RPA3;PCNA
DNA methylation R-HSA-5334118	0.480741394947793	1.17494843860527	3/57	1	H2AX;H2BC8;H2BC3
DNA replication initiation R-HSA-68952	1	0	0/3	1	
DNA strand elongation R-HSA-69190	0.114567745590346	3.86533873346815	2/13	1	RPA3;PCNA
DSCAM interactions R-HSA-376172	1	0	0/1	1	
Dasatinib-resistant KIT mutants R-HSA-9669914	1	0	0/1	1	
Deactivation of the beta-catenin transactivating complex R-HSA-3769402	0.740166932123927	0.752200778598454	1/29	1	UBA52
Deadenylation of mRNA R-HSA-429947	1	0	0/18	1	
Deadenylation-dependent mRNA decay R-HSA-429914	0.258086867617439	1.77050646128748	3/39	1	LSM3;LSM4;LSM5
Death Receptor Signaling R-HSA-73887	0.605259975903222	0.958110139156748	4/92	1	UBA52;NFKB1;RELA;UBE2L3
Dectin-1 mediated noncanonical NF-kB signaling R-HSA-5607761	0.276912074175811	1.54614455621294	4/59	1	UBA52;PSMC5;SKP1;RELA
Dectin-2 family R-HSA-5621480	1	0	0/12	1	
Defective ABCA1 causes TGD R-HSA-5682113	1	0	0/2	1	
Defective ABCA12 causes ARCI4B R-HSA-5682294	1	0	0/1	1	
Defective ABCA3 causes SMDP3 R-HSA-5683678	1	0	0/0	1	
Defective ABCA3 causes SMDP3 R-HSA-5688399	1	0	0/0	1	
Defective ABCB11 causes PFIC2 and BRIC2 R-HSA-5678520	1	0	0/1	1	
Defective ABCB4 causes PFIC3, ICP3 and GBD1 R-HSA-5678771	1	0	0/0	1	
Defective ABCB6 causes MCOPCB7 R-HSA-5683371	1	0	0/0	1	
Defective ABCC2 causes DJS R-HSA-5679001	1	0	0/0	1	
Defective ABCC6 causes PXE R-HSA-5690338	1	0	0/0	1	
Defective ABCC8 can cause hypo- and hyper-glycemias R-HSA-5683177	1	0	0/0	1	
Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome R-HSA-5678420	1	0	0/1	1	
Defective ABCD1 causes ALD R-HSA-5684045	1	0	0/0	1	
Defective ABCD4 causes MAHCJ R-HSA-5683329	1	0	0/2	1	
Defective ABCG5 causes sitosterolemia R-HSA-5679096	1	0	0/0	1	
Defective ABCG8 causes GBD4 and sitosterolemia R-HSA-5679090	1	0	0/0	1	
Defective ACTH causes obesity and POMCD R-HSA-5579031	1	0	0/1	1	
Defective ACY1 causes encephalopathy R-HSA-5579007	1	0	0/0	1	
Defective ADA disrupts (deoxy)adenosine deamination R-HSA-9734735	1	0	0/0	1	
Defective AHCY causes HMAHCHD R-HSA-5578997	1	0	0/1	1	
Defective ALG1 causes CDG-1k R-HSA-4549380	1	0	0/0	1	
Defective ALG11 causes CDG-1p R-HSA-4551295	1	0	0/0	1	
Defective ALG12 causes CDG-1g R-HSA-4720489	1	0	0/0	1	
Defective ALG14 causes ALG14-CMS R-HSA-5633231	1	0	0/0	1	
Defective ALG2 causes CDG-1i R-HSA-4549349	1	0	0/0	1	
Defective ALG3 causes CDG-1d R-HSA-4720475	1	0	0/1	1	
Defective ALG6 causes CDG-1c R-HSA-4724289	1	0	0/0	1	
Defective ALG8 causes CDG-1h R-HSA-4724325	1	0	0/0	1	
Defective ALG9 causes CDG-1l R-HSA-4720454	1	0	0/0	1	
Defective AMN causes MGA1 R-HSA-3359462	1	0	0/0	1	
Defective APRT disrupts adenine salvage R-HSA-9734195	1	0	0/1	1	
Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-5619099	1	0	0/0	1	
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-9036092	1	0	0/1	1	
Defective B3GALT6 causes EDSP2 and SEMDJL1 R-HSA-4420332	1	0	0/7	1	
Defective B3GALTL causes PpS R-HSA-5083635	1	0	0/14	1	
Defective B3GAT3 causes JDSSDHD R-HSA-3560801	1	0	0/8	1	
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) R-HSA-3656244	1	0	0/4	1	
Defective B4GALT1 causes CDG-2d R-HSA-4793953	1	0	0/0	1	
Defective B4GALT7 causes EDS, progeroid type R-HSA-3560783	1	0	0/7	1	
Defective BTD causes biotidinase deficiency R-HSA-3371598	1	0	0/1	1	
Defective Base Excision Repair Associated with MUTYH R-HSA-9605310	1	0	0/0	1	
Defective Base Excision Repair Associated with NEIL1 R-HSA-9616334	1	0	0/1	1	
Defective Base Excision Repair Associated with NEIL3 R-HSA-9629232	1	0	0/0	1	
Defective Base Excision Repair Associated with NTHL1 R-HSA-9616333	1	0	0/0	1	
Defective Base Excision Repair Associated with OGG1 R-HSA-9656249	1	0	0/0	1	
Defective C1GALT1C1 causes TNPS R-HSA-5083632	1	0	0/10	1	
Defective CBLIF causes IFD R-HSA-3359457	1	0	0/0	1	
Defective CD320 causes MMATC R-HSA-3359485	1	0	0/0	1	
Defective CFTR causes cystic fibrosis R-HSA-5678895	0.246563660017392	1.63661119382666	4/56	1	DERL2;UBA52;RNF5;PSMC5
Defective CHST14 causes EDS, musculocontractural type R-HSA-3595174	1	0	0/3	1	
Defective CHST3 causes SEDCJD R-HSA-3595172	1	0	0/4	1	
Defective CHST6 causes MCDC1 R-HSA-3656225	1	0	0/4	1	
Defective CHSY1 causes TPBS R-HSA-3595177	1	0	0/3	1	
Defective CP causes aceruloplasminemia (ACERULOP) R-HSA-5619060	1	0	0/1	1	
Defective CSF2RA causes SMDP4 R-HSA-5688890	1	0	0/2	1	
Defective CSF2RB causes SMDP5 R-HSA-5688849	1	0	0/2	1	
Defective CUBN causes MGA1 R-HSA-3359463	1	0	0/0	1	
Defective CYP11A1 causes AICSR R-HSA-5579026	1	0	0/0	1	
Defective CYP11B1 causes AH4 R-HSA-5579017	1	0	0/0	1	
Defective CYP11B2 causes CMO-1 deficiency R-HSA-5579009	1	0	0/0	1	
Defective CYP17A1 causes AH5 R-HSA-5579028	1	0	0/0	1	
Defective CYP19A1 causes AEXS R-HSA-5579030	1	0	0/0	1	
Defective CYP1B1 causes Glaucoma R-HSA-5579000	1	0	0/0	1	
Defective CYP21A2 causes AH3 R-HSA-5579021	1	0	0/0	1	
Defective CYP24A1 causes HCAI R-HSA-5579010	1	0	0/0	1	
Defective CYP26B1 causes RHFCA R-HSA-5579015	1	0	0/0	1	
Defective CYP26C1 causes FFDD4 R-HSA-5579004	1	0	0/0	1	
Defective CYP27A1 causes CTX R-HSA-5578996	1	0	0/1	1	
Defective CYP27B1 causes VDDR1A R-HSA-5579014	1	0	0/0	1	
Defective CYP27B1 causes VDDR1B R-HSA-5579027	1	0	0/0	1	
Defective CYP2U1 causes SPG56 R-HSA-5579011	1	0	0/1	1	
Defective CYP4F22 causes ARCI5 R-HSA-5579005	1	0	0/0	1	
Defective CYP7B1 causes SPG5A and CBAS3 R-HSA-5579013	1	0	0/0	1	
Defective DHDDS causes RP59 R-HSA-4755609	1	0	0/0	1	
Defective DNA double strand break response due to BARD1 loss of function R-HSA-9699150	1	0	0/1	1	
Defective DNA double strand break response due to BRCA1 loss of function R-HSA-9663199	1	0	0/1	1	
Defective DOLK causes DOLK-CDG R-HSA-4755583	1	0	0/0	1	
Defective DPAGT1 causes CDG-1j, CMSTA2 R-HSA-4549356	1	0	0/1	1	
Defective DPM1 causes DPM1-CDG R-HSA-4717374	1	0	0/2	1	
Defective DPM2 causes DPM2-CDG R-HSA-4719377	1	0	0/2	1	
Defective DPM3 causes DPM3-CDG R-HSA-4719360	1	0	0/2	1	
Defective EXT1 causes exostoses 1, TRPS2 and CHDS R-HSA-3656253	1	0	0/4	1	
Defective EXT2 causes exostoses 2 R-HSA-3656237	1	0	0/4	1	
Defective F8 accelerates dissociation of the A2 domain R-HSA-9672387	1	0	0/1	1	
Defective F8 binding to the cell membrane R-HSA-9672395	1	0	0/1	1	
Defective F8 binding to von Willebrand factor R-HSA-9672393	1	0	0/2	1	
Defective F8 cleavage by thrombin R-HSA-9672391	1	0	0/3	1	
Defective F8 secretion R-HSA-9672397	1	0	0/1	1	
Defective F8 sulfation at Y1699 R-HSA-9674519	1	0	0/1	1	
Defective F9 activation R-HSA-9673221	1	0	0/2	1	
Defective F9 secretion R-HSA-9673218	1	0	0/0	1	
Defective F9 variant does not activate FX R-HSA-9673202	1	0	0/1	1	
Defective FMO3 causes TMAU R-HSA-5579019	1	0	0/0	1	
Defective GALE causes EDG R-HSA-5609977	1	0	0/0	1	
Defective GALK1 causes GALCT2 R-HSA-5609976	1	0	0/0	1	
Defective GALNT12 causes CRCS1 R-HSA-5083636	1	0	0/8	1	
Defective GALNT3 causes HFTC R-HSA-5083625	1	0	0/8	1	
Defective GALT can cause GALCT R-HSA-5609978	1	0	0/0	1	
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) R-HSA-5619073	1	0	0/0	1	
Defective GCLC causes HAGGSD R-HSA-5578999	1	0	0/2	1	
Defective GFPT1 causes CMSTA1 R-HSA-4085023	1	0	0/0	1	
Defective GGT1 causes GLUTH R-HSA-5579022	1	0	0/0	1	
Defective GGT1 in aflatoxin detoxification causes GLUTH R-HSA-9035968	1	0	0/0	1	
Defective GNE causes sialuria, NK and IBM2 R-HSA-4085011	1	0	0/1	1	
Defective GSS causes GSS deficiency R-HSA-5579006	1	0	0/1	1	
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function R-HSA-9704331	1	0	0/14	1	
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function R-HSA-9704646	1	0	0/14	1	
Defective HEXA causes GM2G1 R-HSA-3656234	1	0	0/1	1	
Defective HEXB causes GM2G2 R-HSA-3656248	1	0	0/1	1	
Defective HK1 causes hexokinase deficiency (HK deficiency) R-HSA-5619056	1	0	0/1	1	
Defective HLCS causes multiple carboxylase deficiency R-HSA-3371599	1	0	0/3	1	
Defective HPRT1 disrupts guanine and hypoxanthine salvage R-HSA-9734281	1	0	0/0	1	
Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations R-HSA-9670615	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations R-HSA-9670613	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere R-HSA-9670621	1	0	0/1	1	
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function R-HSA-9645722	1	0	0/2	1	
Defective Intrinsic Pathway for Apoptosis R-HSA-9734009	0.161617941350537	3.03489390408789	2/16	1	TP53;JUN
Defective LARGE causes MDDGA6 and MDDGB6 R-HSA-5083627	1	0	0/0	1	
Defective LFNG causes SCDO3 R-HSA-5083630	1	0	0/5	1	
Defective MAN1B1 causes MRT15 R-HSA-4793950	1	0	0/0	1	
Defective MAOA causes BRUNS R-HSA-5579012	1	0	0/1	1	
Defective MAT1A causes MATD R-HSA-5579024	1	0	0/1	1	
Defective MGAT2 causes CDG-2a R-HSA-4793952	1	0	0/0	1	
Defective MMAA causes MMA, cblA type R-HSA-3359475	1	0	0/2	1	
Defective MMAB causes MMA, cblB type R-HSA-3359471	1	0	0/0	1	
Defective MMACHC causes MAHCC R-HSA-3359474	1	0	0/1	1	
Defective MMADHC causes MMAHCD R-HSA-3359473	1	0	0/1	1	
Defective MOGS causes CDG-2b R-HSA-4793954	1	0	0/0	1	
Defective MPDU1 causes CDG-1f R-HSA-4687000	1	0	0/0	1	
Defective MPI causes MPI-CDG R-HSA-4043916	1	0	0/0	1	
Defective MTR causes HMAG R-HSA-3359469	1	0	0/1	1	
Defective MTRR causes HMAE R-HSA-3359467	1	0	0/1	1	
Defective MUT causes MMAM R-HSA-3359478	1	0	0/2	1	
Defective MUTYH substrate binding R-HSA-9608287	1	0	0/0	1	
Defective MUTYH substrate processing R-HSA-9608290	1	0	0/0	1	
Defective Mismatch Repair Associated With MLH1 R-HSA-5545483	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH2 R-HSA-5632928	1	0	0/1	1	
Defective Mismatch Repair Associated With MSH3 R-HSA-5632927	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH6 R-HSA-5632968	1	0	0/1	1	
Defective Mismatch Repair Associated With PMS2 R-HSA-5632987	1	0	0/0	1	
Defective NEU1 causes sialidosis R-HSA-4341670	1	0	0/2	1	
Defective NTHL1 substrate binding R-HSA-9630222	1	0	0/0	1	
Defective NTHL1 substrate processing R-HSA-9630221	1	0	0/0	1	
Defective OGG1 Localization R-HSA-9657050	1	0	0/0	1	
Defective OGG1 Substrate Binding R-HSA-9656255	1	0	0/0	1	
Defective OGG1 Substrate Processing R-HSA-9656256	1	0	0/0	1	
Defective OPLAH causes OPLAHD R-HSA-5578998	1	0	0/1	1	
Defective PAPSS2 causes SEMD-PA R-HSA-3560796	1	0	0/0	1	
Defective PGM1 causes PGM1-CDG R-HSA-5609974	1	0	0/1	1	
Defective PMM2 causes PMM2-CDG R-HSA-4043911	1	0	0/1	1	
Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine R-HSA-9735763	1	0	0/1	1	
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 R-HSA-5083628	1	0	0/0	1	
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 R-HSA-5083633	1	0	0/1	1	
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 R-HSA-5083629	1	0	0/1	1	
Defective RFT1 causes CDG-1n R-HSA-4570571	1	0	0/0	1	
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) R-HSA-5619042	1	0	0/0	1	
Defective RIPK1-mediated regulated necrosis R-HSA-9693928	1	0	0/7	1	
Defective SERPING1 causes hereditary angioedema R-HSA-9657689	1	0	0/3	1	
Defective SFTPA2 causes IPF R-HSA-5687868	1	0	0/0	1	
Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) R-HSA-5619048	1	0	0/1	1	
Defective SLC12A1 causes Bartter syndrome 1 (BS1) R-HSA-5619104	1	0	0/1	1	
Defective SLC12A3 causes Gitelman syndrome (GS) R-HSA-5619087	1	0	0/0	1	
Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) R-HSA-5619039	1	0	0/1	1	
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) R-HSA-5619070	1	0	0/2	1	
Defective SLC17A5 causes Salla disease (SD) and ISSD R-HSA-5619035	1	0	0/1	1	
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) R-HSA-5619076	1	0	0/0	1	
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) R-HSA-5619067	1	0	0/0	1	
Defective SLC1A3 causes episodic ataxia 6 (EA6) R-HSA-5619062	1	0	0/1	1	
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) R-HSA-5619111	1	0	0/1	1	
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1) R-HSA-5619071	1	0	0/0	1	
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1) R-HSA-5619066	1	0	0/0	1	
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) R-HSA-5619053	1	0	0/1	1	
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) R-HSA-5619077	1	0	0/1	1	
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) R-HSA-5619055	1	0	0/0	1	
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) R-HSA-5619036	1	0	0/0	1	
Defective SLC26A2 causes chondrodysplasias R-HSA-3560792	1	0	0/1	1	
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1) R-HSA-5619085	1	0	0/0	1	
Defective SLC26A4 causes Pendred syndrome (PDS) R-HSA-5619046	1	0	0/0	1	
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS) R-HSA-5619108	1	0	0/1	1	
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) R-HSA-5619063	1	0	0/0	1	
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) R-HSA-5619043	1	0	0/0	1	
Defective SLC2A10 causes arterial tortuosity syndrome (ATS) R-HSA-5619068	1	0	0/0	1	
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS) R-HSA-5619098	1	0	0/0	1	
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) R-HSA-5619047	1	0	0/0	1	
Defective SLC33A1 causes spastic paraplegia 42 (SPG42) R-HSA-5619061	1	0	0/0	1	
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) R-HSA-5619040	1	0	0/1	1	
Defective SLC34A2 causes PALM R-HSA-5687583	1	0	0/0	1	
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) R-HSA-5619045	1	0	0/0	1	
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) R-HSA-5619097	1	0	0/0	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5619037	1	0	0/1	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5663020	1	0	0/1	1	
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) R-HSA-5619072	1	0	0/1	1	
Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) R-HSA-5619083	1	0	0/0	1	
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C) R-HSA-5619078	1	0	0/0	1	
Defective SLC35D1 causes SCHBCKD R-HSA-5579020	1	0	0/0	1	
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG) R-HSA-5619041	1	0	0/0	1	
Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) R-HSA-5619088	1	0	0/0	1	
Defective SLC3A1 causes cystinuria (CSNU) R-HSA-5619113	1	0	0/1	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) R-HSA-5655799	1	0	0/2	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) R-HSA-5619049	1	0	0/1	1	
Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) R-HSA-5619050	1	0	0/1	1	
Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) R-HSA-5619054	1	0	0/0	1	
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) R-HSA-5656364	1	0	0/1	1	
Defective SLC5A2 causes renal glucosuria (GLYS1) R-HSA-5658208	1	0	0/0	1	
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) R-HSA-5619096	1	0	0/1	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5619114	1	0	0/0	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5658471	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5619079	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5659729	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5619044	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5659735	1	0	0/0	1	
Defective SLC6A2 causes orthostatic intolerance (OI) R-HSA-5619109	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5619081	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5660724	1	0	0/0	1	
Defective SLC6A5 causes hyperekplexia 3 (HKPX3) R-HSA-5619089	1	0	0/0	1	
Defective SLC7A7 causes lysinuric protein intolerance (LPI) R-HSA-5660862	1	0	0/1	1	
Defective SLC7A9 causes cystinuria (CSNU) R-HSA-5660883	1	0	0/1	1	
Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH) R-HSA-5619092	1	0	0/1	1	
Defective SLC9A9 causes autism 16 (AUTS16) R-HSA-5619052	1	0	0/1	1	
Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619110	1	0	0/0	1	
Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619058	1	0	0/0	1	
Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2) R-HSA-5619095	1	0	0/0	1	
Defective SRD5A3 causes SRD5A3-CDG, KHRZ R-HSA-4755579	1	0	0/1	1	
Defective ST3GAL3 causes MCT12 and EIEE15 R-HSA-3656243	1	0	0/5	1	
Defective TBXAS1 causes GHDD R-HSA-5579032	1	0	0/0	1	
Defective TCN2 causes TCN2 deficiency R-HSA-3359454	1	0	0/0	1	
Defective TPMT causes TPMT deficiency R-HSA-5578995	1	0	0/1	1	
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) R-HSA-5619107	1	0	0/10	1	
Defective UGT1A1 causes hyperbilirubinemia R-HSA-5579002	1	0	0/0	1	
Defective UGT1A4 causes hyperbilirubinemia R-HSA-5579016	1	0	0/0	1	
Defective VWF binding to collagen type I  R-HSA-9845622	1	0	0/3	1	
Defective VWF cleavage by ADAMTS13 variant R-HSA-9845621	1	0	0/4	1	
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069	0.177991752687346	2.83195799693249	2/17	1	TFDP1;E2F1
Defective binding of VWF variant to GPIb:IX:V R-HSA-9846298	1	0	0/4	1	
Defective cofactor function of FVIIIa variant R-HSA-9672396	1	0	0/1	1	
Defective factor IX causes hemophilia B R-HSA-9668250	1	0	0/4	1	
Defective factor IX causes thrombophilia R-HSA-9672383	1	0	0/1	1	
Defective factor VIII causes hemophilia A R-HSA-9662001	1	0	0/3	1	
Defective factor XII causes hereditary angioedema R-HSA-9657688	1	0	0/3	1	
Defective gamma-carboxylation of F9 R-HSA-9673240	1	0	0/1	1	
Defective homologous recombination repair (HRR) due to BRCA1 loss of function R-HSA-9701192	1	0	0/14	1	
Defective homologous recombination repair (HRR) due to BRCA2 loss of function R-HSA-9701190	0.524000974672891	1.40863417894967	1/16	1	RPA3
Defective homologous recombination repair (HRR) due to PALB2 loss of function R-HSA-9701193	1	0	0/14	1	
Defective pro-SFTPB causes SMDP1 and RDS R-HSA-5688031	1	0	0/1	1	
Defective pro-SFTPC causes SMDP2 and RDS R-HSA-5688354	1	0	0/0	1	
Defective pyroptosis R-HSA-9710421	0.548743152711061	1.05584339321167	3/63	1	H2AX;H2BC8;H2BC3
Defective regulation of TLR7 by endogenous ligand R-HSA-9824856	1	0	0/1	1	
Defective translocation of RB1 mutants to the nucleus R-HSA-9661070	1	0	0/1	1	
Defects in biotin (Btn) metabolism R-HSA-3323169	1	0	0/4	1	
Defects in cobalamin (B12) metabolism R-HSA-3296469	1	0	0/6	1	
Defects in vitamin and cofactor metabolism R-HSA-3296482	1	0	0/10	1	
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) R-HSA-9651496	1	0	0/9	1	
Defects of platelet adhesion to exposed collagen R-HSA-9823587	1	0	0/5	1	
Defensins R-HSA-1461973	1	0	0/9	1	
Degradation of AXIN R-HSA-4641257	0.690132381601193	0.842240269286321	2/52	1	UBA52;PSMC5
Degradation of DVL R-HSA-4641258	0.690132381601193	0.842240269286321	2/52	1	UBA52;PSMC5
Degradation of GABA R-HSA-916853	1	0	0/1	1	
Degradation of GLI1 by the proteasome R-HSA-5610780	0.492415282671302	1.15328898052379	3/58	1	UBA52;PSMC5;SKP1
Degradation of GLI2 by the proteasome R-HSA-5610783	0.503960097412131	1.13240288602238	3/59	1	UBA52;PSMC5;SKP1
Degradation of beta-catenin by the destruction complex R-HSA-195253	0.463353960472296	1.15951592153728	4/77	1	UBA52;PSMC5;SKP1;MYC
Degradation of cysteine and homocysteine R-HSA-1614558	1	0	0/5	1	
Degradation of the extracellular matrix R-HSA-1474228	1	0	0/60	1	
Deletions in the AMER1 gene destabilize the destruction complex R-HSA-5467343	1	0	0/1	1	
Deletions in the AXIN1 gene destabilize the destruction complex R-HSA-5467345	1	0	0/1	1	
Depolymerization of the Nuclear Lamina R-HSA-4419969	1	0	0/7	1	
Deposition of new CENPA-containing nucleosomes at the centromere R-HSA-606279	0.371043202967936	1.41317586036907	3/48	1	H2AX;H2BC8;H2BC3
Depurination R-HSA-73927	0.283006250373054	1.6764752847409	3/41	1	H2AX;H2BC8;H2BC3
Depyrimidination R-HSA-73928	0.308126600339051	1.59184051160436	3/43	1	H2AX;H2BC8;H2BC3
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models R-HSA-8862803	0.452789218493456	1.76203882355408	1/13	1	JUN
Dermatan sulfate biosynthesis R-HSA-2022923	1	0	0/4	1	
Detoxification of Reactive Oxygen Species R-HSA-3299685	0.566274760919946	1.24232925880823	1/18	1	CYCS
Deubiquitination R-HSA-5688426	0.454870240426388	1.08940711416653	9/184	1	UBA52;PSMC5;CCNA2;H2BC8;H2BC3;TP53;MYC;TAF10;UCHL3
Developmental Cell Lineages R-HSA-9734767	1	0	0/5	1	
Differentiation of keratinocytes in interfollicular epidermis in mammalian skin R-HSA-9725554	1	0	0/5	1	
Digestion R-HSA-8935690	1	0	0/2	1	
Digestion and absorption R-HSA-8963743	1	0	0/4	1	
Digestion of dietary carbohydrate R-HSA-189085	1	0	0/1	1	
Digestion of dietary lipid R-HSA-192456	1	0	0/1	1	
Dimerization of procaspase-8 R-HSA-69416	1	0	0/10	1	
Disassembly of the destruction complex and recruitment of AXIN to the membrane R-HSA-4641262	1	0	0/20	1	
Diseases associated with N-glycosylation of proteins R-HSA-3781860	1	0	0/4	1	
Diseases associated with O-glycosylation of proteins R-HSA-3906995	1	0	0/30	1	
Diseases associated with glycosaminoglycan metabolism R-HSA-3560782	1	0	0/17	1	
Diseases associated with glycosylation precursor biosynthesis R-HSA-5609975	1	0	0/6	1	
Diseases associated with surfactant metabolism R-HSA-5687613	1	0	0/2	1	
Diseases associated with the TLR signaling cascade R-HSA-5602358	0.296584199081995	1.92778058369726	2/24	1	NFKB1;RELA
Diseases associated with visual transduction R-HSA-2474795	1	0	0/1	1	
Diseases of Base Excision Repair R-HSA-9605308	1	0	0/1	1	
Diseases of Cellular Senescence R-HSA-9630747	1	0	0/3	1	
Diseases of DNA Double-Strand Break Repair R-HSA-9675136	0.524000974672891	1.40863417894967	1/16	1	RPA3
Diseases of DNA repair R-HSA-9675135	0.566274760919946	1.24232925880823	1/18	1	RPA3
Diseases of Immune System R-HSA-5260271	0.296584199081995	1.92778058369726	2/24	1	NFKB1;RELA
Diseases of Mismatch Repair (MMR) R-HSA-5423599	1	0	0/1	1	
Diseases of Telomere Maintenance R-HSA-9673013	1	0	0/1	1	
Diseases of carbohydrate metabolism R-HSA-5663084	0.545626551046988	1.32029355805218	1/17	1	UBA52
Diseases of cellular response to stress R-HSA-9675132	1	0	0/3	1	
Diseases of glycosylation R-HSA-3781865	1	0	0/57	1	
Diseases of hemostasis R-HSA-9671793	1	0	0/12	1	
Diseases of metabolism R-HSA-5668914	0.990364670697713	0.211021338279319	1/99	1	UBA52
Diseases of mitochondrial beta oxidation R-HSA-9759774	1	0	0/2	1	
Diseases of mitotic cell cycle R-HSA-9675126	0.221370295219772	1.93293106726052	3/36	1	CDC26;TFDP1;E2F1
Diseases of nucleotide metabolism R-HSA-9735804	1	0	0/2	1	
Diseases of programmed cell death R-HSA-9645723	0.349144656034677	1.31076103830825	5/86	1	H2AX;H2BC8;H2BC3;TP53;JUN
Diseases of propionyl-CoA catabolism R-HSA-9759785	1	0	0/2	1	
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202	0.9566169531549	0.598849655933832	9/316	1	DERL2;UBA52;PSMC5;SKP1;POLR2F;TP53;JUN;RPS6;MYC
Diseases of the neuronal system R-HSA-9675143	1	0	0/1	1	
Disinhibition of SNARE formation R-HSA-114516	1	0	0/4	1	
Disorders of Developmental Biology R-HSA-9675151	1	0	0/10	1	
Disorders of Nervous System Development R-HSA-9697154	1	0	0/10	1	
Disorders of transmembrane transporters R-HSA-5619115	0.671016322358894	0.876420662897191	4/100	1	DERL2;UBA52;RNF5;PSMC5
Displacement of DNA glycosylase by APEX1 R-HSA-110357	1	0	0/2	1	
Dissolution of Fibrin Clot R-HSA-75205	1	0	0/10	1	
Dopamine Neurotransmitter Release Cycle R-HSA-212676	1	0	0/5	1	
Dopamine clearance from the synaptic cleft R-HSA-379401	1	0	0/1	1	
Dopamine receptors R-HSA-390651	1	0	0/0	1	
Downregulation of ERBB2 signaling R-HSA-8863795	0.585989544514493	1.17302584275925	1/19	1	UBA52
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803	0.309813381545497	3.02371343760045	1/8	1	UBA52
Downregulation of ERBB4 signaling R-HSA-1253288	0.309813381545497	3.02371343760045	1/8	1	UBA52
Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173795	0.763315860802052	0.701695123324785	1/31	1	UBA52
Downregulation of TGF-beta receptor signaling R-HSA-2173788	0.701156651958545	0.843107752812615	1/26	1	UBA52
Downstream TCR signaling R-HSA-202424	0.413104893300487	1.20429251822082	5/93	1	UBA52;PSMC5;SKP1;NFKB1;RELA
Downstream signal transduction R-HSA-186763	1	0	0/29	1	
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372	0.152183470552746	1.73446338247081	6/80	1	UBA52;PSMC5;SKP1;REL;NFKB1;RELA
Downstream signaling of activated FGFR1 R-HSA-5654687	1	0	0/12	1	
Downstream signaling of activated FGFR2 R-HSA-5654696	1	0	0/14	1	
Downstream signaling of activated FGFR3 R-HSA-5654708	1	0	0/12	1	
Downstream signaling of activated FGFR4 R-HSA-5654716	1	0	0/12	1	
Drug ADME R-HSA-9748784	0.829325851059439	0.567917875934568	1/38	1	GUK1
Drug resistance in ERBB2 KD mutants R-HSA-9665230	1	0	0/2	1	
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737	1	0	0/2	1	
Drug resistance of ALK mutants R-HSA-9700649	1	0	0/0	1	
Drug resistance of FLT3 mutants R-HSA-9702506	1	0	0/0	1	
Drug resistance of KIT mutants R-HSA-9669937	1	0	0/1	1	
Drug resistance of PDGFR mutants R-HSA-9674415	1	0	0/1	1	
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119	1	0	0/5	1	
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282	1	0	0/2	1	
Drug-mediated inhibition of MET activation R-HSA-9734091	1	0	0/1	1	
Dual incision in TC-NER R-HSA-6782135	0.0712594467696534	2.75975058300382	4/35	1	UBA52;POLR2F;RPA3;PCNA
E2F mediated regulation of DNA replication R-HSA-113510	0.129838474458708	3.54219595929698	2/14	1	TFDP1;E2F1
E2F-enabled inhibition of pre-replication complex formation R-HSA-113507	1	0	0/4	1	
ECM proteoglycans R-HSA-3000178	1	0	0/40	1	
EGFR Transactivation by Gastrin R-HSA-2179392	1	0	0/9	1	
EGFR downregulation R-HSA-182971	0.671967212159988	0.916883980868546	1/24	1	UBA52
EGFR interacts with phospholipase C-gamma R-HSA-212718	1	0	0/9	1	
EGR2 and SOX10-mediated initiation of Schwann cell myelination R-HSA-9619665	1	0	0/13	1	
EML4 and NUDC in mitotic spindle formation R-HSA-9648025	0.217037432902463	1.73814751933326	4/53	1	DYNLL1;RPS27;ZWINT;BUB1
EPH-Ephrin signaling R-HSA-2682334	0.923043201169376	0.387423490385319	1/55	1	ARPC1A
EPH-ephrin mediated repulsion of cells R-HSA-3928665	1	0	0/25	1	
EPHA-mediated growth cone collapse R-HSA-3928663	1	0	0/14	1	
EPHB-mediated forward signaling R-HSA-3928662	0.727761648685022	0.780258941667337	1/28	1	ARPC1A
ER to Golgi Anterograde Transport R-HSA-199977	0.987784045875635	0.222661273784119	1/94	1	DYNLL1
ER-Phagosome pathway R-HSA-1236974	0.718151309599496	0.808366924379189	3/81	1	UBA52;PSMC5;VAMP8
ERBB2 Activates PTK6 Signaling R-HSA-8847993	1	0	0/8	1	
ERBB2 Regulates Cell Motility R-HSA-6785631	1	0	0/9	1	
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression R-HSA-427389	0.611289660071891	0.958342936414784	3/69	1	H2AX;H2BC8;H2BC3
ERK/MAPK targets R-HSA-198753	1	0	0/16	1	
ERKs are inactivated R-HSA-202670	1	0	0/7	1	
ESR-mediated signaling R-HSA-8939211	0.308273811309225	1.23967666025922	10/182	1	POLR2F;H2AX;H2BC8;H2BC3;JUN;SP1;FOS;ATF2;TBP;MYC
Early Phase of HIV Life Cycle R-HSA-162594	1	0	0/10	1	
Early SARS-CoV-2 Infection Events R-HSA-9772572	1	0	0/16	1	
Effects of PIP2 hydrolysis R-HSA-114508	1	0	0/12	1	
Eicosanoid ligand-binding receptors R-HSA-391903	1	0	0/1	1	
Eicosanoids R-HSA-211979	1	0	0/3	1	
Elastic fibre formation R-HSA-1566948	1	0	0/22	1	
Electric Transmission Across Gap Junctions R-HSA-112303	1	0	0/1	1	
Electron transport from NADPH to Ferredoxin R-HSA-2395516	1	0	0/0	1	
Elevation of cytosolic Ca2+ levels R-HSA-139853	1	0	0/5	1	
Endogenous sterols R-HSA-211976	1	0	0/8	1	
Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729	0.545626551046988	1.32029355805218	1/17	1	UBA52
Endosomal/Vacuolar pathway R-HSA-1236977	1	0	0/7	1	
Energy dependent regulation of mTOR by LKB1-AMPK R-HSA-380972	1	0	0/24	1	
Enhanced binding of GP1BA variant to VWF multimer:collagen  R-HSA-9845620	1	0	0/4	1	
Enhanced cleavage of VWF variant by ADAMTS13 R-HSA-9845619	1	0	0/4	1	
Entry of Influenza Virion into Host Cell via Endocytosis R-HSA-168275	1	0	0/2	1	
Enzymatic degradation of Dopamine by monoamine oxidase R-HSA-379398	1	0	0/1	1	
Enzymatic degradation of dopamine by COMT R-HSA-379397	1	0	0/1	1	
Ephrin signaling R-HSA-3928664	1	0	0/11	1	
Epigenetic regulation of gene expression R-HSA-212165	0.548616408668774	1.01315082266278	6/131	1	POLR2F;H2AX;H2BC8;H2BC3;DPY30;TBP
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919	1	0	0/3	1	
Erythrocytes take up carbon dioxide and release oxygen R-HSA-1237044	1	0	0/7	1	
Erythrocytes take up oxygen and release carbon dioxide R-HSA-1247673	1	0	0/7	1	
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276	1	0	0/9	1	
Erythropoietin activates Phospholipase C gamma (PLCG) R-HSA-9027277	1	0	0/4	1	
Erythropoietin activates RAS R-HSA-9027284	1	0	0/10	1	
Erythropoietin activates STAT5 R-HSA-9027283	1	0	0/5	1	
Essential fructosuria R-HSA-5657562	1	0	0/1	1	
Essential pentosuria R-HSA-5662853	1	0	0/0	1	
Establishment of Sister Chromatid Cohesion R-HSA-2468052	1	0	0/9	1	
Estrogen biosynthesis R-HSA-193144	1	0	0/0	1	
Estrogen-dependent gene expression R-HSA-9018519	0.0739738622741469	1.77121225376406	10/132	1	POLR2F;H2AX;H2BC8;H2BC3;JUN;SP1;FOS;ATF2;TBP;MYC
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638	0.671967212159988	0.916883980868546	1/24	1	FOS
Estrogen-stimulated signaling through PRKCZ R-HSA-9634635	1	0	0/6	1	
Ethanol oxidation R-HSA-71384	1	0	0/4	1	
Evasion by RSV of host interferon responses R-HSA-9833109	0.794248751548842	0.637413509336522	1/34	1	UBA52
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791	1	0	0/2	1	
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794	1	0	0/3	1	
Evasion of Oncogene Induced Senescence Due to p14ARF Defects R-HSA-9646303	1	0	0/1	1	
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697	1	0	0/2	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects R-HSA-9646304	1	0	0/1	1	
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693	1	0	0/3	1	
Events associated with phagocytolytic activity of PMN cells R-HSA-8941413	1	0	0/0	1	
Export of Viral Ribonucleoproteins from Nucleus R-HSA-168274	1	0	0/12	1	
Expression and Processing of Neurotrophins R-HSA-9036866	1	0	0/2	1	
Expression and translocation of olfactory receptors R-HSA-9752946	1	0	0/1	1	
Extra-nuclear estrogen signaling R-HSA-9009391	0.929943045606531	0.37339208772031	1/57	1	FOS
Extracellular matrix organization R-HSA-1474244	1	0	0/133	1	
Extrinsic Pathway of Fibrin Clot Formation R-HSA-140834	1	0	0/3	1	
FASTK family proteins regulate processing and stability of mitochondrial RNAs R-HSA-9837092	1	0	0/0	1	
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis R-HSA-8854050	0.432884471943028	1.27024796263272	3/53	1	UBA52;PSMC5;SKP1
FBXW7 Mutants and NOTCH1 in Cancer R-HSA-2644605	0.206782414170199	5.2933772792375	1/5	1	SKP1
FCERI mediated Ca+2 mobilization R-HSA-2871809	1	0	0/19	1	
FCERI mediated MAPK activation R-HSA-2871796	0.27952948330592	2.02003720593716	2/23	1	JUN;FOS
FCERI mediated NF-kB activation R-HSA-2871837	0.250854557781074	1.52105443539661	5/75	1	UBA52;PSMC5;SKP1;NFKB1;RELA
FCGR activation R-HSA-2029481	1	0	0/10	1	
FCGR3A-mediated IL10 synthesis R-HSA-9664323	1	0	0/25	1	
FCGR3A-mediated phagocytosis R-HSA-9664422	0.812601772791195	0.600680353804841	1/36	1	ARPC1A
FGFR1 ligand binding and activation R-HSA-190242	1	0	0/3	1	
FGFR1 mutant receptor activation R-HSA-1839124	1	0	0/20	1	
FGFR1b ligand binding and activation R-HSA-190370	1	0	0/2	1	
FGFR1c and Klotho ligand binding and activation R-HSA-190374	1	0	0/0	1	
FGFR1c ligand binding and activation R-HSA-190373	1	0	0/3	1	
FGFR2 alternative splicing R-HSA-6803529	0.604812877024766	1.11101589883285	1/20	1	POLR2F
FGFR2 ligand binding and activation R-HSA-190241	1	0	0/4	1	
FGFR2 mutant receptor activation R-HSA-1839126	0.585989544514493	1.17302584275925	1/19	1	POLR2F
FGFR2b ligand binding and activation R-HSA-190377	1	0	0/3	1	
FGFR2c ligand binding and activation R-HSA-190375	1	0	0/3	1	
FGFR3 ligand binding and activation R-HSA-190239	1	0	0/2	1	
FGFR3 mutant receptor activation R-HSA-2033514	1	0	0/2	1	
FGFR3b ligand binding and activation R-HSA-190371	1	0	0/0	1	
FGFR3c ligand binding and activation R-HSA-190372	1	0	0/2	1	
FGFR4 ligand binding and activation R-HSA-190322	1	0	0/2	1	
FGFR4 mutant receptor activation R-HSA-1839128	1	0	0/1	1	
FGFRL1 modulation of FGFR1 signaling R-HSA-5658623	1	0	0/4	1	
FLT3 Signaling R-HSA-9607240	0.752009883910059	0.726077314688426	1/30	1	UBA52
FLT3 mutants bind TKIs R-HSA-9702509	1	0	0/0	1	
FLT3 signaling by CBL mutants R-HSA-9706377	0.206782414170199	5.2933772792375	1/5	1	UBA52
FLT3 signaling in disease R-HSA-9682385	0.63994378502192	1.00470864523097	1/22	1	UBA52
FLT3 signaling through SRC family kinases R-HSA-9706374	1	0	0/4	1	
FMO oxidises nucleophiles R-HSA-217271	1	0	0/0	1	
FOXO-mediated transcription R-HSA-9614085	1	0	0/49	1	
FOXO-mediated transcription of cell cycle genes R-HSA-9617828	1	0	0/11	1	
FOXO-mediated transcription of cell death genes R-HSA-9614657	1	0	0/14	1	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9615017	1	0	0/21	1	
FRS-mediated FGFR1 signaling R-HSA-5654693	1	0	0/8	1	
FRS-mediated FGFR2 signaling R-HSA-5654700	1	0	0/10	1	
FRS-mediated FGFR3 signaling R-HSA-5654706	1	0	0/8	1	
FRS-mediated FGFR4 signaling R-HSA-5654712	1	0	0/8	1	
Factors involved in megakaryocyte development and platelet production R-HSA-983231	0.990364670697713	0.211021338279319	1/99	1	TP53
Fanconi Anemia Pathway R-HSA-6783310	0.27952948330592	2.02003720593716	2/23	1	UBA52;RPA3
FasL/ CD95L signaling R-HSA-75157	1	0	0/4	1	
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion R-HSA-434316	1	0	0/3	1	
Fatty acid metabolism R-HSA-8978868	1	0	0/74	1	
Fatty acids R-HSA-211935	1	0	0/5	1	
Fatty acyl-CoA biosynthesis R-HSA-75105	1	0	0/14	1	
Fc epsilon receptor (FCERI) signaling R-HSA-2454202	0.256423413530259	1.39524567892903	7/114	1	UBA52;PSMC5;SKP1;JUN;NFKB1;RELA;FOS
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480	0.919343938183822	0.394836266298919	1/54	1	ARPC1A
Fertilization R-HSA-1187000	1	0	0/4	1	
Fibronectin matrix formation R-HSA-1566977	1	0	0/3	1	
Ficolins bind to repetitive carbohydrate structures on the target cell surface R-HSA-2855086	1	0	0/3	1	
Folding of actin by CCT/TriC R-HSA-390450	1	0	0/10	1	
Formation of ATP by chemiosmotic coupling R-HSA-163210	0.145545260024666	3.26902954467283	2/15	1	ATP5MF;ATP5F1D
Formation of Fibrin Clot (Clotting Cascade) R-HSA-140877	1	0	0/22	1	
Formation of HIV elongation complex in the absence of HIV Tat R-HSA-167152	0.363925104048103	1.62957500645577	2/28	1	POLR2F;SUPT4H1
Formation of HIV-1 elongation complex containing HIV-1 Tat R-HSA-167200	0.330484949669379	1.76624926591966	2/26	1	POLR2F;SUPT4H1
Formation of Incision Complex in GG-NER R-HSA-5696395	0.24537329698268	2.23374304689324	2/21	1	UBA52;RPA3
Formation of RNA Pol II elongation complex  R-HSA-112382	0.459822349285752	1.32206320461919	2/34	1	POLR2F;SUPT4H1
Formation of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584	0.524000974672891	1.40863417894967	1/16	1	TP53
Formation of TC-NER Pre-Incision Complex R-HSA-6781823	0.428725997440487	1.4108924833167	2/32	1	UBA52;POLR2F
Formation of WDR5-containing histone-modifying complexes R-HSA-9772755	0.701156651958545	0.843107752812615	1/26	1	DPY30
Formation of annular gap junctions R-HSA-196025	1	0	0/9	1	
Formation of apoptosome R-HSA-111458	0.206782414170199	5.2933772792375	1/5	1	CYCS
Formation of axial mesoderm R-HSA-9796292	1	0	0/11	1	
Formation of definitive endoderm R-HSA-9823730	1	0	0/10	1	
Formation of editosomes by ADAR proteins R-HSA-77042	1	0	0/0	1	
Formation of intermediate mesoderm R-HSA-9761174	1	0	0/3	1	
Formation of lateral plate mesoderm R-HSA-9758920	1	0	0/1	1	
Formation of paraxial mesoderm R-HSA-9793380	0.933158601827751	0.366745598688576	1/58	1	PSMC5
Formation of the Early Elongation Complex R-HSA-113418	0.262447347130839	2.12165544098413	2/22	1	POLR2F;SUPT4H1
Formation of the Editosome R-HSA-75094	1	0	0/0	1	
Formation of the HIV-1 Early Elongation Complex R-HSA-167158	0.262447347130839	2.12165544098413	2/22	1	POLR2F;SUPT4H1
Formation of the active cofactor, UDP-glucuronate R-HSA-173599	1	0	0/0	1	
Formation of the anterior neural plate R-HSA-9823739	1	0	0/4	1	
Formation of the beta-catenin:TCF transactivating complex R-HSA-201722	0.503195588876364	1.09812336982383	4/81	1	H2AX;H2BC8;H2BC3;MYC
Formation of the cornified envelope R-HSA-6809371	1	0	0/11	1	
Formation of the nephric duct R-HSA-9830364	1	0	0/9	1	
Formation of the posterior neural plate R-HSA-9832991	1	0	0/5	1	
Formation of the ureteric bud R-HSA-9830674	1	0	0/8	1	
Formation of tubulin folding intermediates by CCT/TriC R-HSA-389960	1	0	0/26	1	
Formation of xylulose-5-phosphate R-HSA-5661270	1	0	0/1	1	
Formyl peptide receptors bind formyl peptides and many other ligands R-HSA-444473	1	0	0/5	1	
Free fatty acid receptors R-HSA-444209	1	0	0/0	1	
Free fatty acids regulate insulin secretion R-HSA-400451	1	0	0/4	1	
Frs2-mediated activation R-HSA-170968	1	0	0/7	1	
Fructose biosynthesis R-HSA-5652227	1	0	0/1	1	
Fructose catabolism R-HSA-70350	1	0	0/2	1	
Fructose metabolism R-HSA-5652084	1	0	0/3	1	
G alpha (12/13) signalling events R-HSA-416482	1	0	0/38	1	
G alpha (i) signalling events R-HSA-418594	0.994011155718058	0.190974616468979	1/109	1	CXCL8
G alpha (q) signalling events R-HSA-416476	1	0	0/78	1	
G alpha (s) signalling events R-HSA-418555	1	0	0/46	1	
G alpha (z) signalling events R-HSA-418597	1	0	0/25	1	
G beta:gamma signalling through BTK R-HSA-8964315	1	0	0/9	1	
G beta:gamma signalling through CDC42 R-HSA-8964616	1	0	0/11	1	
G beta:gamma signalling through PI3Kgamma R-HSA-392451	1	0	0/15	1	
G beta:gamma signalling through PLC beta R-HSA-418217	1	0	0/8	1	
G protein gated Potassium channels R-HSA-1296059	1	0	0/11	1	
G-protein activation R-HSA-202040	1	0	0/13	1	
G-protein beta:gamma signalling R-HSA-397795	1	0	0/19	1	
G-protein mediated events R-HSA-112040	1	0	0/30	1	
G1/S DNA Damage Checkpoints R-HSA-69615	0.328650766015218	1.41548473068211	4/64	1	UBA52;PSMC5;CCNA2;TP53
G2/M Checkpoints R-HSA-69481	0.292150003968531	1.33120649905568	7/119	1	UBA52;PSMC5;H2AX;H2BC8;H2BC3;RPA3;TP53
G2/M DNA damage checkpoint R-HSA-69473	0.147311335550711	1.87430856065249	5/62	1	H2AX;H2BC8;H2BC3;RPA3;TP53
G2/M DNA replication checkpoint R-HSA-69478	1	0	0/2	1	
G2/M Transition R-HSA-69275	0.563753445402968	0.996664371444052	6/133	1	UBA52;PSMC5;SKP1;CCNA2;DYNLL1;TP53
GAB1 signalosome R-HSA-180292	1	0	0/15	1	
GABA B receptor activation R-HSA-977444	1	0	0/18	1	
GABA receptor activation R-HSA-977443	1	0	0/18	1	
GABA synthesis R-HSA-888568	1	0	0/0	1	
GABA synthesis, release, reuptake and degradation R-HSA-888590	1	0	0/6	1	
GDP-fucose biosynthesis R-HSA-6787639	1	0	0/1	1	
GLI proteins bind promoters of Hh responsive genes to promote transcription R-HSA-5635851	1	0	0/7	1	
GLI3 is processed to GLI3R by the proteasome R-HSA-5610785	0.503960097412131	1.13240288602238	3/59	1	UBA52;PSMC5;SKP1
GP1b-IX-V activation signalling R-HSA-430116	1	0	0/9	1	
GPCR downstream signalling R-HSA-388396	0.999962346339083	0.0941262057106853	1/214	1	CXCL8
GPCR ligand binding R-HSA-500792	0.996282240311658	0.174325483890322	1/119	1	CXCL8
GPER1 signaling R-HSA-9634597	1	0	0/22	1	
GPVI-mediated activation cascade R-HSA-114604	1	0	0/26	1	
GRB2 events in EGFR signaling R-HSA-179812	1	0	0/13	1	
GRB2 events in ERBB2 signaling R-HSA-1963640	1	0	0/11	1	
GRB2:SOS provides linkage to MAPK signaling for Integrins  R-HSA-354194	1	0	0/7	1	
GRB7 events in ERBB2 signaling R-HSA-1306955	1	0	0/2	1	
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 R-HSA-9762114	0.40836414679745	1.3238525111593	3/51	1	UBA52;PSMC5;SKP1
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842	1	0	0/5	1	
Galactose catabolism R-HSA-70370	1	0	0/1	1	
Gamma-carboxylation of protein precursors R-HSA-159740	1	0	0/3	1	
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins R-HSA-159854	1	0	0/4	1	
Gap junction assembly R-HSA-190861	1	0	0/21	1	
Gap junction degradation R-HSA-190873	1	0	0/9	1	
Gap junction trafficking R-HSA-190828	1	0	0/29	1	
Gap junction trafficking and regulation R-HSA-157858	1	0	0/30	1	
Gap-filling DNA repair synthesis and ligation in TC-NER R-HSA-6782210	0.0653246318527895	2.85242584903792	4/34	1	UBA52;POLR2F;RPA3;PCNA
Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-881907	1	0	0/16	1	
Gastrulation R-HSA-9758941	0.982978871132895	0.241230884902078	1/87	1	PSMC5
Gene Silencing by RNA R-HSA-211000	0.578670602540342	0.992706347844211	4/89	1	POLR2F;H2AX;H2BC8;H2BC3
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation R-HSA-8950505	0.622784856026871	1.05523077016551	1/21	1	RPLP0
Gene expression (Transcription) R-HSA-74160	0.460007033779811	1.03459703273325	36/775	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;TFDP1;E2F1;POLR2F;SUPT4H1;H2AX;H2BC8;H2BC3;RPA3;TP53;JUN;DPY30;NFKB1;RELA;CYCS;SP1;FOS;ATF2;BAX;COX5A;COX4I1;COX16;COX7A2L;TBP;PCNA;MYC;E2F4;TAF10;SNRPE;SNRPG;SSU72;LSM10
Generation of second messenger molecules R-HSA-202433	1	0	0/24	1	
Generic Transcription Pathway R-HSA-212436	0.310627800504542	1.1228660789982	32/645	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;TFDP1;E2F1;POLR2F;SUPT4H1;H2AX;H2BC8;H2BC3;RPA3;TP53;JUN;DPY30;NFKB1;RELA;CYCS;SP1;FOS;ATF2;BAX;COX5A;COX4I1;COX16;COX7A2L;TBP;PCNA;MYC;E2F4;TAF10
Germ layer formation at gastrulation R-HSA-9754189	1	0	0/11	1	
Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399	0.258086867617439	1.77050646128748	3/39	1	UBA52;RPA3;PCNA
Glucagon signaling in metabolic regulation R-HSA-163359	1	0	0/17	1	
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion R-HSA-381676	1	0	0/17	1	
Glucagon-type ligand receptors R-HSA-420092	1	0	0/14	1	
Glucocorticoid biosynthesis R-HSA-194002	1	0	0/1	1	
Gluconeogenesis R-HSA-70263	1	0	0/11	1	
Glucose metabolism R-HSA-70326	1	0	0/36	1	
Glucuronidation R-HSA-156588	1	0	0/2	1	
Glutamate Neurotransmitter Release Cycle R-HSA-210500	1	0	0/10	1	
Glutamate and glutamine metabolism R-HSA-8964539	1	0	0/4	1	
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721	1	0	0/14	1	
Glutathione conjugation R-HSA-156590	1	0	0/22	1	
Glutathione synthesis and recycling R-HSA-174403	1	0	0/9	1	
Glycerophospholipid biosynthesis R-HSA-1483206	1	0	0/40	1	
Glycerophospholipid catabolism R-HSA-6814848	1	0	0/0	1	
Glycine degradation R-HSA-6783984	1	0	0/4	1	
Glycogen breakdown (glycogenolysis) R-HSA-70221	1	0	0/7	1	
Glycogen metabolism R-HSA-8982491	0.426772182116293	1.92268712388978	1/12	1	UBA52
Glycogen storage disease type 0 (liver GYS2) R-HSA-3858516	1	0	0/0	1	
Glycogen storage disease type 0 (muscle GYS1) R-HSA-3828062	1	0	0/2	1	
Glycogen storage disease type II (GAA) R-HSA-5357609	1	0	0/1	1	
Glycogen storage disease type IV (GBE1) R-HSA-3878781	1	0	0/0	1	
Glycogen storage disease type Ia (G6PC) R-HSA-3274531	1	0	0/0	1	
Glycogen storage disease type Ib (SLC37A4) R-HSA-3229133	1	0	0/1	1	
Glycogen storage disease type XV (GYG1) R-HSA-3814836	1	0	0/2	1	
Glycogen storage diseases R-HSA-3229121	0.309813381545497	3.02371343760045	1/8	1	UBA52
Glycogen synthesis R-HSA-3322077	0.27704115757633	3.52822750116427	1/7	1	UBA52
Glycolysis R-HSA-70171	1	0	0/32	1	
Glycoprotein hormones R-HSA-209822	1	0	0/3	1	
Glycosaminoglycan metabolism R-HSA-1630316	1	0	0/41	1	
Glycosphingolipid biosynthesis R-HSA-9840309	1	0	0/5	1	
Glycosphingolipid catabolism R-HSA-9840310	1	0	0/14	1	
Glycosphingolipid metabolism R-HSA-1660662	1	0	0/19	1	
Glycosphingolipid transport R-HSA-9845576	1	0	0/2	1	
Glyoxylate metabolism and glycine degradation R-HSA-389661	1	0	0/8	1	
Golgi Associated Vesicle Biogenesis R-HSA-432722	0.714767486376561	0.810474977491103	1/27	1	VAMP8
Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658	1	0	0/8	1	
Golgi-to-ER retrograde transport R-HSA-8856688	0.965420894849423	0.293351873340124	1/72	1	DYNLL1
Growth hormone receptor signaling R-HSA-982772	1	0	0/24	1	
HATs acetylate histones R-HSA-3214847	0.655302901847286	0.895539956553981	4/98	1	H2BC8;H2BC3;ATF2;TAF10
HCMV Early Events R-HSA-9609690	0.686235314443557	0.858081484982988	4/102	1	DYNLL1;H2BC8;H2BC3;NFKB1
HCMV Infection R-HSA-9609646	0.761061913329409	0.769242373392326	4/113	1	DYNLL1;H2BC8;H2BC3;NFKB1
HCMV Late Events R-HSA-9610379	0.856044656097386	0.581540888325958	2/74	1	H2BC8;H2BC3
HCN channels R-HSA-1296061	1	0	0/0	1	
HDACs deacetylate histones R-HSA-3214815	0.702058454574056	0.830074922487068	3/79	1	H2BC8;H2BC3;BRMS1
HDL assembly R-HSA-8963896	1	0	0/8	1	
HDL clearance R-HSA-8964011	1	0	0/2	1	
HDL remodeling R-HSA-8964058	1	0	0/7	1	
HDMs demethylate histones R-HSA-3214842	1	0	0/37	1	
HDR through Homologous Recombination (HRR) R-HSA-5685942	0.163137251375391	2.28092342838936	3/31	1	UBA52;RPA3;PCNA
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) R-HSA-5693567	0.0647443203155312	2.09250705143019	7/79	1	UBA52;CCNA2;H2AX;H2BC8;H2BC3;RPA3;PCNA
HDR through MMEJ (alt-NHEJ) R-HSA-5685939	1	0	0/6	1	
HDR through Single Strand Annealing (SSA) R-HSA-5685938	0.501352035090244	1.50960242203817	1/15	1	RPA3
HHAT G278V doesn't palmitoylate Hh-Np R-HSA-5658034	1	0	0/2	1	
HIV Infection R-HSA-162906	0.508715766352322	1.04932820657442	7/148	1	UBA52;PSMC5;SKP1;POLR2F;SUPT4H1;TBP;TAF10
HIV Life Cycle R-HSA-162587	0.28592483524268	1.4373511341776	5/79	1	UBA52;POLR2F;SUPT4H1;TBP;TAF10
HIV Transcription Elongation R-HSA-167169	0.330484949669379	1.76624926591966	2/26	1	POLR2F;SUPT4H1
HIV Transcription Initiation R-HSA-167161	0.141328891355645	2.45748852829867	3/29	1	POLR2F;TBP;TAF10
HIV elongation arrest and recovery R-HSA-167287	0.296584199081995	1.92778058369726	2/24	1	POLR2F;SUPT4H1
HS-GAG biosynthesis R-HSA-2022928	1	0	0/4	1	
HS-GAG degradation R-HSA-2024096	1	0	0/8	1	
HSF1-dependent transactivation R-HSA-3371571	0.727761648685022	0.780258941667337	1/28	1	HSF1
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497	0.882626763476446	0.465997493441312	1/46	1	DYNLL1
Hedgehog 'off' state R-HSA-5610787	0.788689175527862	0.714624572797438	3/91	1	UBA52;PSMC5;SKP1
Hedgehog 'on' state R-HSA-5632684	0.827564651894636	0.625759506470564	2/69	1	UBA52;PSMC5
Hedgehog ligand biogenesis R-HSA-5358346	0.480741394947793	1.17494843860527	3/57	1	DERL2;UBA52;PSMC5
Heme biosynthesis R-HSA-189451	1	0	0/5	1	
Heme degradation R-HSA-189483	1	0	0/9	1	
Heme signaling R-HSA-9707616	0.871100880794874	0.487914657830819	1/44	1	ATF2
Hemostasis R-HSA-109582	0.999999585819089	0.0643060887060429	1/305	1	TP53
Heparan sulfate/heparin (HS-GAG) metabolism R-HSA-1638091	1	0	0/14	1	
Hereditary fructose intolerance R-HSA-5657560	1	0	0/0	1	
Hh mutants abrogate ligand secretion R-HSA-5387390	0.468944527361077	1.19742503924612	3/56	1	DERL2;UBA52;PSMC5
Hh mutants are degraded by ERAD R-HSA-5362768	0.445008708324645	1.24502193433828	3/54	1	DERL2;UBA52;PSMC5
Highly calcium permeable nicotinic acetylcholine receptors R-HSA-629597	1	0	0/3	1	
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors R-HSA-629594	1	0	0/3	1	
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors R-HSA-629587	1	0	0/3	1	
Histamine receptors R-HSA-390650	1	0	0/0	1	
Histidine catabolism R-HSA-70921	1	0	0/4	1	
Homologous DNA Pairing and Strand Exchange R-HSA-5693579	0.566274760919946	1.24232925880823	1/18	1	RPA3
Homology Directed Repair R-HSA-5693538	0.072109595965432	2.0349069028249	7/81	1	UBA52;CCNA2;H2AX;H2BC8;H2BC3;RPA3;PCNA
Hormone ligand-binding receptors R-HSA-375281	1	0	0/2	1	
Host Interactions of HIV factors R-HSA-162909	0.812527155320671	0.682832558585905	3/95	1	UBA52;PSMC5;SKP1
HuR (ELAVL1) binds and stabilizes mRNA R-HSA-450520	1	0	0/7	1	
Hyaluronan biosynthesis and export R-HSA-2142850	1	0	0/0	1	
Hyaluronan metabolism R-HSA-2142845	1	0	0/4	1	
Hyaluronan uptake and degradation R-HSA-2160916	1	0	0/4	1	
Hydrolysis of LPC R-HSA-1483115	1	0	0/4	1	
Hydrolysis of LPE R-HSA-1483152	1	0	0/0	1	
Hydroxycarboxylic acid-binding receptors R-HSA-3296197	1	0	0/0	1	
Hypusine synthesis from eIF5A-lysine R-HSA-204626	1	0	0/4	1	
IFNG signaling activates MAPKs R-HSA-9732724	1	0	0/8	1	
IGF1R signaling cascade R-HSA-2428924	1	0	0/27	1	
IKBKB deficiency causes SCID R-HSA-5602636	1	0	0/3	1	
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) R-HSA-5603027	1	0	0/3	1	
IKK complex recruitment mediated by RIP1 R-HSA-937041	0.604812877024766	1.11101589883285	1/20	1	UBA52
IL-6-type cytokine receptor ligand interactions R-HSA-6788467	1	0	0/12	1	
IRAK1 recruits IKK complex R-HSA-937039	0.399525249474029	2.11529879670146	1/11	1	UBA52
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation R-HSA-975144	0.399525249474029	2.11529879670146	1/11	1	UBA52
IRAK2 mediated activation of TAK1 complex R-HSA-937042	0.341107769845094	2.6453817850105	1/9	1	UBA52
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation R-HSA-975163	0.426772182116293	1.92268712388978	1/12	1	UBA52
IRAK4 deficiency (TLR2/4) R-HSA-5603041	1	0	0/13	1	
IRAK4 deficiency (TLR5) R-HSA-5603037	1	0	0/1	1	
IRE1alpha activates chaperones R-HSA-381070	1	0	0/24	1	
IRF3 mediated activation of type 1 IFN R-HSA-1606341	1	0	0/3	1	
IRF3-mediated induction of type I IFN R-HSA-3270619	1	0	0/6	1	
IRS activation R-HSA-74713	1	0	0/4	1	
IRS-mediated signalling R-HSA-112399	1	0	0/25	1	
IRS-related events triggered by IGF1R R-HSA-2428928	1	0	0/27	1	
ISG15 antiviral mechanism R-HSA-1169408	0.837122498402455	0.552829745416831	1/39	1	UBA52
Imatinib-resistant KIT mutants R-HSA-9669917	1	0	0/1	1	
Imatinib-resistant PDGFR mutants R-HSA-9674396	1	0	0/1	1	
Immune System R-HSA-168256	0.999865251549883	0.492280969986962	26/998	1	UBA52;PSMC5;EIF2S2;CDC26;SKP1;CXCL8;DYNLL1;POLR2F;TP53;JUN;REL;NFKB1;RELA;FOS;ATF2;UBE2A;UBE2L3;UBE2F;VAMP8;ATP6V1F;ATP6V0E1;EEF1A1;RPLP0;ARPC1A;MYC;SRP14
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell R-HSA-198933	1	0	0/45	1	
Impaired BRCA2 binding to PALB2 R-HSA-9709603	1	0	0/14	1	
Impaired BRCA2 binding to RAD51 R-HSA-9709570	0.452789218493456	1.76203882355408	1/13	1	RPA3
Impaired BRCA2 binding to SEM1 (DSS1) R-HSA-9763198	1	0	0/1	1	
Impaired BRCA2 translocation to the nucleus R-HSA-9709275	1	0	0/1	1	
Inactivation of APC/C via direct inhibition of the APC/C complex R-HSA-141430	0.566274760919946	1.24232925880823	1/18	1	CDC26
Inactivation of CDC42 and RAC1 R-HSA-428543	1	0	0/5	1	
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462	0.686900048024346	0.878459259064141	1/25	1	UBA52
Inactivation, recovery and regulation of the phototransduction cascade R-HSA-2514859	1	0	0/9	1	
Incretin synthesis, secretion, and inactivation R-HSA-400508	0.399525249474029	2.11529879670146	1/11	1	SEC11A
Induction of Cell-Cell Fusion R-HSA-9733458	1	0	0/4	1	
Infection with Mycobacterium tuberculosis R-HSA-9635486	0.524000974672891	1.40863417894967	1/16	1	UBA52
Inflammasomes R-HSA-622312	0.211408656218083	2.49763475961611	2/19	1	NFKB1;RELA
Influenza Virus Induced Apoptosis R-HSA-168277	1	0	0/1	1	
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits R-HSA-997272	1	0	0/11	1	
Inhibition of DNA recombination at telomere R-HSA-9670095	0.246563660017392	1.63661119382666	4/56	1	POLR2F;H2AX;H2BC8;H2BC3
Inhibition of Host mRNA Processing and RNA Silencing R-HSA-168315	1	0	0/0	1	
Inhibition of PKR R-HSA-169131	1	0	0/1	1	
Inhibition of Signaling by Overexpressed EGFR R-HSA-5638303	1	0	0/8	1	
Inhibition of TSC complex formation by PKB R-HSA-165181	1	0	0/3	1	
Inhibition of membrane repair R-HSA-9635644	1	0	0/1	1	
Inhibition of nitric oxide production R-HSA-9636249	1	0	0/3	1	
Inhibition of replication initiation of damaged DNA by RB1/E2F1 R-HSA-113501	0.0721621680941335	5.31709371407414	2/10	1	TFDP1;E2F1
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components R-HSA-141405	0.566274760919946	1.24232925880823	1/18	1	CDC26
Initial triggering of complement R-HSA-166663	1	0	0/11	1	
Initiation of Nuclear Envelope (NE) Reformation R-HSA-2995383	1	0	0/8	1	
InlA-mediated entry of Listeria monocytogenes into host cells R-HSA-8876493	0.309813381545497	3.02371343760045	1/8	1	UBA52
InlB-mediated entry of Listeria monocytogenes into host cell R-HSA-8875360	0.37099061448409	2.35079399308912	1/10	1	UBA52
Innate Immune System R-HSA-168249	0.951071065519438	0.680626088029276	17/522	1	UBA52;PSMC5;SKP1;DYNLL1;POLR2F;TP53;JUN;NFKB1;RELA;FOS;ATF2;VAMP8;ATP6V1F;ATP6V0E1;EEF1A1;ARPC1A;SRP14
Inositol phosphate metabolism R-HSA-1483249	1	0	0/15	1	
Inositol transporters R-HSA-429593	1	0	0/0	1	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane R-HSA-9609523	1	0	0/13	1	
Insulin effects increased synthesis of Xylulose-5-Phosphate R-HSA-163754	1	0	0/2	1	
Insulin processing R-HSA-264876	1	0	0/8	1	
Insulin receptor recycling R-HSA-77387	0.161617941350537	3.03489390408789	2/16	1	ATP6V1F;ATP6V0E1
Insulin receptor signalling cascade R-HSA-74751	1	0	0/29	1	
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA R-HSA-428359	1	0	0/0	1	
Integration of energy metabolism R-HSA-163685	1	0	0/48	1	
Integration of provirus R-HSA-162592	1	0	0/7	1	
Integration of viral DNA into host genomic DNA R-HSA-175567	1	0	0/3	1	
Integrin cell surface interactions R-HSA-216083	1	0	0/50	1	
Integrin signaling R-HSA-354192	1	0	0/14	1	
Interaction With Cumulus Cells And The Zona Pellucida R-HSA-2534343	1	0	0/3	1	
Interaction between L1 and Ankyrins R-HSA-445095	1	0	0/13	1	
Interaction between PHLDA1 and AURKA R-HSA-8854521	1	0	0/2	1	
Interactions of Rev with host cellular proteins R-HSA-177243	1	0	0/14	1	
Interactions of Tat with host cellular proteins R-HSA-176034	1	0	0/2	1	
Interactions of Vpr with host cellular proteins R-HSA-176033	1	0	0/14	1	
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate R-HSA-880009	1	0	0/3	1	
Interconversion of nucleotide di- and triphosphates R-HSA-499943	0.0998089904091194	4.25231271824667	2/12	1	GUK1;NME4
Interconversion of polyamines R-HSA-351200	1	0	0/0	1	
Interferon Signaling R-HSA-913531	0.990943895134767	0.34288966812687	3/182	1	UBA52;EIF2S2;TP53
Interferon alpha/beta signaling R-HSA-909733	0.936227336365012	0.360328277473136	1/59	1	UBA52
Interferon gamma signaling R-HSA-877300	1	0	0/59	1	
Interleukin receptor SHC signaling R-HSA-912526	1	0	0/16	1	
Interleukin-1 family signaling R-HSA-446652	0.429199332201964	1.15588719725083	6/116	1	UBA52;PSMC5;SKP1;TP53;NFKB1;RELA
Interleukin-1 signaling R-HSA-9020702	0.274487812376274	1.40420800452663	6/97	1	UBA52;PSMC5;SKP1;TP53;NFKB1;RELA
Interleukin-10 signaling R-HSA-6783783	0.812601772791195	0.600680353804841	1/36	1	CXCL8
Interleukin-12 family signaling R-HSA-447115	0.829325851059439	0.567917875934568	1/38	1	RPLP0
Interleukin-12 signaling R-HSA-9020591	0.727761648685022	0.780258941667337	1/28	1	RPLP0
Interleukin-15 signaling R-HSA-8983432	1	0	0/9	1	
Interleukin-18 signaling R-HSA-9012546	1	0	0/4	1	
Interleukin-2 family signaling R-HSA-451927	1	0	0/30	1	
Interleukin-2 signaling R-HSA-9020558	1	0	0/8	1	
Interleukin-20 family signaling R-HSA-8854691	1	0	0/25	1	
Interleukin-21 signaling R-HSA-9020958	1	0	0/10	1	
Interleukin-23 signaling R-HSA-9020933	1	0	0/7	1	
Interleukin-27 signaling R-HSA-9020956	1	0	0/11	1	
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988	0.803638397051725	0.618506809282829	1/35	1	UBA52
Interleukin-33 signaling R-HSA-9014843	1	0	0/1	1	
Interleukin-35 Signalling R-HSA-8984722	1	0	0/12	1	
Interleukin-36 pathway R-HSA-9014826	1	0	0/1	1	
Interleukin-37 signaling R-HSA-9008059	1	0	0/11	1	
Interleukin-38 signaling R-HSA-9007892	1	0	0/2	1	
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807	0.66322114407094	0.885879717358511	4/99	1	CXCL8;TP53;FOS;MYC
Interleukin-6 family signaling R-HSA-6783589	1	0	0/19	1	
Interleukin-6 signaling R-HSA-1059683	1	0	0/11	1	
Interleukin-7 signaling R-HSA-1266695	1	0	0/33	1	
Interleukin-9 signaling R-HSA-8985947	1	0	0/9	1	
Intestinal absorption R-HSA-8963676	1	0	0/2	1	
Intestinal hexose absorption R-HSA-8981373	1	0	0/2	1	
Intestinal infectious diseases R-HSA-8942233	1	0	0/0	1	
Intestinal lipid absorption R-HSA-8963678	1	0	0/0	1	
Intestinal saccharidase deficiencies R-HSA-5659898	1	0	0/1	1	
Intra-Golgi and retrograde Golgi-to-ER traffic R-HSA-6811442	0.992755359147685	0.198530713260435	1/105	1	DYNLL1
Intra-Golgi traffic R-HSA-6811438	1	0	0/25	1	
Intracellular metabolism of fatty acids regulates insulin secretion R-HSA-434313	1	0	0/1	1	
Intracellular oxygen transport R-HSA-8981607	1	0	0/0	1	
Intracellular signaling by second messengers R-HSA-9006925	0.976942995787618	0.471767843272244	5/222	1	UBA52;PSMC5;TP53;JUN;ATF2
Intraflagellar transport R-HSA-5620924	0.396721330326088	1.51241896463767	2/30	1	DYNLL1;IFT43
Intrinsic Pathway of Fibrin Clot Formation R-HSA-140837	1	0	0/12	1	
Invadopodia formation R-HSA-8941237	1	0	0/3	1	
Inwardly rectifying K+ channels R-HSA-1296065	1	0	0/13	1	
Ion channel transport R-HSA-983712	0.630816115142367	0.929672288614347	3/71	1	UBA52;ATP6V1F;ATP6V0E1
Ion homeostasis R-HSA-5578775	1	0	0/27	1	
Ion influx/efflux at host-pathogen interface R-HSA-6803544	1	0	0/2	1	
Ion transport by P-type ATPases R-HSA-936837	1	0	0/19	1	
Ionotropic activity of kainate receptors R-HSA-451306	1	0	0/4	1	
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 R-HSA-450321	0.622784856026871	1.05523077016551	1/21	1	UBA52
Josephin domain DUBs R-HSA-5689877	0.242721710581898	4.23445267568269	1/6	1	UBA52
KEAP1-NFE2L2 pathway R-HSA-9755511	0.249439476080337	1.40877830145769	7/113	1	UBA52;PSMC5;SKP1;NFKB1;RELA;SP1;MYC
KIT mutants bind TKIs R-HSA-9669921	1	0	0/1	1	
KSRP (KHSRP) binds and destabilizes mRNA R-HSA-450604	1	0	0/16	1	
KW2449-resistant FLT3 mutants R-HSA-9702569	1	0	0/0	1	
Keratan sulfate biosynthesis R-HSA-2022854	1	0	0/9	1	
Keratan sulfate degradation R-HSA-2022857	1	0	0/7	1	
Keratan sulfate/keratin metabolism R-HSA-1638074	1	0	0/12	1	
Keratinization R-HSA-6805567	1	0	0/11	1	
Ketone body metabolism R-HSA-74182	1	0	0/1	1	
Kidney development R-HSA-9830369	1	0	0/21	1	
Killing mechanisms R-HSA-9664420	0.242721710581898	4.23445267568269	1/6	1	JUN
Kinesins R-HSA-983189	1	0	0/28	1	
L1CAM interactions R-HSA-373760	1	0	0/70	1	
LDL clearance R-HSA-8964038	1	0	0/8	1	
LDL remodeling R-HSA-8964041	1	0	0/3	1	
LGI-ADAM interactions R-HSA-5682910	1	0	0/1	1	
LGK974 inhibits PORCN R-HSA-5340573	1	0	0/0	1	
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production R-HSA-3134973	1	0	0/5	1	
LTC4-CYSLTR mediated IL4 production R-HSA-9664535	1	0	0/2	1	
Lactose synthesis R-HSA-5653890	1	0	0/0	1	
Laminin interactions R-HSA-3000157	1	0	0/17	1	
Late Phase of HIV Life Cycle R-HSA-162599	0.208793479111728	1.6401884952875	5/70	1	UBA52;POLR2F;SUPT4H1;TBP;TAF10
Late SARS-CoV-2 Infection Events R-HSA-9772573	0.784412680894045	0.657501709845148	1/33	1	UBA52
Late endosomal microautophagy R-HSA-9615710	0.524000974672891	1.40863417894967	1/16	1	UBA52
Latent infection - Other responses of Mtb to phagocytosis R-HSA-1222499	1	0	0/0	1	
Leading Strand Synthesis R-HSA-69109	0.206782414170199	5.2933772792375	1/5	1	PCNA
Lectin pathway of complement activation R-HSA-166662	1	0	0/4	1	
Leishmania infection R-HSA-9658195	0.66322114407094	0.885879717358511	4/99	1	JUN;NFKB1;RELA;ARPC1A
Leishmania parasite growth and survival R-HSA-9664433	1	0	0/42	1	
Leishmania phagocytosis R-HSA-9664417	0.812601772791195	0.600680353804841	1/36	1	ARPC1A
Leukotriene receptors R-HSA-391906	1	0	0/1	1	
Lewis blood group biosynthesis R-HSA-9037629	1	0	0/3	1	
Ligand-receptor interactions R-HSA-5632681	1	0	0/5	1	
Linoleic acid (LA) metabolism R-HSA-2046105	1	0	0/3	1	
Lipid particle organization R-HSA-8964572	1	0	0/2	1	
Lipophagy R-HSA-9613354	1	0	0/4	1	
Listeria monocytogenes entry into host cells R-HSA-8876384	0.477631583419205	1.62611481395553	1/14	1	UBA52
Localization of the PINCH-ILK-PARVIN complex to focal adhesions R-HSA-446343	1	0	0/4	1	
Long-term potentiation R-HSA-9620244	1	0	0/13	1	
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling R-HSA-2644607	0.206782414170199	5.2933772792375	1/5	1	SKP1
Loss of Function of SMAD2/3 in Cancer R-HSA-3304349	1	0	0/7	1	
Loss of Function of SMAD4 in Cancer R-HSA-3304347	1	0	0/3	1	
Loss of Function of TGFBR1 in Cancer R-HSA-3656534	1	0	0/7	1	
Loss of Function of TGFBR2 in Cancer R-HSA-3642278	1	0	0/3	1	
Loss of MECP2 binding ability to 5hmC-DNA R-HSA-9022534	1	0	0/1	1	
Loss of MECP2 binding ability to 5mC-DNA R-HSA-9022538	1	0	0/3	1	
Loss of MECP2 binding ability to the NCoR/SMRT complex R-HSA-9022537	1	0	0/6	1	
Loss of Nlp from mitotic centrosomes R-HSA-380259	0.812601772791195	0.600680353804841	1/36	1	DYNLL1
Loss of function of MECP2 in Rett syndrome R-HSA-9005891	1	0	0/10	1	
Loss of phosphorylation of MECP2 at T308 R-HSA-9022535	1	0	0/3	1	
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284	0.812601772791195	0.600680353804841	1/36	1	DYNLL1
Lysine catabolism R-HSA-71064	1	0	0/6	1	
Lysosomal oligosaccharide catabolism R-HSA-8853383	1	0	0/2	1	
Lysosome Vesicle Biogenesis R-HSA-432720	0.671967212159988	0.916883980868546	1/24	1	VAMP8
Lysosphingolipid and LPA receptors R-HSA-419408	1	0	0/2	1	
M Phase R-HSA-68886	0.737824417984994	0.845772859276775	10/257	1	UBA52;PSMC5;CDC26;DYNLL1;H2AX;H2BC8;H2BC3;RPS27;ZWINT;BUB1
M-decay: degradation of maternal mRNAs by maternally stored factors R-HSA-9820841	0.566274760919946	1.24232925880823	1/18	1	RPS2
MAP2K and MAPK activation R-HSA-5674135	1	0	0/22	1	
MAPK family signaling cascades R-HSA-5683057	0.968515367685357	0.465171957948976	4/181	1	UBA52;PSMC5;JUN;MYC
MAPK targets/ Nuclear events mediated by MAP kinases R-HSA-450282	0.101142247248105	2.90706588742707	3/25	1	JUN;FOS;ATF2
MAPK1 (ERK2) activation R-HSA-112411	1	0	0/8	1	
MAPK1/MAPK3 signaling R-HSA-5684996	0.99451590336793	0.26603402851655	2/156	1	UBA52;PSMC5
MAPK3 (ERK1) activation R-HSA-110056	1	0	0/9	1	
MAPK6/MAPK4 signaling R-HSA-5687128	0.432775479452354	1.21015192324679	4/74	1	UBA52;PSMC5;JUN;MYC
MASTL Facilitates Mitotic Progression R-HSA-2465910	1	0	0/10	1	
MDK and PTN in ALK signaling R-HSA-9851151	1	0	0/1	1	
MECP2 regulates neuronal receptors and channels R-HSA-9022699	1	0	0/9	1	
MECP2 regulates transcription factors R-HSA-9022707	1	0	0/4	1	
MECP2 regulates transcription of genes involved in GABA signaling R-HSA-9022927	1	0	0/1	1	
MECP2 regulates transcription of neuronal ligands R-HSA-9022702	1	0	0/5	1	
MET Receptor Activation R-HSA-6806942	1	0	0/1	1	
MET activates PI3K/AKT signaling R-HSA-8851907	1	0	0/5	1	
MET activates PTK2 signaling R-HSA-8874081	1	0	0/19	1	
MET activates PTPN11 R-HSA-8865999	1	0	0/4	1	
MET activates RAP1 and RAC1 R-HSA-8875555	1	0	0/7	1	
MET activates RAS signaling R-HSA-8851805	1	0	0/8	1	
MET activates STAT3 R-HSA-8875791	1	0	0/2	1	
MET interacts with TNS proteins R-HSA-8875513	1	0	0/2	1	
MET promotes cell motility R-HSA-8875878	1	0	0/25	1	
MET receptor recycling R-HSA-8875656	1	0	0/7	1	
MGMT-mediated DNA damage reversal R-HSA-5657655	1	0	0/0	1	
MHC class II antigen presentation R-HSA-2132295	0.954121333738253	0.320935334937687	1/66	1	DYNLL1
MITF-M-dependent gene expression R-HSA-9856651	0.635491219440609	0.937030698222518	2/47	1	ATP6V1F;ATP6V0E1
MITF-M-regulated melanocyte development R-HSA-9730414	0.794146700811527	0.67710905589429	2/64	1	ATP6V1F;ATP6V0E1
MPS I - Hurler syndrome R-HSA-2206302	1	0	0/1	1	
MPS II - Hunter syndrome R-HSA-2206296	1	0	0/0	1	
MPS IIIA - Sanfilippo syndrome A R-HSA-2206307	1	0	0/1	1	
MPS IIIB - Sanfilippo syndrome B R-HSA-2206282	1	0	0/1	1	
MPS IIIC - Sanfilippo syndrome C R-HSA-2206291	1	0	0/1	1	
MPS IIID - Sanfilippo syndrome D R-HSA-2206305	1	0	0/1	1	
MPS IV - Morquio syndrome A R-HSA-2206290	1	0	0/0	1	
MPS IV - Morquio syndrome B R-HSA-2206308	1	0	0/0	1	
MPS IX - Natowicz syndrome R-HSA-2206280	1	0	0/0	1	
MPS VI - Maroteaux-Lamy syndrome R-HSA-2206285	1	0	0/0	1	
MPS VII - Sly syndrome R-HSA-2206292	1	0	0/0	1	
MTF1 activates gene expression R-HSA-5660489	1	0	0/0	1	
MTOR signalling R-HSA-165159	0.794248751548842	0.637413509336522	1/34	1	RPS6
Macroautophagy R-HSA-1632852	0.733567487089934	0.787744053694987	3/83	1	UBA52;DYNLL1;HSF1
Malate-aspartate shuttle R-HSA-9856872	1	0	0/3	1	
Manipulation of host energy metabolism R-HSA-9636667	1	0	0/2	1	
Masitinib-resistant KIT mutants R-HSA-9669924	1	0	0/1	1	
Maternal to zygotic transition (MZT) R-HSA-9816359	0.367421438619014	1.2785093871665	5/88	1	H2AX;H2BC8;H2BC3;TP53;RPS2
Maturation of TCA enzymes and regulation of TCA cycle R-HSA-9854311	1	0	0/5	1	
Maturation of hRSV A proteins R-HSA-9828806	0.426772182116293	1.92268712388978	1/12	1	SEC11A
Maturation of nucleoprotein R-HSA-9683610	1	0	0/8	1	
Maturation of nucleoprotein R-HSA-9694631	1	0	0/10	1	
Maturation of protein 3a R-HSA-9683673	1	0	0/4	1	
Maturation of protein 3a R-HSA-9694719	1	0	0/4	1	
Maturation of protein E R-HSA-9683683	0.169147252592067	7.0579254813706	1/4	1	UBA52
Maturation of protein E R-HSA-9694493	0.169147252592067	7.0579254813706	1/4	1	UBA52
Maturation of replicase proteins R-HSA-9694301	1	0	0/0	1	
Maturation of spike protein R-HSA-9683686	1	0	0/2	1	
Maturation of spike protein R-HSA-9694548	1	0	0/14	1	
Meiosis R-HSA-1500620	0.503195588876364	1.09812336982383	4/81	1	H2AX;H2BC8;H2BC3;RPA3
Meiotic recombination R-HSA-912446	0.370470442601175	1.32566180724103	4/68	1	H2AX;H2BC8;H2BC3;RPA3
Meiotic synapsis R-HSA-1221632	0.457031266610523	1.22076592574228	3/55	1	H2AX;H2BC8;H2BC3
Melanin biosynthesis R-HSA-5662702	1	0	0/1	1	
Membrane Trafficking R-HSA-199991	0.999350882546067	0.282582107717493	4/287	1	UBA52;DYNLL1;VAMP8;ARPC1A
Membrane binding and targetting of GAG proteins R-HSA-174490	0.27704115757633	3.52822750116427	1/7	1	UBA52
Metabolic disorders of biological oxidation enzymes R-HSA-5579029	1	0	0/10	1	
Metabolism of Angiotensinogen to Angiotensins R-HSA-2022377	1	0	0/7	1	
Metabolism of amine-derived hormones R-HSA-209776	1	0	0/5	1	
Metabolism of carbohydrates R-HSA-71387	0.9934129540526	0.194681384673418	1/107	1	UBA52
Metabolism of cofactors R-HSA-8978934	0.242721710581898	4.23445267568269	1/6	1	COQ3
Metabolism of fat-soluble vitamins R-HSA-6806667	1	0	0/13	1	
Metabolism of folate and pterines R-HSA-196757	1	0	0/9	1	
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se R-HSA-2408550	1	0	0/3	1	
Metabolism of ingested MeSeO2H into MeSeH R-HSA-5263617	1	0	0/1	1	
Metabolism of ingested SeMet, Sec, MeSec into H2Se R-HSA-2408508	1	0	0/4	1	
Metabolism of lipids R-HSA-556833	0.999999518567532	0.0650017625664903	1/302	1	SP1
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131	1	0	0/7	1	
Metabolism of non-coding RNA R-HSA-194441	0.24537329698268	2.23374304689324	2/21	1	SNRPE;SNRPG
Metabolism of nucleotides R-HSA-15869	0.546871130387055	1.11162888632792	2/40	1	GUK1;NME4
Metabolism of polyamines R-HSA-351202	0.907151328210533	0.418853467918592	1/51	1	PSMC5
Metabolism of porphyrins R-HSA-189445	1	0	0/13	1	
Metabolism of serotonin R-HSA-380612	1	0	0/1	1	
Metabolism of steroid hormones R-HSA-196071	1	0	0/7	1	
Metabolism of steroids R-HSA-8957322	0.911406601673461	0.410533816938532	1/52	1	SP1
Metabolism of vitamin K R-HSA-6806664	1	0	0/0	1	
Metabolism of vitamins and cofactors R-HSA-196854	0.947162992645434	0.336728914587051	1/63	1	COQ3
Metabolism of water-soluble vitamins and cofactors R-HSA-196849	1	0	0/44	1	
Metal ion SLC transporters R-HSA-425410	1	0	0/3	1	
Metal sequestration by antimicrobial proteins R-HSA-6799990	1	0	0/3	1	
Metalloprotease DUBs R-HSA-5689901	0.671967212159988	0.916883980868546	1/24	1	UBA52
Metallothioneins bind metals R-HSA-5661231	1	0	0/0	1	
Methionine salvage pathway R-HSA-1237112	1	0	0/4	1	
Methylation R-HSA-156581	1	0	0/7	1	
MicroRNA (miRNA) biogenesis R-HSA-203927	0.566274760919946	1.24232925880823	1/18	1	POLR2F
Microbial modulation of RIPK1-mediated regulated necrosis R-HSA-9686347	1	0	0/4	1	
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane R-HSA-190840	1	0	0/20	1	
Mineralocorticoid biosynthesis R-HSA-193993	1	0	0/0	1	
Minus-strand DNA synthesis R-HSA-164516	1	0	0/1	1	
Miro GTPase Cycle R-HSA-9715370	1	0	0/1	1	
Miscellaneous substrates R-HSA-211958	1	0	0/5	1	
Miscellaneous transport and binding events R-HSA-5223345	1	0	0/8	1	
Mitochondrial ABC transporters R-HSA-1369007	1	0	0/3	1	
Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289	1	0	0/21	1	
Mitochondrial RNA degradation R-HSA-9836573	1	0	0/0	1	
Mitochondrial Uncoupling R-HSA-166187	1	0	0/0	1	
Mitochondrial biogenesis R-HSA-1592230	0.339094230446951	1.39192303138768	4/65	1	CYCS;ATF2;ATP5MF;ATP5F1D
Mitochondrial calcium ion transport R-HSA-8949215	1	0	0/13	1	
Mitochondrial iron-sulfur cluster biogenesis R-HSA-1362409	1	0	0/1	1	
Mitochondrial protein degradation R-HSA-9837999	0.188589482615972	1.85300832447952	4/50	1	COX5A;UQCRQ;COX4I1;MRPL12
Mitochondrial protein import R-HSA-1268020	1	0	0/26	1	
Mitochondrial tRNA aminoacylation R-HSA-379726	1	0	0/6	1	
Mitochondrial transcription initiation R-HSA-163282	1	0	0/2	1	
Mitochondrial transcription termination R-HSA-163316	1	0	0/0	1	
Mitophagy R-HSA-5205647	0.524000974672891	1.40863417894967	1/16	1	UBA52
Mitotic Anaphase R-HSA-68882	0.494066520358879	1.06500513304254	7/146	1	UBA52;PSMC5;CDC26;DYNLL1;RPS27;ZWINT;BUB1
Mitotic G2-G2/M phases R-HSA-453274	0.411754546647968	1.15988805278544	7/135	1	UBA52;PSMC5;SKP1;CCNA2;DYNLL1;E2F1;TP53
Mitotic Metaphase and Anaphase R-HSA-2555396	0.494066520358879	1.06500513304254	7/146	1	UBA52;PSMC5;CDC26;DYNLL1;RPS27;ZWINT;BUB1
Mitotic Metaphase/Anaphase Transition R-HSA-68881	1	0	0/1	1	
Mitotic Prometaphase R-HSA-68877	0.647262314516977	0.905407867004184	4/97	1	DYNLL1;RPS27;ZWINT;BUB1
Mitotic Prophase R-HSA-68875	0.800904716352309	0.698375389336399	3/93	1	H2AX;H2BC8;H2BC3
Mitotic Spindle Checkpoint R-HSA-69618	0.0736107877385553	2.38126209931747	5/50	1	CDC26;DYNLL1;RPS27;ZWINT;BUB1
Mitotic Telophase/Cytokinesis R-HSA-68884	1	0	0/11	1	
Modulation by Mtb of host immune system R-HSA-9637628	0.242721710581898	4.23445267568269	1/6	1	UBA52
Molecules associated with elastic fibres R-HSA-2129379	1	0	0/17	1	
Molybdenum cofactor biosynthesis R-HSA-947581	1	0	0/2	1	
Mtb iron assimilation by chelation R-HSA-1222449	1	0	0/0	1	
Mucopolysaccharidoses R-HSA-2206281	1	0	0/5	1	
Multifunctional anion exchangers R-HSA-427601	1	0	0/2	1	
Muscarinic acetylcholine receptors R-HSA-390648	1	0	0/0	1	
Muscle contraction R-HSA-397014	1	0	0/97	1	
MyD88 deficiency (TLR2/4) R-HSA-5602498	1	0	0/13	1	
MyD88 deficiency (TLR5) R-HSA-5602680	1	0	0/1	1	
Myoclonic epilepsy of Lafora R-HSA-3785653	0.242721710581898	4.23445267568269	1/6	1	UBA52
Myogenesis R-HSA-525793	1	0	0/18	1	
N-Glycan antennae elongation R-HSA-975577	1	0	0/3	1	
N-glycan antennae elongation in the medial/trans-Golgi R-HSA-975576	1	0	0/5	1	
N-glycan trimming and elongation in the cis-Golgi R-HSA-964739	1	0	0/0	1	
NADE modulates death signalling R-HSA-205025	1	0	0/4	1	
NADPH regeneration R-HSA-389542	1	0	0/0	1	
NCAM signaling for neurite out-growth R-HSA-375165	1	0	0/33	1	
NCAM1 interactions R-HSA-419037	1	0	0/20	1	
NEIL3-mediated resolution of ICLs R-HSA-9636003	1	0	0/0	1	
NEP/NS2 Interacts with the Cellular Export Machinery R-HSA-168333	1	0	0/11	1	
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 R-HSA-933543	1	0	0/11	1	
NFE2L2 regulates pentose phosphate pathway genes R-HSA-9818028	1	0	0/8	1	
NFE2L2 regulating ER-stress associated genes R-HSA-9818035	1	0	0/5	1	
NFE2L2 regulating MDR associated enzymes R-HSA-9818032	1	0	0/7	1	
NFE2L2 regulating TCA cycle genes R-HSA-9818025	1	0	0/1	1	
NFE2L2 regulating anti-oxidant/detoxification enzymes R-HSA-9818027	1	0	0/19	1	
NFE2L2 regulating inflammation associated genes R-HSA-9818026	1	0	0/5	1	
NFE2L2 regulating tumorigenic genes R-HSA-9818030	0.399525249474029	2.11529879670146	1/11	1	SP1
NFG and proNGF binds to p75NTR R-HSA-205017	1	0	0/1	1	
NGF processing R-HSA-167060	1	0	0/2	1	
NGF-independant TRKA activation R-HSA-187024	1	0	0/3	1	
NGF-stimulated transcription R-HSA-9031628	0.489920246170283	1.24366815934197	2/36	1	FOS;ATF2
NIK-->noncanonical NF-kB signaling R-HSA-5676590	0.480741394947793	1.17494843860527	3/57	1	UBA52;PSMC5;SKP1
NOD1/2 Signaling Pathway R-HSA-168638	0.763315860802052	0.701695123324785	1/31	1	UBA52
NOSIP mediated eNOS trafficking R-HSA-203754	1	0	0/0	1	
NOSTRIN mediated eNOS trafficking R-HSA-203641	1	0	0/2	1	
NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947	0.371043202967936	1.41317586036907	3/48	1	UBA52;SKP1;MYC
NOTCH2 Activation and Transmission of Signal to the Nucleus R-HSA-2979096	0.452789218493456	1.76203882355408	1/13	1	UBA52
NOTCH2 intracellular domain regulates transcription R-HSA-2197563	1	0	0/12	1	
NOTCH3 Activation and Transmission of Signal to the Nucleus R-HSA-9013507	0.524000974672891	1.40863417894967	1/16	1	UBA52
NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508	1	0	0/24	1	
NOTCH4 Activation and Transmission of Signal to the Nucleus R-HSA-9013700	1	0	0/8	1	
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695	1	0	0/20	1	
NPAS4 regulates expression of target genes R-HSA-9768919	0.452789218493456	1.76203882355408	1/13	1	FOS
NR1D1 (REV-ERBA) represses gene expression R-HSA-1368071	1	0	0/3	1	
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis  R-HSA-9632974	1	0	0/4	1	
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis R-HSA-9029558	1	0	0/5	1	
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose R-HSA-9031528	1	0	0/3	1	
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis R-HSA-9623433	1	0	0/6	1	
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake  R-HSA-9031525	1	0	0/4	1	
NR1H2 and NR1H3-mediated signaling R-HSA-9024446	1	0	0/23	1	
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux R-HSA-9029569	1	0	0/20	1	
NRAGE signals death through JNK R-HSA-193648	1	0	0/28	1	
NRIF signals cell death from the nucleus R-HSA-205043	0.426772182116293	1.92268712388978	1/12	1	UBA52
NS1 Mediated Effects on Host Pathways R-HSA-168276	1	0	0/14	1	
NTF3 activates NTRK2 (TRKB) signaling R-HSA-9025046	1	0	0/1	1	
NTF3 activates NTRK3 signaling R-HSA-9034013	1	0	0/0	1	
NTF4 activates NTRK2 (TRKB) signaling R-HSA-9026357	1	0	0/1	1	
NTRK2 activates RAC1 R-HSA-9032759	1	0	0/3	1	
NVP-TAE684-resistant ALK mutants R-HSA-9717301	1	0	0/0	1	
Na+/Cl- dependent neurotransmitter transporters R-HSA-442660	1	0	0/4	1	
Nectin/Necl  trans heterodimerization R-HSA-420597	1	0	0/2	1	
Neddylation R-HSA-8951664	0.563753445402968	0.996664371444052	6/133	1	UBA52;PSMC5;SKP1;UBE2F;UCHL3;COMMD6
Nef Mediated CD4 Down-regulation R-HSA-167590	1	0	0/6	1	
Nef Mediated CD8 Down-regulation R-HSA-182218	1	0	0/4	1	
Nef and signal transduction R-HSA-164944	1	0	0/7	1	
Nef mediated downregulation of CD28 cell surface expression R-HSA-164939	1	0	0/1	1	
Nef mediated downregulation of MHC class I complex cell surface expression R-HSA-164940	1	0	0/5	1	
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters R-HSA-164938	1	0	0/12	1	
Negative epigenetic regulation of rRNA expression R-HSA-5250941	0.294840926222009	1.41781952428007	5/80	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
Negative feedback regulation of MAPK pathway R-HSA-5674499	1	0	0/4	1	
Negative regulation of FGFR1 signaling R-HSA-5654726	0.545626551046988	1.32029355805218	1/17	1	UBA52
Negative regulation of FGFR2 signaling R-HSA-5654727	0.585989544514493	1.17302584275925	1/19	1	UBA52
Negative regulation of FGFR3 signaling R-HSA-5654732	0.545626551046988	1.32029355805218	1/17	1	UBA52
Negative regulation of FGFR4 signaling R-HSA-5654733	0.545626551046988	1.32029355805218	1/17	1	UBA52
Negative regulation of FLT3 R-HSA-9706369	0.309813381545497	3.02371343760045	1/8	1	UBA52
Negative regulation of MAPK pathway R-HSA-5675221	0.622784856026871	1.05523077016551	1/21	1	UBA52
Negative regulation of MET activity R-HSA-6807004	0.452789218493456	1.76203882355408	1/13	1	UBA52
Negative regulation of NMDA receptor-mediated neuronal transmission R-HSA-9617324	1	0	0/12	1	
Negative regulation of NOTCH4 signaling R-HSA-9604323	0.420666715016203	1.29650338349409	3/52	1	UBA52;PSMC5;SKP1
Negative regulation of TCF-dependent signaling by DVL-interacting proteins R-HSA-5368598	1	0	0/2	1	
Negative regulation of TCF-dependent signaling by WNT ligand antagonists R-HSA-3772470	1	0	0/6	1	
Negative regulation of activity of TFAP2 (AP-2) family transcription factors R-HSA-8866904	1	0	0/6	1	
Negative regulation of the PI3K/AKT network R-HSA-199418	1	0	0/64	1	
Negative regulators of DDX58/IFIH1 signaling R-HSA-936440	0.714767486376561	0.810474977491103	1/27	1	UBA52
Nephrin family interactions R-HSA-373753	1	0	0/15	1	
Nephron development R-HSA-9831926	1	0	0/7	1	
Netrin mediated repulsion signals R-HSA-418886	1	0	0/5	1	
Netrin-1 signaling R-HSA-373752	1	0	0/18	1	
Neurexins and neuroligins R-HSA-6794361	1	0	0/16	1	
Neurodegenerative Diseases R-HSA-8863678	0.452789218493456	1.76203882355408	1/13	1	JUN
Neurofascin interactions R-HSA-447043	1	0	0/4	1	
Neuronal System R-HSA-112316	1	0	0/140	1	
Neurophilin interactions with VEGF and VEGFR R-HSA-194306	1	0	0/2	1	
Neurotoxicity of clostridium toxins R-HSA-168799	1	0	0/3	1	
Neurotransmitter clearance R-HSA-112311	1	0	0/2	1	
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314	1	0	0/93	1	
Neurotransmitter release cycle R-HSA-112310	1	0	0/15	1	
Neurotransmitter uptake and metabolism In glial cells R-HSA-112313	1	0	0/2	1	
Neutrophil degranulation R-HSA-6798695	0.942138736219728	0.55196926101788	5/192	1	DYNLL1;NFKB1;VAMP8;EEF1A1;SRP14
Nicotinamide salvaging R-HSA-197264	1	0	0/7	1	
Nicotinate metabolism R-HSA-196807	1	0	0/12	1	
Nilotinib-resistant KIT mutants R-HSA-9669926	1	0	0/1	1	
Nitric oxide stimulates guanylate cyclase R-HSA-392154	1	0	0/7	1	
NoRC negatively regulates rRNA expression R-HSA-427413	0.28592483524268	1.4373511341776	5/79	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
Non-integrin membrane-ECM interactions R-HSA-3000171	1	0	0/33	1	
Noncanonical activation of NOTCH3 R-HSA-9017802	1	0	0/6	1	
Nonhomologous End-Joining (NHEJ) R-HSA-5693571	0.395986040988239	1.35235537341895	3/50	1	H2AX;H2BC8;H2BC3
Norepinephrine Neurotransmitter Release Cycle R-HSA-181430	1	0	0/6	1	
Notch-HLH transcription pathway R-HSA-350054	1	0	0/28	1	
NrCAM interactions R-HSA-447038	1	0	0/3	1	
Nuclear Envelope (NE) Reassembly R-HSA-2995410	1	0	0/43	1	
Nuclear Envelope Breakdown R-HSA-2980766	1	0	0/19	1	
Nuclear Events (kinase and transcription factor activation) R-HSA-198725	0.690132381601193	0.842240269286321	2/52	1	FOS;ATF2
Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854	1	0	0/12	1	
Nuclear Receptor transcription pathway R-HSA-383280	1	0	0/33	1	
Nuclear events mediated by NFE2L2 R-HSA-9759194	0.11606828033002	1.78800611985304	7/91	1	UBA52;PSMC5;SKP1;NFKB1;RELA;SP1;MYC
Nuclear events stimulated by ALK signaling in cancer R-HSA-9725371	0.347274957090143	1.69518080840278	2/27	1	SKP1;RPS6
Nuclear import of Rev protein R-HSA-180746	1	0	0/12	1	
Nuclear signaling by ERBB4 R-HSA-1251985	1	0	0/22	1	
Nucleosome assembly R-HSA-774815	0.371043202967936	1.41317586036907	3/48	1	H2AX;H2BC8;H2BC3
Nucleotide Excision Repair R-HSA-5696398	0.256600910800206	1.60531833950966	4/57	1	UBA52;POLR2F;RPA3;PCNA
Nucleotide biosynthesis R-HSA-8956320	1	0	0/5	1	
Nucleotide catabolism R-HSA-8956319	1	0	0/17	1	
Nucleotide catabolism defects R-HSA-9735786	1	0	0/1	1	
Nucleotide salvage R-HSA-8956321	1	0	0/9	1	
Nucleotide salvage defects R-HSA-9734207	1	0	0/1	1	
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways R-HSA-168643	0.383542247485903	1.38210467345675	3/49	1	UBA52;NFKB1;RELA
Nucleotide-like (purinergic) receptors R-HSA-418038	1	0	0/5	1	
O-glycosylation of TSR domain-containing proteins R-HSA-5173214	1	0	0/15	1	
O-linked glycosylation R-HSA-5173105	1	0	0/38	1	
O-linked glycosylation of mucins R-HSA-913709	1	0	0/22	1	
O2/CO2 exchange in erythrocytes R-HSA-1480926	1	0	0/7	1	
OAS antiviral response R-HSA-8983711	1	0	0/5	1	
OGDH complex synthesizes succinyl-CoA from 2-OG R-HSA-9853506	1	0	0/2	1	
Oleoyl-phe metabolism R-HSA-9673163	1	0	0/0	1	
Olfactory Signaling Pathway R-HSA-381753	1	0	0/3	1	
Oligomerization of connexins into connexons R-HSA-190704	1	0	0/2	1	
Oncogenic MAPK signaling R-HSA-6802957	1	0	0/42	1	
Opioid Signalling R-HSA-111885	1	0	0/50	1	
Opsins R-HSA-419771	1	0	0/1	1	
Orc1 removal from chromatin R-HSA-68949	0.287167693795017	1.51814634498572	4/60	1	UBA52;PSMC5;SKP1;CCNA2
Orexin and neuropeptides FF and QRFP bind to their respective receptors R-HSA-389397	1	0	0/3	1	
Organelle biogenesis and maintenance R-HSA-1852241	0.745882521993451	0.810525476365603	6/161	1	DYNLL1;CYCS;ATF2;ATP5MF;ATP5F1D;IFT43
Organic anion transport R-HSA-561048	1	0	0/0	1	
Organic anion transporters R-HSA-428643	1	0	0/4	1	
Organic cation transport R-HSA-549127	1	0	0/4	1	
Organic cation/anion/zwitterion transport R-HSA-549132	1	0	0/4	1	
Other interleukin signaling R-HSA-449836	1	0	0/11	1	
Other semaphorin interactions R-HSA-416700	1	0	0/13	1	
Ovarian tumor domain proteases R-HSA-5689896	0.330484949669379	1.76624926591966	2/26	1	UBA52;TP53
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha R-HSA-1234176	0.763441025382084	0.724562009906393	2/60	1	UBA52;PSMC5
P2Y receptors R-HSA-417957	1	0	0/3	1	
PAOs oxidise polyamines to amines R-HSA-141334	1	0	0/0	1	
PCP/CE pathway R-HSA-4086400	0.866189891954505	0.565526368646486	2/76	1	UBA52;PSMC5
PD-1 signaling R-HSA-389948	1	0	0/18	1	
PDE3B signalling R-HSA-165160	1	0	0/2	1	
PDGFR mutants bind TKIs R-HSA-9674428	1	0	0/1	1	
PDH complex synthesizes acetyl-CoA from PYR R-HSA-9861559	1	0	0/2	1	
PECAM1 interactions R-HSA-210990	1	0	0/11	1	
PERK regulates gene expression R-HSA-381042	0.363925104048103	1.62957500645577	2/28	1	EIF2S2;CXCL8
PI Metabolism R-HSA-1483255	1	0	0/39	1	
PI and PC transport between ER and Golgi membranes R-HSA-1483196	1	0	0/0	1	
PI-3K cascade:FGFR1 R-HSA-5654689	1	0	0/7	1	
PI-3K cascade:FGFR2 R-HSA-5654695	1	0	0/9	1	
PI-3K cascade:FGFR3 R-HSA-5654710	1	0	0/7	1	
PI-3K cascade:FGFR4 R-HSA-5654720	1	0	0/7	1	
PI3K Cascade R-HSA-109704	1	0	0/21	1	
PI3K events in ERBB2 signaling R-HSA-1963642	1	0	0/11	1	
PI3K events in ERBB4 signaling R-HSA-1250342	1	0	0/6	1	
PI3K/AKT Signaling in Cancer R-HSA-2219528	1	0	0/69	1	
PI3K/AKT activation R-HSA-198203	1	0	0/8	1	
PI5P Regulates TP53 Acetylation R-HSA-6811555	0.242721710581898	4.23445267568269	1/6	1	TP53
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558	1	0	0/59	1	
PINK1-PRKN Mediated Mitophagy R-HSA-5205685	0.37099061448409	2.35079399308912	1/10	1	UBA52
PIP3 activates AKT signaling R-HSA-1257604	0.951569503331303	0.533936767475046	5/198	1	UBA52;PSMC5;TP53;JUN;ATF2
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884	0.566274760919946	1.24232925880823	1/18	1	POLR2F
PKA activation R-HSA-163615	1	0	0/10	1	
PKA activation in glucagon signalling R-HSA-164378	1	0	0/8	1	
PKA-mediated phosphorylation of CREB R-HSA-111931	1	0	0/12	1	
PKA-mediated phosphorylation of key metabolic factors R-HSA-163358	1	0	0/5	1	
PKB-mediated events R-HSA-109703	1	0	0/2	1	
PKMTs methylate histone lysines R-HSA-3214841	0.457031266610523	1.22076592574228	3/55	1	DPY30;NFKB1;RELA
PKR-mediated signaling R-HSA-9833482	0.845206042748101	0.598470403350532	2/72	1	EIF2S2;TP53
PLC beta mediated events R-HSA-112043	1	0	0/28	1	
PLC-gamma1 signalling R-HSA-167021	1	0	0/2	1	
PLCG1 events in ERBB2 signaling R-HSA-1251932	1	0	0/3	1	
POLB-Dependent Long Patch Base Excision Repair R-HSA-110362	1	0	0/2	1	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation R-HSA-2892247	1	0	0/6	1	
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation R-HSA-2892245	1	0	0/4	1	
PP2A-mediated dephosphorylation of key metabolic factors R-HSA-163767	1	0	0/6	1	
PPARA activates gene expression R-HSA-1989781	0.956231890783477	0.315989844193443	1/67	1	SP1
PRC2 methylates histones and DNA R-HSA-212300	0.570235423514874	1.02123545372942	3/65	1	H2AX;H2BC8;H2BC3
PTEN Loss of Function in Cancer R-HSA-5674404	1	0	0/1	1	
PTEN Regulation R-HSA-6807070	0.632737193596496	0.923286358866001	5/119	1	UBA52;PSMC5;TP53;JUN;ATF2
PTK6 Activates STAT3 R-HSA-8849474	1	0	0/3	1	
PTK6 Down-Regulation R-HSA-8849472	1	0	0/2	1	
PTK6 Expression R-HSA-8849473	1	0	0/5	1	
PTK6 Regulates Cell Cycle R-HSA-8849470	1	0	0/6	1	
PTK6 Regulates Proteins Involved in RNA Processing R-HSA-8849468	1	0	0/1	1	
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases R-HSA-8849471	1	0	0/12	1	
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 R-HSA-8849469	0.309813381545497	3.02371343760045	1/8	1	UBA52
PTK6 promotes HIF1A stabilization R-HSA-8857538	1	0	0/6	1	
Packaging Of Telomere Ends R-HSA-171306	0.283006250373054	1.6764752847409	3/41	1	H2AX;H2BC8;H2BC3
Paracetamol ADME R-HSA-9753281	1	0	0/12	1	
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955	1	0	0/27	1	
Parasite infection R-HSA-9664407	0.812601772791195	0.600680353804841	1/36	1	ARPC1A
Parasitic Infection Pathways R-HSA-9824443	0.66322114407094	0.885879717358511	4/99	1	JUN;NFKB1;RELA;ARPC1A
Passive transport by Aquaporins R-HSA-432047	1	0	0/3	1	
Pausing and recovery of HIV elongation R-HSA-167290	0.296584199081995	1.92778058369726	2/24	1	POLR2F;SUPT4H1
Pausing and recovery of Tat-mediated HIV elongation R-HSA-167238	0.262447347130839	2.12165544098413	2/22	1	POLR2F;SUPT4H1
Pentose phosphate pathway R-HSA-71336	1	0	0/9	1	
Pentose phosphate pathway disease R-HSA-6791465	1	0	0/2	1	
Peptide hormone biosynthesis R-HSA-209952	1	0	0/5	1	
Peptide hormone metabolism R-HSA-2980736	0.803638397051725	0.618506809282829	1/35	1	SEC11A
Peptide ligand-binding receptors R-HSA-375276	0.95190958560182	0.326035359069223	1/65	1	CXCL8
Peroxisomal lipid metabolism R-HSA-390918	1	0	0/10	1	
Peroxisomal protein import R-HSA-9033241	0.686900048024346	0.878459259064141	1/25	1	UBA52
Pervasive developmental disorders R-HSA-9005895	1	0	0/10	1	
Pexophagy R-HSA-9664873	0.341107769845094	2.6453817850105	1/9	1	UBA52
Phase 0 - rapid depolarisation R-HSA-5576892	1	0	0/16	1	
Phase 1 - inactivation of fast Na+ channels R-HSA-5576894	1	0	0/0	1	
Phase 2 - plateau phase R-HSA-5576893	1	0	0/6	1	
Phase 3 - rapid repolarisation R-HSA-5576890	1	0	0/2	1	
Phase 4 - resting membrane potential R-HSA-5576886	1	0	0/4	1	
Phase I - Functionalization of compounds R-HSA-211945	1	0	0/26	1	
Phase II - Conjugation of compounds R-HSA-156580	1	0	0/47	1	
Phenylalanine and tyrosine metabolism R-HSA-8963691	1	0	0/4	1	
Phenylalanine metabolism R-HSA-8964208	1	0	0/3	1	
Phenylketonuria R-HSA-2160456	1	0	0/0	1	
Phosphate bond hydrolysis by NTPDase proteins R-HSA-8850843	1	0	0/3	1	
Phosphate bond hydrolysis by NUDT proteins R-HSA-2393930	1	0	0/3	1	
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR2 R-HSA-5654221	1	0	0/5	1	
Phospholipase C-mediated cascade; FGFR3 R-HSA-5654227	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR4 R-HSA-5654228	1	0	0/3	1	
Phospholipid metabolism R-HSA-1483257	1	0	0/79	1	
Phosphorylation of CD3 and TCR zeta chains R-HSA-202427	1	0	0/16	1	
Phosphorylation of Emi1 R-HSA-176417	1	0	0/4	1	
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes R-HSA-69200	1	0	0/4	1	
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes R-HSA-170145	0.129736663484848	10.5841732097137	1/3	1	CCNA2
Phosphorylation of the APC/C R-HSA-176412	0.604812877024766	1.11101589883285	1/20	1	CDC26
Physiological factors R-HSA-5578768	1	0	0/7	1	
Plasma lipoprotein assembly R-HSA-8963898	1	0	0/14	1	
Plasma lipoprotein assembly, remodeling, and clearance R-HSA-174824	0.85844995786207	0.511980933919639	1/42	1	UBA52
Plasma lipoprotein clearance R-HSA-8964043	0.585989544514493	1.17302584275925	1/19	1	UBA52
Plasma lipoprotein remodeling R-HSA-8963899	1	0	0/18	1	
Plasmalogen biosynthesis R-HSA-75896	1	0	0/0	1	
Platelet Adhesion to exposed collagen R-HSA-75892	1	0	0/10	1	
Platelet Aggregation (Plug Formation) R-HSA-76009	1	0	0/20	1	
Platelet activation, signaling and aggregation R-HSA-76002	1	0	0/127	1	
Platelet calcium homeostasis R-HSA-418360	1	0	0/12	1	
Platelet degranulation  R-HSA-114608	1	0	0/51	1	
Platelet homeostasis R-HSA-418346	1	0	0/38	1	
Platelet sensitization by LDL R-HSA-432142	1	0	0/12	1	
Plus-strand DNA synthesis R-HSA-164525	1	0	0/1	1	
Polo-like kinase mediated events R-HSA-156711	1	0	0/6	1	
Polymerase switching R-HSA-69091	0.206782414170199	5.2933772792375	1/5	1	PCNA
Polymerase switching on the C-strand of the telomere R-HSA-174411	0.242721710581898	4.23445267568269	1/6	1	PCNA
Positive epigenetic regulation of rRNA expression R-HSA-5250913	0.367421438619014	1.2785093871665	5/88	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
Post NMDA receptor activation events R-HSA-438064	1	0	0/57	1	
Post-chaperonin tubulin folding pathway R-HSA-389977	1	0	0/20	1	
Post-transcriptional silencing by small RNAs R-HSA-426496	1	0	0/1	1	
Post-translational modification: synthesis of GPI-anchored proteins R-HSA-163125	1	0	0/13	1	
Post-translational protein modification R-HSA-597592	0.810796741302129	0.84454169200881	26/659	1	DERL2;UBA52;RNF5;PSMC5;SKP1;CCNA2;DYNLL1;H2BC8;H2BC3;TP53;RELA;RPS23;RPS6;RPS2;UBE2A;UBE2L3;UBE2F;EEF1A1;RPL27A;RPL8;PCNA;MYC;TOP2A;TAF10;UCHL3;COMMD6
Post-translational protein phosphorylation R-HSA-8957275	1	0	0/34	1	
Postmitotic nuclear pore complex (NPC) reformation R-HSA-9615933	1	0	0/12	1	
Postsynaptic nicotinic acetylcholine receptors R-HSA-622327	1	0	0/5	1	
Potassium Channels R-HSA-1296071	1	0	0/25	1	
Potassium transport channels R-HSA-1296067	1	0	0/1	1	
Potential therapeutics for SARS R-HSA-9679191	0.95190958560182	0.326035359069223	1/65	1	BRMS1
Pre-NOTCH Expression and Processing R-HSA-1912422	0.106340993038895	1.83248556414987	7/89	1	TFDP1;E2F1;H2AX;H2BC8;H2BC3;TP53;JUN
Pre-NOTCH Processing in Golgi R-HSA-1912420	1	0	0/11	1	
Pre-NOTCH Processing in the Endoplasmic Reticulum R-HSA-1912399	1	0	0/5	1	
Pre-NOTCH Transcription and Translation R-HSA-1912408	0.072109595965432	2.0349069028249	7/81	1	TFDP1;E2F1;H2AX;H2BC8;H2BC3;TP53;JUN
Prednisone ADME R-HSA-9757110	1	0	0/1	1	
Prefoldin mediated transfer of substrate  to CCT/TriC R-HSA-389957	0.130823046636653	2.5563222192599	3/28	1	PFDN1;PFDN5;VBP1
Pregnenolone biosynthesis R-HSA-196108	1	0	0/5	1	
Presynaptic depolarization and calcium channel opening R-HSA-112308	1	0	0/2	1	
Presynaptic function of Kainate receptors R-HSA-500657	1	0	0/8	1	
Presynaptic nicotinic acetylcholine receptors R-HSA-622323	1	0	0/5	1	
Presynaptic phase of homologous DNA pairing and strand exchange R-HSA-5693616	0.524000974672891	1.40863417894967	1/16	1	RPA3
Prevention of phagosomal-lysosomal fusion R-HSA-9636383	0.206782414170199	5.2933772792375	1/5	1	UBA52
Processing and activation of SUMO R-HSA-3215018	1	0	0/6	1	
Processing of Capped Intron-Containing Pre-mRNA R-HSA-72203	0.312773078370013	1.27138614949546	8/142	1	POLR2F;LSM3;LSM4;LSM5;SNRPE;SNRPG;SF3B5;SNRNP27
Processing of Intronless Pre-mRNAs R-HSA-77595	1	0	0/8	1	
Processing of SMDT1 R-HSA-8949664	1	0	0/9	1	
Programmed Cell Death R-HSA-5357801	0.225395738312735	1.38487742740833	9/148	1	UBA52;PSMC5;DYNLL1;TFDP1;E2F1;TP53;CYCS;BAX;UBE2L3
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 R-HSA-964827	1	0	0/0	1	
Prolactin receptor signaling R-HSA-1170546	0.501352035090244	1.50960242203817	1/15	1	SKP1
Proline catabolism R-HSA-70688	1	0	0/0	1	
Prolonged ERK activation events R-HSA-169893	1	0	0/8	1	
Propionyl-CoA catabolism R-HSA-71032	1	0	0/4	1	
Prostacyclin signalling through prostacyclin receptor R-HSA-392851	1	0	0/8	1	
Prostanoid ligand receptors R-HSA-391908	1	0	0/0	1	
Protein folding R-HSA-391251	0.318228079983844	1.43984505169485	4/63	1	TP53;PFDN1;PFDN5;VBP1
Protein lipoylation R-HSA-9857492	1	0	0/3	1	
Protein localization R-HSA-9609507	0.963751244125793	0.297620768097575	1/71	1	UBA52
Protein repair R-HSA-5676934	1	0	0/2	1	
Protein-protein interactions at synapses R-HSA-6794362	1	0	0/20	1	
Proton-coupled monocarboxylate transport R-HSA-433692	1	0	0/2	1	
Proton-coupled neutral amino acid transporters R-HSA-428559	1	0	0/0	1	
Proton/oligopeptide cotransporters R-HSA-427975	1	0	0/0	1	
Purine catabolism R-HSA-74259	1	0	0/9	1	
Purine ribonucleoside monophosphate biosynthesis R-HSA-73817	1	0	0/4	1	
Purine salvage R-HSA-74217	1	0	0/7	1	
Purinergic signaling in leishmaniasis infection R-HSA-9660826	0.296584199081995	1.92778058369726	2/24	1	NFKB1;RELA
Pyrimidine biosynthesis R-HSA-500753	1	0	0/1	1	
Pyrimidine catabolism R-HSA-73621	1	0	0/7	1	
Pyrimidine salvage R-HSA-73614	1	0	0/3	1	
Pyrophosphate hydrolysis R-HSA-71737	1	0	0/2	1	
Pyruvate metabolism R-HSA-70268	0.452789218493456	1.76203882355408	1/13	1	UBA52
RA biosynthesis pathway R-HSA-5365859	1	0	0/5	1	
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198	1	0	0/20	1	
RAB geranylgeranylation R-HSA-8873719	1	0	0/10	1	
RAC1 GTPase cycle R-HSA-9013149	1	0	0/76	1	
RAC2 GTPase cycle R-HSA-9013404	1	0	0/41	1	
RAC3 GTPase cycle R-HSA-9013423	1	0	0/45	1	
RAF activation R-HSA-5673000	1	0	0/22	1	
RAF-independent MAPK1/3 activation R-HSA-112409	1	0	0/12	1	
RAF/MAP kinase cascade R-HSA-5673001	0.992937526655634	0.277266308272145	2/150	1	UBA52;PSMC5
RAS GTPase cycle mutants R-HSA-9649913	1	0	0/3	1	
RAS processing R-HSA-9648002	0.452789218493456	1.76203882355408	1/13	1	UBA52
RAS signaling downstream of NF1 loss-of-function variants R-HSA-6802953	1	0	0/5	1	
RET signaling R-HSA-8853659	1	0	0/22	1	
RHO GTPase Effectors R-HSA-195258	0.704191176558102	0.864115127642678	8/202	1	DYNLL1;H2AX;H2BC8;H2BC3;RPS27;ZWINT;BUB1;ARPC1A
RHO GTPase cycle R-HSA-9012999	1	0	0/209	1	
RHO GTPases Activate Formins R-HSA-5663220	0.401759187481922	1.26532142135965	4/71	1	DYNLL1;RPS27;ZWINT;BUB1
RHO GTPases Activate NADPH Oxidases R-HSA-5668599	1	0	0/17	1	
RHO GTPases Activate ROCKs R-HSA-5627117	1	0	0/13	1	
RHO GTPases Activate Rhotekin and Rhophilins R-HSA-5666185	1	0	0/3	1	
RHO GTPases Activate WASPs and WAVEs R-HSA-5663213	0.686900048024346	0.878459259064141	1/25	1	ARPC1A
RHO GTPases activate CIT R-HSA-5625900	1	0	0/11	1	
RHO GTPases activate IQGAPs R-HSA-5626467	1	0	0/31	1	
RHO GTPases activate KTN1 R-HSA-5625970	1	0	0/6	1	
RHO GTPases activate PAKs R-HSA-5627123	1	0	0/15	1	
RHO GTPases activate PKNs R-HSA-5625740	0.710189986609751	0.819079999712745	3/80	1	H2AX;H2BC8;H2BC3
RHO GTPases regulate CFTR trafficking R-HSA-5627083	1	0	0/1	1	
RHOA GTPase cycle R-HSA-8980692	1	0	0/66	1	
RHOB GTPase cycle R-HSA-9013026	1	0	0/36	1	
RHOBTB GTPase Cycle R-HSA-9706574	1	0	0/22	1	
RHOBTB1 GTPase cycle R-HSA-9013422	1	0	0/15	1	
RHOBTB2 GTPase cycle R-HSA-9013418	1	0	0/14	1	
RHOBTB3 ATPase cycle R-HSA-9706019	1	0	0/4	1	
RHOC GTPase cycle R-HSA-9013106	1	0	0/40	1	
RHOD GTPase cycle R-HSA-9013405	1	0	0/23	1	
RHOF GTPase cycle R-HSA-9035034	1	0	0/18	1	
RHOG GTPase cycle R-HSA-9013408	1	0	0/30	1	
RHOH GTPase cycle R-HSA-9013407	1	0	0/17	1	
RHOJ GTPase cycle R-HSA-9013409	1	0	0/32	1	
RHOQ GTPase cycle R-HSA-9013406	1	0	0/29	1	
RHOT1 GTPase cycle R-HSA-9013425	1	0	0/1	1	
RHOT2 GTPase cycle R-HSA-9013419	1	0	0/1	1	
RHOU GTPase cycle R-HSA-9013420	1	0	0/26	1	
RHOV GTPase cycle R-HSA-9013424	1	0	0/20	1	
RIP-mediated NFkB activation via ZBP1 R-HSA-1810476	0.177991752687346	2.83195799693249	2/17	1	NFKB1;RELA
RIPK1-mediated regulated necrosis R-HSA-5213460	0.313579151415377	1.84339522129094	2/25	1	UBA52;UBE2L3
RMTs methylate histone arginines R-HSA-3214858	0.763441025382084	0.724562009906393	2/60	1	H2AX;RPS2
RNA Pol II CTD phosphorylation and interaction with CE R-HSA-77075	0.585989544514493	1.17302584275925	1/19	1	POLR2F
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection R-HSA-167160	0.585989544514493	1.17302584275925	1/19	1	POLR2F
RNA Polymerase I Promoter Clearance R-HSA-73854	0.349144656034677	1.31076103830825	5/86	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
RNA Polymerase I Promoter Escape R-HSA-73772	0.208793479111728	1.6401884952875	5/70	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
RNA Polymerase I Promoter Opening R-HSA-73728	0.480741394947793	1.17494843860527	3/57	1	H2AX;H2BC8;H2BC3
RNA Polymerase I Transcription Initiation R-HSA-73762	0.380413712395692	1.56882568333678	2/29	1	POLR2F;TBP
RNA Polymerase I Transcription R-HSA-73864	0.358278291832628	1.29443860404156	5/87	1	POLR2F;H2AX;H2BC8;H2BC3;TBP
RNA Polymerase I Transcription Termination R-HSA-73863	0.145545260024666	3.26902954467283	2/15	1	POLR2F;TBP
RNA Polymerase II HIV Promoter Escape R-HSA-167162	0.141328891355645	2.45748852829867	3/29	1	POLR2F;TBP;TAF10
RNA Polymerase II Pre-transcription Events R-HSA-674695	0.152782660143688	2.03143328135813	4/46	1	POLR2F;SUPT4H1;TBP;TAF10
RNA Polymerase II Promoter Escape R-HSA-73776	0.141328891355645	2.45748852829867	3/29	1	POLR2F;TBP;TAF10
RNA Polymerase II Transcription Elongation R-HSA-75955	0.459822349285752	1.32206320461919	2/34	1	POLR2F;SUPT4H1
RNA Polymerase II Transcription Initiation And Promoter Clearance R-HSA-76042	0.141328891355645	2.45748852829867	3/29	1	POLR2F;TBP;TAF10
RNA Polymerase II Transcription Initiation R-HSA-75953	0.141328891355645	2.45748852829867	3/29	1	POLR2F;TBP;TAF10
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening R-HSA-73779	0.141328891355645	2.45748852829867	3/29	1	POLR2F;TBP;TAF10
RNA Polymerase II Transcription R-HSA-73857	0.230856548798843	1.17050876963117	36/704	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;TFDP1;E2F1;POLR2F;SUPT4H1;H2AX;H2BC8;H2BC3;RPA3;TP53;JUN;DPY30;NFKB1;RELA;CYCS;SP1;FOS;ATF2;BAX;COX5A;COX4I1;COX16;COX7A2L;TBP;PCNA;MYC;E2F4;TAF10;SNRPE;SNRPG;SSU72;LSM10
RNA Polymerase II Transcription Termination R-HSA-73856	0.152107061370153	2.36585785693254	3/30	1	SNRPE;SNRPG;LSM10
RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476	0.262447347130839	2.12165544098413	2/22	1	POLR2F;TBP
RNA Polymerase III Chain Elongation R-HSA-73780	0.309813381545497	3.02371343760045	1/8	1	POLR2F
RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061	0.145545260024666	3.26902954467283	2/15	1	POLR2F;TBP
RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066	0.129838474458708	3.54219595929698	2/14	1	POLR2F;TBP
RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071	0.0998089904091194	4.25231271824667	2/12	1	POLR2F;TBP
RNA Polymerase III Transcription Initiation R-HSA-76046	0.194606983206704	2.65444203232878	2/18	1	POLR2F;TBP
RNA Polymerase III Transcription R-HSA-74158	0.262447347130839	2.12165544098413	2/22	1	POLR2F;TBP
RNA Polymerase III Transcription Termination R-HSA-73980	0.426772182116293	1.92268712388978	1/12	1	POLR2F
RNA polymerase II transcribes snRNA genes R-HSA-6807505	0.0638794974946974	2.49323348433672	5/48	1	POLR2F;SUPT4H1;SP1;TBP;SSU72
RND1 GTPase cycle R-HSA-9696273	1	0	0/14	1	
RND2 GTPase cycle R-HSA-9696270	1	0	0/15	1	
RND3 GTPase cycle R-HSA-9696264	1	0	0/15	1	
ROBO receptors bind AKAP5 R-HSA-9010642	1	0	0/6	1	
RORA activates gene expression R-HSA-1368082	1	0	0/16	1	
ROS and RNS production in phagocytes R-HSA-1222556	0.161617941350537	3.03489390408789	2/16	1	ATP6V1F;ATP6V0E1
RPIA deficiency: failed conversion of R5P to RU5P R-HSA-5659996	1	0	0/1	1	
RPIA deficiency: failed conversion of RU5P to R5P R-HSA-6791461	1	0	0/1	1	
RSK activation R-HSA-444257	1	0	0/6	1	
RSV-host interactions R-HSA-9833110	0.958245862115291	0.311191967987284	1/68	1	UBA52
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) R-HSA-8877330	1	0	0/5	1	
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known R-HSA-8939243	1	0	0/28	1	
RUNX1 regulates estrogen receptor mediated transcription R-HSA-8931987	1	0	0/6	1	
RUNX1 regulates expression of components of tight junctions R-HSA-8935964	1	0	0/3	1	
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function R-HSA-8936459	0.473423778385171	1.14354940178181	4/78	1	H2AX;H2BC8;H2BC3;DPY30
RUNX1 regulates transcription of genes involved in BCR signaling R-HSA-8939245	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in WNT signaling R-HSA-8939256	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in differentiation of HSCs R-HSA-8939236	0.647506975414951	0.9068863234253	5/121	1	UBA52;PSMC5;H2AX;H2BC8;H2BC3
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes R-HSA-8939242	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246	1	0	0/6	1	
RUNX1 regulates transcription of genes involved in interleukin signaling R-HSA-8939247	1	0	0/4	1	
RUNX2 regulates bone development R-HSA-8941326	1	0	0/24	1	
RUNX2 regulates chondrocyte maturation R-HSA-8941284	1	0	0/5	1	
RUNX2 regulates genes involved in cell migration R-HSA-8941332	1	0	0/7	1	
RUNX2 regulates genes involved in differentiation of myeloid cells R-HSA-8941333	1	0	0/4	1	
RUNX2 regulates osteoblast differentiation R-HSA-8940973	1	0	0/19	1	
RUNX3 Regulates Immune Response and Cell Migration R-HSA-8949275	1	0	0/5	1	
RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-8952158	1	0	0/5	1	
RUNX3 regulates CDKN1A transcription R-HSA-8941855	0.27704115757633	3.52822750116427	1/7	1	TP53
RUNX3 regulates NOTCH signaling R-HSA-8941856	1	0	0/14	1	
RUNX3 regulates RUNX1-mediated transcription R-HSA-8951911	1	0	0/3	1	
RUNX3 regulates WNT signaling R-HSA-8951430	0.309813381545497	3.02371343760045	1/8	1	MYC
RUNX3 regulates YAP1-mediated transcription R-HSA-8951671	1	0	0/6	1	
RUNX3 regulates p14-ARF R-HSA-8951936	1	0	0/10	1	
Rab regulation of trafficking R-HSA-9007101	1	0	0/34	1	
Rap1 signalling R-HSA-392517	1	0	0/8	1	
Ras activation upon Ca2+ influx through NMDA receptor R-HSA-442982	1	0	0/14	1	
Reactions specific to the complex N-glycan synthesis pathway R-HSA-975578	1	0	0/2	1	
Reactions specific to the hybrid N-glycan synthesis pathway R-HSA-975574	1	0	0/0	1	
Receptor Mediated Mitophagy R-HSA-8934903	1	0	0/8	1	
Receptor-type tyrosine-protein phosphatases R-HSA-388844	1	0	0/3	1	
Recognition and association of DNA glycosylase with site containing an affected purine R-HSA-110330	0.283006250373054	1.6764752847409	3/41	1	H2AX;H2BC8;H2BC3
Recognition and association of DNA glycosylase with site containing an affected pyrimidine R-HSA-110328	0.308126600339051	1.59184051160436	3/43	1	H2AX;H2BC8;H2BC3
Recruitment of NuMA to mitotic centrosomes R-HSA-380320	0.926573683542403	0.380280243418757	1/56	1	DYNLL1
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270	0.851668895633996	0.52491646278713	1/41	1	DYNLL1
Recycling of bile acids and salts R-HSA-159418	1	0	0/7	1	
Recycling of eIF2:GDP R-HSA-72731	0.129736663484848	10.5841732097137	1/3	1	EIF2S2
Recycling pathway of L1 R-HSA-437239	1	0	0/36	1	
Reduction of cytosolic Ca++ levels R-HSA-418359	1	0	0/7	1	
Reelin signalling pathway R-HSA-8866376	1	0	0/3	1	
Regorafenib-resistant KIT mutants R-HSA-9669929	1	0	0/1	1	
Regorafenib-resistant PDGFR mutants R-HSA-9674403	1	0	0/1	1	
Regulation by TREX1 R-HSA-3248023	1	0	0/0	1	
Regulation by c-FLIP R-HSA-3371378	1	0	0/10	1	
Regulation of APC/C activators between G1/S and early anaphase R-HSA-176408	0.259521332231789	1.4992471366225	5/76	1	UBA52;PSMC5;CDC26;SKP1;CCNA2
Regulation of Apoptosis R-HSA-169911	0.658199457661773	0.89669505038564	2/49	1	UBA52;PSMC5
Regulation of CDH11 Expression and Function R-HSA-9759475	0.426772182116293	1.92268712388978	1/12	1	SP1
Regulation of CDH11 function R-HSA-9762292	1	0	0/6	1	
Regulation of CDH11 gene transcription R-HSA-9762293	0.242721710581898	4.23445267568269	1/6	1	SP1
Regulation of CDH11 mRNA translation by microRNAs R-HSA-9759811	1	0	0/2	1	
Regulation of CDH19 Expression and Function R-HSA-9764302	1	0	0/3	1	
Regulation of Complement cascade R-HSA-977606	1	0	0/21	1	
Regulation of Expression and Function of Type II Classical Cadherins R-HSA-9764260	0.426772182116293	1.92268712388978	1/12	1	SP1
Regulation of FOXO transcriptional activity by acetylation R-HSA-9617629	1	0	0/10	1	
Regulation of FZD by ubiquitination R-HSA-4641263	0.452789218493456	1.76203882355408	1/13	1	UBA52
Regulation of Glucokinase by Glucokinase Regulatory Protein R-HSA-170822	1	0	0/10	1	
Regulation of HMOX1 expression and activity R-HSA-9707587	1	0	0/4	1	
Regulation of HSF1-mediated heat shock response R-HSA-3371453	0.518952411798806	1.17398183030652	2/38	1	RPA3;HSF1
Regulation of Homotypic Cell-Cell Adhesion R-HSA-9759476	0.426772182116293	1.92268712388978	1/12	1	SP1
Regulation of IFNA/IFNB signaling R-HSA-912694	1	0	0/26	1	
Regulation of IFNG signaling R-HSA-877312	1	0	0/14	1	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-381426	1	0	0/44	1	
Regulation of KIT signaling R-HSA-1433559	1	0	0/13	1	
Regulation of MECP2 expression and activity R-HSA-9022692	1	0	0/20	1	
Regulation of MITF-M dependent genes involved in invasion R-HSA-9854909	1	0	0/2	1	
Regulation of MITF-M dependent genes involved in metabolism R-HSA-9854907	1	0	0/3	1	
Regulation of MITF-M-dependent genes involved in DNA damage repair and senescence R-HSA-9825895	1	0	0/2	1	
Regulation of MITF-M-dependent genes involved in apoptosis R-HSA-9824594	1	0	0/7	1	
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation R-HSA-9825892	1	0	0/12	1	
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy R-HSA-9857377	0.114567745590346	3.86533873346815	2/13	1	ATP6V1F;ATP6V0E1
Regulation of MITF-M-dependent genes involved in pigmentation R-HSA-9824585	1	0	0/16	1	
Regulation of NF-kappa B signaling R-HSA-9758274	0.145545260024666	3.26902954467283	2/15	1	UBA52;TP53
Regulation of NPAS4 gene expression R-HSA-9768759	1	0	0/4	1	
Regulation of NPAS4 gene transcription R-HSA-9768777	1	0	0/3	1	
Regulation of NPAS4 mRNA translation R-HSA-9768778	1	0	0/1	1	
Regulation of PAK-2p34 activity by PS-GAP/RHG10 R-HSA-211728	1	0	0/1	1	
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942	0.383542247485903	1.38210467345675	3/49	1	UBA52;SKP1;DYNLL1
Regulation of PTEN gene transcription R-HSA-8943724	0.492415282671302	1.15328898052379	3/58	1	TP53;JUN;ATF2
Regulation of PTEN localization R-HSA-8948747	0.27704115757633	3.52822750116427	1/7	1	UBA52
Regulation of PTEN mRNA translation R-HSA-8943723	1	0	0/2	1	
Regulation of PTEN stability and activity R-HSA-8948751	0.755171998666624	0.737465689905408	2/59	1	UBA52;PSMC5
Regulation of RAS by GAPs R-HSA-5658442	0.7288666706529	0.779043625656498	2/56	1	UBA52;PSMC5
Regulation of RUNX1 Expression and Activity R-HSA-8934593	1	0	0/10	1	
Regulation of RUNX2 expression and activity R-HSA-8939902	0.570235423514874	1.02123545372942	3/65	1	UBA52;PSMC5;SKP1
Regulation of RUNX3 expression and activity R-HSA-8941858	0.710036374405601	0.809426910722397	2/54	1	UBA52;PSMC5
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7  R-HSA-9824878	0.399525249474029	2.11529879670146	1/11	1	UBA52
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation R-HSA-9828211	0.37099061448409	2.35079399308912	1/10	1	UBA52
Regulation of TLR by endogenous ligand R-HSA-5686938	1	0	0/13	1	
Regulation of TNFR1 signaling R-HSA-5357905	0.444393924017351	1.36504166081555	2/33	1	UBA52;UBE2L3
Regulation of TP53 Activity R-HSA-5633007	0.266658088423079	1.42018068090296	6/96	1	UBA52;CCNA2;RPA3;TP53;TBP;TAF10
Regulation of TP53 Activity through Acetylation R-HSA-6804758	0.656326253281738	0.958800817046349	1/23	1	TP53
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759	0.27704115757633	3.52822750116427	1/7	1	TP53
Regulation of TP53 Activity through Methylation R-HSA-6804760	0.0998089904091194	4.25231271824667	2/12	1	UBA52;TP53
Regulation of TP53 Degradation R-HSA-6804757	0.174399272797084	2.20155827185314	3/32	1	UBA52;CCNA2;TP53
Regulation of TP53 Expression R-HSA-6804754	0.0884673733624665	21.1535855938183	1/2	1	TP53
Regulation of TP53 Expression and Degradation R-HSA-6806003	0.185873135499092	2.12777881148111	3/33	1	UBA52;CCNA2;TP53
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482	0.812601772791195	0.600680353804841	1/36	1	ARPC1A
Regulation of activated PAK-2p34 by proteasome mediated degradation R-HSA-211733	0.658199457661773	0.89669505038564	2/49	1	UBA52;PSMC5
Regulation of beta-cell development R-HSA-186712	1	0	0/21	1	
Regulation of cholesterol biosynthesis by SREBP (SREBF) R-HSA-1655829	0.763315860802052	0.701695123324785	1/31	1	SP1
Regulation of commissural axon pathfinding by SLIT and ROBO R-HSA-428542	1	0	0/5	1	
Regulation of cortical dendrite branching R-HSA-8985801	1	0	0/2	1	
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components R-HSA-446388	1	0	0/5	1	
Regulation of gap junction activity R-HSA-191650	1	0	0/2	1	
Regulation of gene expression by Hypoxia-inducible Factor R-HSA-1234158	1	0	0/8	1	
Regulation of gene expression in beta cells R-HSA-210745	1	0	0/8	1	
Regulation of gene expression in early pancreatic precursor cells R-HSA-210747	1	0	0/1	1	
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells R-HSA-210746	1	0	0/0	1	
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells R-HSA-210744	1	0	0/12	1	
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism R-HSA-9634600	1	0	0/8	1	
Regulation of innate immune responses to cytosolic DNA R-HSA-3134975	0.341107769845094	2.6453817850105	1/9	1	UBA52
Regulation of insulin secretion R-HSA-422356	1	0	0/28	1	
Regulation of lipid metabolism by PPARalpha R-HSA-400206	0.960167644618536	0.306535194429365	1/69	1	SP1
Regulation of localization of FOXO transcription factors R-HSA-9614399	1	0	0/12	1	
Regulation of mRNA stability by proteins that bind AU-rich elements R-HSA-450531	0.88875991680887	0.529037184299361	2/81	1	UBA52;PSMC5
Regulation of mitotic cell cycle R-HSA-453276	0.294840926222009	1.41781952428007	5/80	1	UBA52;PSMC5;CDC26;SKP1;CCNA2
Regulation of necroptotic cell death R-HSA-5675482	0.313579151415377	1.84339522129094	2/25	1	UBA52;UBE2L3
Regulation of ornithine decarboxylase (ODC) R-HSA-350562	0.898021481382186	0.436532609484579	1/49	1	PSMC5
Regulation of pyruvate dehydrogenase (PDH) complex R-HSA-204174	1	0	0/5	1	
Regulation of pyruvate metabolism R-HSA-9861718	0.37099061448409	2.35079399308912	1/10	1	UBA52
Regulation of signaling by CBL R-HSA-912631	0.585989544514493	1.17302584275925	1/19	1	UBA52
Regulation of signaling by NODAL R-HSA-1433617	1	0	0/2	1	
Regulation of the apoptosome activity R-HSA-9627069	0.206782414170199	5.2933772792375	1/5	1	CYCS
Regulation of thyroid hormone activity R-HSA-350864	1	0	0/0	1	
Relaxin receptors R-HSA-444821	1	0	0/0	1	
Release of Hh-Np from the secreting cell R-HSA-5362798	1	0	0/3	1	
Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-159782	1	0	0/3	1	
Replacement of protamines by nucleosomes in the male pronucleus R-HSA-9821993	0.197539119722927	2.05862883712494	3/34	1	H2AX;H2BC8;H2BC3
Replication of the SARS-CoV-1 genome R-HSA-9682706	1	0	0/4	1	
Replication of the SARS-CoV-2 genome R-HSA-9694686	1	0	0/4	1	
Repression of WNT target genes R-HSA-4641265	0.452789218493456	1.76203882355408	1/13	1	MYC
Reproduction R-HSA-1474165	0.587645238092616	0.980906208822907	4/90	1	H2AX;H2BC8;H2BC3;RPA3
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250	1	0	0/2	1	
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249	1	0	0/2	1	
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251	1	0	0/2	1	
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246	1	0	0/2	1	
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247	1	0	0/2	1	
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244	1	0	0/2	1	
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245	1	0	0/2	1	
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233	1	0	0/2	1	
Resolution of AP sites via the single-nucleotide replacement pathway R-HSA-110381	1	0	0/2	1	
Resolution of Abasic Sites (AP sites) R-HSA-73933	0.0998089904091194	4.25231271824667	2/12	1	RPA3;PCNA
Resolution of D-Loop Structures R-HSA-5693537	1	0	0/18	1	
Resolution of D-loop Structures through Holliday Junction Intermediates R-HSA-5693568	1	0	0/18	1	
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554	1	0	0/15	1	
Resolution of Sister Chromatid Cohesion R-HSA-2500257	0.318228079983844	1.43984505169485	4/63	1	DYNLL1;RPS27;ZWINT;BUB1
Respiratory Syncytial Virus Infection Pathway R-HSA-9820952	0.904229774183484	0.503010824878063	2/85	1	UBA52;SEC11A
Respiratory syncytial virus (RSV) attachment and entry R-HSA-9820960	1	0	0/9	1	
Respiratory syncytial virus (RSV) genome replication, transcription and translation R-HSA-9820965	0.501352035090244	1.50960242203817	1/15	1	SEC11A
Respiratory syncytial virus genome replication R-HSA-9834752	1	0	0/2	1	
Respiratory syncytial virus genome transcription R-HSA-9828642	1	0	0/1	1	
Response of EIF2AK1 (HRI) to heme deficiency R-HSA-9648895	0.477631583419205	1.62611481395553	1/14	1	EIF2S2
Response of Mtb to phagocytosis R-HSA-9637690	0.477631583419205	1.62611481395553	1/14	1	UBA52
Response to elevated platelet cytosolic Ca2+ R-HSA-76005	1	0	0/55	1	
Response to metal ions R-HSA-5660526	1	0	0/0	1	
Retinoid cycle disease events R-HSA-2453864	1	0	0/1	1	
Retinoid metabolism and transport R-HSA-975634	1	0	0/13	1	
Retinoid metabolism disease events R-HSA-6809583	1	0	0/0	1	
Retrograde neurotrophin signalling R-HSA-177504	1	0	0/8	1	
Retrograde transport at the Trans-Golgi-Network R-HSA-6811440	1	0	0/26	1	
Reuptake of GABA R-HSA-888593	1	0	0/2	1	
Rev-mediated nuclear export of HIV RNA R-HSA-165054	1	0	0/12	1	
Reversal of alkylation damage by DNA dioxygenases R-HSA-73943	1	0	0/0	1	
Reverse Transcription of HIV RNA R-HSA-162589	1	0	0/1	1	
Reversible hydration of carbon dioxide R-HSA-1475029	1	0	0/7	1	
Rhesus blood group biosynthesis R-HSA-9037628	1	0	0/0	1	
Rhesus glycoproteins mediate ammonium transport. R-HSA-444411	1	0	0/0	1	
Ribavirin ADME R-HSA-9755088	1	0	0/5	1	
Role of ABL in ROBO-SLIT signaling R-HSA-428890	1	0	0/6	1	
Role of LAT2/NTAL/LAB on calcium mobilization R-HSA-2730905	1	0	0/12	1	
Role of phospholipids in phagocytosis R-HSA-2029485	1	0	0/16	1	
Role of second messengers in netrin-1 signaling R-HSA-418890	1	0	0/2	1	
SARS-CoV-1 Genome Replication and Transcription R-HSA-9679514	1	0	0/4	1	
SARS-CoV-1 activates/modulates innate immune responses R-HSA-9692916	0.209377839062297	1.99380895946531	3/35	1	UBA52;NFKB1;RELA
SARS-CoV-1 targets PDZ proteins in cell-cell junction R-HSA-9692912	1	0	0/0	1	
SARS-CoV-1 targets host intracellular signalling and regulatory pathways R-HSA-9735871	0.524000974672891	1.40863417894967	1/16	1	SP1
SARS-CoV-1-mediated effects on programmed cell death R-HSA-9692913	1	0	0/3	1	
SARS-CoV-2 Genome Replication and Transcription R-HSA-9694682	1	0	0/4	1	
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671	0.978435997226894	0.256459796962074	1/82	1	UBA52
SARS-CoV-2 modulates autophagy R-HSA-9754560	1	0	0/2	1	
SARS-CoV-2 targets PDZ proteins in cell-cell junction R-HSA-9705677	1	0	0/1	1	
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779	1	0	0/12	1	
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577	0.266720120016801	1.57518380276432	4/58	1	UBA52;PSMC5;SKP1;CCNA2
SCF-beta-TrCP mediated degradation of Emi1 R-HSA-174113	0.420666715016203	1.29650338349409	3/52	1	UBA52;PSMC5;SKP1
SDK interactions R-HSA-373756	1	0	0/0	1	
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion R-HSA-399955	1	0	0/5	1	
SHC-mediated cascade:FGFR1 R-HSA-5654688	1	0	0/7	1	
SHC-mediated cascade:FGFR2 R-HSA-5654699	1	0	0/9	1	
SHC-mediated cascade:FGFR3 R-HSA-5654704	1	0	0/7	1	
SHC-mediated cascade:FGFR4 R-HSA-5654719	1	0	0/7	1	
SHC-related events triggered by IGF1R R-HSA-2428933	1	0	0/7	1	
SHC1 events in EGFR signaling R-HSA-180336	1	0	0/13	1	
SHC1 events in ERBB2 signaling R-HSA-1250196	1	0	0/15	1	
SHC1 events in ERBB4 signaling R-HSA-1250347	1	0	0/9	1	
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840	1	0	0/5	1	
SIRT1 negatively regulates rRNA expression R-HSA-427359	0.266720120016801	1.57518380276432	4/58	1	H2AX;H2BC8;H2BC3;TBP
SLC transporter disorders R-HSA-5619102	1	0	0/37	1	
SLC-mediated transmembrane transport R-HSA-425407	1	0	0/75	1	
SLIT2:ROBO1 increases RHOA activity R-HSA-8985586	1	0	0/3	1	
SMAC (DIABLO) binds to IAPs  R-HSA-111463	0.0884673733624665	21.1535855938183	1/2	1	CYCS
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes  R-HSA-111464	0.0884673733624665	21.1535855938183	1/2	1	CYCS
SMAC, XIAP-regulated apoptotic response R-HSA-111469	0.0884673733624665	21.1535855938183	1/2	1	CYCS
SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3315487	1	0	0/3	1	
SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3304356	1	0	0/6	1	
SMAD4 MH2 Domain Mutants in Cancer R-HSA-3311021	1	0	0/3	1	
SOS-mediated signalling R-HSA-112412	1	0	0/7	1	
STAT3 nuclear events downstream of ALK signaling R-HSA-9701898	1	0	0/11	1	
STAT5 Activation R-HSA-9645135	1	0	0/5	1	
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518	1	0	0/8	1	
STAT6-mediated induction of chemokines R-HSA-3249367	1	0	0/3	1	
STING mediated induction of host immune responses R-HSA-1834941	1	0	0/8	1	
SUMO E3 ligases SUMOylate target proteins R-HSA-3108232	0.821373732130543	0.696686474184847	4/124	1	TP53;RELA;PCNA;TOP2A
SUMO is conjugated to E1 (UBA2:SAE1) R-HSA-3065676	1	0	0/4	1	
SUMO is proteolytically processed R-HSA-3065679	1	0	0/4	1	
SUMO is transferred from E1 to E2 (UBE2I, UBC9) R-HSA-3065678	1	0	0/5	1	
SUMOylation R-HSA-2990846	0.830883828323185	0.68489988038422	4/126	1	TP53;RELA;PCNA;TOP2A
SUMOylation of DNA damage response and repair proteins R-HSA-3108214	1	0	0/44	1	
SUMOylation of DNA methylation proteins R-HSA-4655427	1	0	0/14	1	
SUMOylation of DNA replication proteins R-HSA-4615885	0.194606983206704	2.65444203232878	2/18	1	PCNA;TOP2A
SUMOylation of RNA binding proteins R-HSA-4570464	1	0	0/24	1	
SUMOylation of SUMOylation proteins R-HSA-4085377	1	0	0/12	1	
SUMOylation of chromatin organization proteins R-HSA-4551638	1	0	0/45	1	
SUMOylation of immune response proteins R-HSA-4755510	0.341107769845094	2.6453817850105	1/9	1	RELA
SUMOylation of intracellular receptors R-HSA-4090294	1	0	0/22	1	
SUMOylation of nuclear envelope proteins R-HSA-9793242	1	0	0/2	1	
SUMOylation of transcription cofactors R-HSA-3899300	1	0	0/35	1	
SUMOylation of transcription factors R-HSA-3232118	0.452789218493456	1.76203882355408	1/13	1	TP53
SUMOylation of ubiquitinylation proteins R-HSA-3232142	1	0	0/15	1	
Scavenging by Class A Receptors R-HSA-3000480	1	0	0/11	1	
Scavenging by Class B Receptors R-HSA-3000471	1	0	0/5	1	
Scavenging by Class F Receptors R-HSA-3000484	1	0	0/3	1	
Scavenging by Class H Receptors R-HSA-3000497	1	0	0/2	1	
Scavenging of heme from plasma R-HSA-2168880	1	0	0/5	1	
Sealing of the nuclear envelope (NE) by ESCRT-III R-HSA-9668328	1	0	0/25	1	
Selective autophagy R-HSA-9663891	0.420666715016203	1.29650338349409	3/52	1	UBA52;DYNLL1;HSF1
Sema3A PAK dependent Axon repulsion R-HSA-399954	1	0	0/10	1	
Sema4D in semaphorin signaling R-HSA-400685	1	0	0/16	1	
Sema4D induced cell migration and growth-cone collapse R-HSA-416572	1	0	0/13	1	
Sema4D mediated inhibition of cell attachment and migration R-HSA-416550	1	0	0/6	1	
Semaphorin interactions R-HSA-373755	1	0	0/41	1	
Sensing of DNA Double Strand Breaks R-HSA-5693548	1	0	0/5	1	
Sensory Perception R-HSA-9709957	1	0	0/64	1	
Sensory perception of salty taste R-HSA-9730628	1	0	0/4	1	
Sensory perception of sour taste R-HSA-9729555	1	0	0/0	1	
Sensory perception of sweet, bitter, and umami (glutamate) taste R-HSA-9717207	1	0	0/3	1	
Sensory perception of taste R-HSA-9717189	1	0	0/7	1	
Sensory processing of sound R-HSA-9659379	1	0	0/31	1	
Sensory processing of sound by inner hair cells of the cochlea R-HSA-9662360	1	0	0/28	1	
Sensory processing of sound by outer hair cells of the cochlea R-HSA-9662361	1	0	0/20	1	
Separation of Sister Chromatids R-HSA-2467813	0.351365925698663	1.23984104731827	7/127	1	UBA52;PSMC5;CDC26;DYNLL1;RPS27;ZWINT;BUB1
Serine biosynthesis R-HSA-977347	1	0	0/2	1	
Serotonin Neurotransmitter Release Cycle R-HSA-181429	1	0	0/5	1	
Serotonin and melatonin biosynthesis R-HSA-209931	1	0	0/1	1	
Serotonin clearance from the synaptic cleft R-HSA-380615	1	0	0/1	1	
Serotonin receptors R-HSA-390666	1	0	0/0	1	
Severe congenital neutropenia type 4 (G6PC3) R-HSA-3282872	1	0	0/1	1	
Sialic acid metabolism R-HSA-4085001	1	0	0/11	1	
Signal Transduction R-HSA-162582	0.999999477878964	0.413729431396877	31/1306	1	DERL2;UBA52;PSMC5;SKP1;CXCL8;DYNLL1;TFDP1;E2F1;POLR2F;H2AX;H2BC8;H2BC3;TP53;JUN;NFKB1;RELA;SP1;FOS;ATF2;RPS6;RPS27;BAX;UBE2L3;ATP6V1F;ATP6V0E1;ZWINT;BUB1;ARPC1A;TBP;MYC;E2F4
Signal amplification R-HSA-392518	1	0	0/18	1	
Signal attenuation R-HSA-74749	1	0	0/8	1	
Signal regulatory protein family interactions R-HSA-391160	1	0	0/10	1	
Signal transduction by L1 R-HSA-445144	1	0	0/14	1	
Signaling by ALK R-HSA-201556	0.656326253281738	0.958800817046349	1/23	1	MYC
Signaling by ALK fusions and activated point mutants R-HSA-9725370	0.140245131102696	1.90823581586637	5/61	1	UBA52;SKP1;TP53;JUN;RPS6
Signaling by ALK in cancer R-HSA-9700206	0.140245131102696	1.90823581586637	5/61	1	UBA52;SKP1;TP53;JUN;RPS6
Signaling by AMER1 mutants R-HSA-4839748	1	0	0/10	1	
Signaling by APC mutants R-HSA-4839744	1	0	0/10	1	
Signaling by AXIN mutants R-HSA-4839735	1	0	0/10	1	
Signaling by Activin R-HSA-1502540	1	0	0/12	1	
Signaling by BMP R-HSA-201451	1	0	0/16	1	
Signaling by BRAF and RAF1 fusions R-HSA-6802952	1	0	0/35	1	
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350	0.656326253281738	0.958800817046349	1/23	1	UBA52
Signaling by CSF3 (G-CSF) R-HSA-9674555	0.740166932123927	0.752200778598454	1/29	1	UBA52
Signaling by CTNNB1 phospho-site mutants R-HSA-4839743	1	0	0/11	1	
Signaling by EGFR R-HSA-177929	0.829325851059439	0.567917875934568	1/38	1	UBA52
Signaling by EGFR in Cancer R-HSA-1643713	0.656326253281738	0.958800817046349	1/23	1	UBA52
Signaling by EGFRvIII in Cancer R-HSA-5637812	1	0	0/13	1	
Signaling by ERBB2 ECD mutants R-HSA-9665348	1	0	0/13	1	
Signaling by ERBB2 KD Mutants R-HSA-9664565	1	0	0/18	1	
Signaling by ERBB2 R-HSA-1227986	0.829325851059439	0.567917875934568	1/38	1	UBA52
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686	1	0	0/15	1	
Signaling by ERBB2 in Cancer R-HSA-1227990	1	0	0/18	1	
Signaling by ERBB4 R-HSA-1236394	0.829325851059439	0.567917875934568	1/38	1	UBA52
Signaling by Erythropoietin R-HSA-9006335	1	0	0/19	1	
Signaling by FGFR R-HSA-190236	0.669125016689837	0.877787349609299	2/50	1	UBA52;POLR2F
Signaling by FGFR in disease R-HSA-1226099	0.871100880794874	0.487914657830819	1/44	1	POLR2F
Signaling by FGFR1 R-HSA-5654736	0.727761648685022	0.780258941667337	1/28	1	UBA52
Signaling by FGFR1 amplification mutants R-HSA-1839120	1	0	0/0	1	
Signaling by FGFR1 in disease R-HSA-5655302	1	0	0/26	1	
Signaling by FGFR2 IIIa TM R-HSA-8851708	0.545626551046988	1.32029355805218	1/17	1	POLR2F
Signaling by FGFR2 R-HSA-5654738	0.623704356491311	0.958573147584744	2/46	1	UBA52;POLR2F
Signaling by FGFR2 amplification mutants R-HSA-2023837	1	0	0/1	1	
Signaling by FGFR2 fusions R-HSA-8853333	1	0	0/1	1	
Signaling by FGFR2 in disease R-HSA-5655253	0.727761648685022	0.780258941667337	1/28	1	POLR2F
Signaling by FGFR3 R-HSA-5654741	0.686900048024346	0.878459259064141	1/25	1	UBA52
Signaling by FGFR3 fusions in cancer R-HSA-8853334	1	0	0/0	1	
Signaling by FGFR3 in disease R-HSA-5655332	1	0	0/11	1	
Signaling by FGFR4 R-HSA-5654743	0.686900048024346	0.878459259064141	1/25	1	UBA52
Signaling by FGFR4 in disease R-HSA-5655291	1	0	0/10	1	
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648	1	0	0/14	1	
Signaling by FLT3 fusion proteins R-HSA-9703465	1	0	0/15	1	
Signaling by GPCR R-HSA-372790	0.999990006921748	0.0829191403760581	1/241	1	CXCL8
Signaling by GSK3beta mutants R-HSA-5339716	1	0	0/11	1	
Signaling by Hedgehog R-HSA-5358351	0.742135711285555	0.791643151550878	4/110	1	DERL2;UBA52;PSMC5;SKP1
Signaling by Hippo R-HSA-2028269	1	0	0/11	1	
Signaling by Insulin receptor R-HSA-74752	0.599258107657191	1.00473465510445	2/44	1	ATP6V1F;ATP6V0E1
Signaling by Interleukins R-HSA-449147	0.883934939211343	0.729130152591414	12/351	1	UBA52;PSMC5;SKP1;CXCL8;TP53;JUN;NFKB1;RELA;FOS;ATF2;RPLP0;MYC
Signaling by KIT in disease R-HSA-9669938	1	0	0/20	1	
Signaling by LRP5 mutants  R-HSA-5339717	1	0	0/2	1	
Signaling by LTK R-HSA-9842663	1	0	0/9	1	
Signaling by LTK in cancer R-HSA-9842640	1	0	0/7	1	
Signaling by Leptin R-HSA-2586552	1	0	0/9	1	
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815	0.545626551046988	1.32029355805218	1/17	1	UBA52
Signaling by MAP2K mutants R-HSA-9652169	1	0	0/2	1	
Signaling by MAPK mutants R-HSA-9652817	1	0	0/2	1	
Signaling by MET R-HSA-6806834	0.893127154367484	0.44593634359623	1/48	1	UBA52
Signaling by MRAS-complex mutants R-HSA-9660537	1	0	0/5	1	
Signaling by MST1 R-HSA-8852405	1	0	0/1	1	
Signaling by NODAL R-HSA-1181150	1	0	0/12	1	
Signaling by NOTCH R-HSA-157118	0.277505278149857	1.26351537993365	11/197	1	UBA52;PSMC5;SKP1;TFDP1;E2F1;H2AX;H2BC8;H2BC3;TP53;JUN;MYC
Signaling by NOTCH1 HD Domain Mutants in Cancer R-HSA-2691230	0.341107769845094	2.6453817850105	1/9	1	UBA52
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer R-HSA-2894858	0.395986040988239	1.35235537341895	3/50	1	UBA52;SKP1;MYC
Signaling by NOTCH1 PEST Domain Mutants in Cancer R-HSA-2644602	0.395986040988239	1.35235537341895	3/50	1	UBA52;SKP1;MYC
Signaling by NOTCH1 R-HSA-1980143	0.492415282671302	1.15328898052379	3/58	1	UBA52;SKP1;MYC
Signaling by NOTCH1 in Cancer R-HSA-2644603	0.395986040988239	1.35235537341895	3/50	1	UBA52;SKP1;MYC
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660825	1	0	0/4	1	
Signaling by NOTCH2 R-HSA-1980145	0.671967212159988	0.916883980868546	1/24	1	UBA52
Signaling by NOTCH3 R-HSA-9012852	0.837122498402455	0.552829745416831	1/39	1	UBA52
Signaling by NOTCH4 R-HSA-9013694	0.685281558585488	0.852955997522021	3/77	1	UBA52;PSMC5;SKP1
Signaling by NTRK1 (TRKA) R-HSA-187037	0.90777227228892	0.49689149152136	2/86	1	FOS;ATF2
Signaling by NTRK2 (TRKB) R-HSA-9006115	1	0	0/17	1	
Signaling by NTRK3 (TRKC) R-HSA-9034015	0.399525249474029	2.11529879670146	1/11	1	BAX
Signaling by NTRKs R-HSA-166520	0.806788962668872	0.690518589956571	3/94	1	FOS;ATF2;BAX
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927	0.844564841172081	0.538515280416297	1/40	1	UBA52
Signaling by Nuclear Receptors R-HSA-9006931	0.500162732749946	1.04160284746996	10/213	1	POLR2F;H2AX;H2BC8;H2BC3;JUN;SP1;FOS;ATF2;TBP;MYC
Signaling by Overexpressed Wild-Type EGFR in Cancer R-HSA-5638302	1	0	0/8	1	
Signaling by PDGF R-HSA-186797	1	0	0/48	1	
Signaling by PDGFR in disease R-HSA-9671555	1	0	0/14	1	
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770	1	0	0/12	1	
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767	1	0	0/12	1	
Signaling by PTK6 R-HSA-8848021	0.844564841172081	0.538515280416297	1/40	1	UBA52
Signaling by RAF1 mutants R-HSA-9656223	1	0	0/24	1	
Signaling by RAS GAP mutants R-HSA-9753510	1	0	0/3	1	
Signaling by RAS GTPase mutants R-HSA-9753512	1	0	0/3	1	
Signaling by RAS mutants R-HSA-6802949	1	0	0/27	1	
Signaling by RNF43 mutants R-HSA-5340588	1	0	0/5	1	
Signaling by Receptor Tyrosine Kinases R-HSA-9006934	0.98508315788408	0.507652443031367	8/327	1	UBA52;POLR2F;FOS;ATF2;BAX;ATP6V1F;ATP6V0E1;MYC
Signaling by Retinoic Acid R-HSA-5362517	1	0	0/15	1	
Signaling by Rho GTPases R-HSA-194315	0.996415397151521	0.436599111943269	8/374	1	DYNLL1;H2AX;H2BC8;H2BC3;RPS27;ZWINT;BUB1;ARPC1A
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542	0.996741597635846	0.432678317254881	8/377	1	DYNLL1;H2AX;H2BC8;H2BC3;RPS27;ZWINT;BUB1;ARPC1A
Signaling by SCF-KIT R-HSA-1433557	1	0	0/34	1	
Signaling by TCF7L2 mutants R-HSA-5339700	1	0	0/3	1	
Signaling by TGF-beta Receptor Complex R-HSA-170834	0.358278291832628	1.29443860404156	5/87	1	UBA52;TFDP1;SP1;MYC;E2F4
Signaling by TGF-beta Receptor Complex in Cancer R-HSA-3304351	1	0	0/8	1	
Signaling by TGFB family members R-HSA-9006936	0.467244649035507	1.1256519512236	5/99	1	UBA52;TFDP1;SP1;MYC;E2F4
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192	1	0	0/27	1	
Signaling by VEGF R-HSA-194138	1	0	0/76	1	
Signaling by WNT R-HSA-195721	0.893301515008281	0.664720823275771	7/225	1	UBA52;PSMC5;SKP1;H2AX;H2BC8;H2BC3;MYC
Signaling by WNT in cancer R-HSA-4791275	1	0	0/21	1	
Signaling by activated point mutants of FGFR1 R-HSA-1839122	1	0	0/2	1	
Signaling by activated point mutants of FGFR3 R-HSA-1839130	1	0	0/2	1	
Signaling by cytosolic FGFR1 fusion mutants R-HSA-1839117	1	0	0/17	1	
Signaling by cytosolic PDGFRA and PDGFRB fusion proteins R-HSA-9673766	1	0	0/0	1	
Signaling by extracellular domain mutants of KIT R-HSA-9680187	1	0	0/1	1	
Signaling by high-kinase activity BRAF mutants R-HSA-6802948	1	0	0/19	1	
Signaling by juxtamembrane domain KIT mutants R-HSA-9669935	1	0	0/1	1	
Signaling by kinase domain mutants of KIT R-HSA-9669933	1	0	0/1	1	
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB R-HSA-9673768	1	0	0/2	1	
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946	1	0	0/27	1	
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439	1	0	0/20	1	
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336	1	0	0/1	1	
Signaling by the B Cell Receptor (BCR) R-HSA-983705	0.258887798531979	1.43651225816609	6/95	1	UBA52;PSMC5;SKP1;REL;NFKB1;RELA
Signaling downstream of RAS mutants R-HSA-9649948	1	0	0/27	1	
Signalling to ERK5 R-HSA-198765	1	0	0/2	1	
Signalling to ERKs R-HSA-187687	1	0	0/21	1	
Signalling to RAS R-HSA-167044	1	0	0/13	1	
Signalling to STAT3 R-HSA-198745	1	0	0/2	1	
Signalling to p38 via RIT and RIN R-HSA-187706	1	0	0/3	1	
Small interfering RNA (siRNA) biogenesis R-HSA-426486	1	0	0/3	1	
Smooth Muscle Contraction R-HSA-445355	1	0	0/23	1	
Sodium-coupled phosphate cotransporters R-HSA-427652	1	0	0/2	1	
Sodium-coupled sulphate, di- and tri-carboxylate transporters R-HSA-433137	1	0	0/2	1	
Sodium/Calcium exchangers R-HSA-425561	1	0	0/7	1	
Sodium/Proton exchangers R-HSA-425986	1	0	0/5	1	
Somitogenesis R-HSA-9824272	0.887999275303312	0.455748887970108	1/47	1	PSMC5
Sorafenib-resistant KIT mutants R-HSA-9669936	1	0	0/1	1	
Sorafenib-resistant PDGFR mutants R-HSA-9674404	1	0	0/1	1	
Specification of primordial germ cells R-HSA-9827857	1	0	0/5	1	
Specification of the neural plate border R-HSA-9834899	1	0	0/9	1	
Sperm Motility And Taxes R-HSA-1300642	1	0	0/0	1	
Sphingolipid catabolism R-HSA-9845614	1	0	0/6	1	
Sphingolipid de novo biosynthesis R-HSA-1660661	1	0	0/14	1	
Sphingolipid metabolism R-HSA-428157	1	0	0/39	1	
Spry regulation of FGF signaling R-HSA-1295596	0.501352035090244	1.50960242203817	1/15	1	UBA52
Stabilization of p53 R-HSA-69541	0.468944527361077	1.19742503924612	3/56	1	UBA52;PSMC5;TP53
Sterols are 12-hydroxylated by CYP8B1 R-HSA-211994	1	0	0/0	1	
Stimulation of the cell death response by PAK-2p34 R-HSA-211736	1	0	0/1	1	
Stimuli-sensing channels R-HSA-2672351	0.85844995786207	0.511980933919639	1/42	1	UBA52
Striated Muscle Contraction R-HSA-390522	1	0	0/28	1	
Sulfide oxidation to sulfate R-HSA-1614517	1	0	0/3	1	
Sulfur amino acid metabolism R-HSA-1614635	1	0	0/14	1	
Sunitinib-resistant KIT mutants R-HSA-9669934	1	0	0/1	1	
Sunitinib-resistant PDGFR mutants R-HSA-9674401	1	0	0/1	1	
Suppression of apoptosis R-HSA-9635465	1	0	0/3	1	
Suppression of autophagy R-HSA-9636569	1	0	0/1	1	
Suppression of phagosomal maturation R-HSA-9637687	0.309813381545497	3.02371343760045	1/8	1	UBA52
Surfactant metabolism R-HSA-5683826	1	0	0/7	1	
Switching of origins to a post-replicative state R-HSA-69052	0.303804843702422	1.39880185430583	5/81	1	UBA52;PSMC5;CDC26;SKP1;CCNA2
Synaptic adhesion-like molecules R-HSA-8849932	1	0	0/4	1	
Syndecan interactions R-HSA-3000170	1	0	0/15	1	
Synthesis And Processing Of GAG, GAGPOL Polyproteins R-HSA-174495	0.27704115757633	3.52822750116427	1/7	1	UBA52
Synthesis and processing of ENV and VPU R-HSA-171286	1	0	0/1	1	
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) R-HSA-2142816	1	0	0/3	1	
Synthesis of 12-eicosatetraenoic acid derivatives R-HSA-2142712	1	0	0/3	1	
Synthesis of 15-eicosatetraenoic acid derivatives R-HSA-2142770	1	0	0/4	1	
Synthesis of 5-eicosatetraenoic acids R-HSA-2142688	1	0	0/5	1	
Synthesis of CL R-HSA-1483076	1	0	0/1	1	
Synthesis of DNA R-HSA-69239	0.121101765149541	1.76652330585436	7/92	1	UBA52;PSMC5;CDC26;SKP1;CCNA2;RPA3;PCNA
Synthesis of Dolichyl-phosphate R-HSA-446199	1	0	0/1	1	
Synthesis of GDP-mannose R-HSA-446205	1	0	0/2	1	
Synthesis of Hepoxilins (HX) and Trioxilins (TrX) R-HSA-2142696	1	0	0/0	1	
Synthesis of IP2, IP, and Ins in the cytosol R-HSA-1855183	1	0	0/6	1	
Synthesis of IP3 and IP4 in the cytosol R-HSA-1855204	1	0	0/8	1	
Synthesis of IPs in the ER lumen R-HSA-1855231	1	0	0/1	1	
Synthesis of IPs in the nucleus R-HSA-1855191	1	0	0/0	1	
Synthesis of Ketone Bodies R-HSA-77111	1	0	0/1	1	
Synthesis of Leukotrienes (LT) and Eoxins (EX) R-HSA-2142691	1	0	0/10	1	
Synthesis of Lipoxins (LX) R-HSA-2142700	1	0	0/2	1	
Synthesis of PA R-HSA-1483166	1	0	0/13	1	
Synthesis of PC R-HSA-1483191	1	0	0/9	1	
Synthesis of PE R-HSA-1483213	1	0	0/3	1	
Synthesis of PG R-HSA-1483148	1	0	0/3	1	
Synthesis of PI R-HSA-1483226	1	0	0/3	1	
Synthesis of PIPs at the ER membrane R-HSA-1483248	1	0	0/4	1	
Synthesis of PIPs at the Golgi membrane R-HSA-1660514	1	0	0/11	1	
Synthesis of PIPs at the early endosome membrane R-HSA-1660516	1	0	0/10	1	
Synthesis of PIPs at the late endosome membrane R-HSA-1660517	1	0	0/9	1	
Synthesis of PIPs at the plasma membrane R-HSA-1660499	1	0	0/27	1	
Synthesis of PIPs in the nucleus R-HSA-8847453	1	0	0/2	1	
Synthesis of PS R-HSA-1483101	1	0	0/2	1	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) R-HSA-2162123	1	0	0/4	1	
Synthesis of UDP-N-acetyl-glucosamine R-HSA-446210	1	0	0/1	1	
Synthesis of bile acids and bile salts R-HSA-192105	1	0	0/10	1	
Synthesis of bile acids and bile salts via 24-hydroxycholesterol R-HSA-193775	1	0	0/2	1	
Synthesis of bile acids and bile salts via 27-hydroxycholesterol R-HSA-193807	1	0	0/5	1	
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol R-HSA-193368	1	0	0/9	1	
Synthesis of diphthamide-EEF2 R-HSA-5358493	1	0	0/4	1	
Synthesis of dolichyl-phosphate mannose R-HSA-162699	1	0	0/2	1	
Synthesis of dolichyl-phosphate-glucose R-HSA-480985	1	0	0/1	1	
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) R-HSA-2142670	1	0	0/2	1	
Synthesis of glycosylphosphatidylinositol (GPI) R-HSA-162710	1	0	0/8	1	
Synthesis of pyrophosphates in the cytosol R-HSA-1855167	1	0	0/2	1	
Synthesis of substrates in N-glycan biosythesis R-HSA-446219	1	0	0/19	1	
Synthesis of very long-chain fatty acyl-CoAs R-HSA-75876	1	0	0/8	1	
Synthesis of wybutosine at G37 of tRNA(Phe) R-HSA-6782861	1	0	0/1	1	
Synthesis, secretion, and deacylation of Ghrelin R-HSA-422085	0.399525249474029	2.11529879670146	1/11	1	SEC11A
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771	0.37099061448409	2.35079399308912	1/10	1	SEC11A
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511	0.27704115757633	3.52822750116427	1/7	1	SEC11A
TAK1-dependent IKK and NF-kappa-B activation   R-HSA-445989	0.0906428979323242	2.51435732030574	4/38	1	UBA52;TP53;NFKB1;RELA
TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P R-HSA-6791462	1	0	0/1	1	
TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P R-HSA-6791055	1	0	0/1	1	
TBC/RABGAPs R-HSA-8854214	1	0	0/16	1	
TCF dependent signaling in response to WNT R-HSA-201681	0.809288878985862	0.745186826594328	6/174	1	UBA52;PSMC5;H2AX;H2BC8;H2BC3;MYC
TCR signaling R-HSA-202403	0.502514523174183	1.07854357648059	5/103	1	UBA52;PSMC5;SKP1;NFKB1;RELA
TET1,2,3 and TDG demethylate DNA R-HSA-5221030	1	0	0/1	1	
TFAP2 (AP-2) family regulates transcription of cell cycle factors R-HSA-8866911	0.169147252592067	7.0579254813706	1/4	1	MYC
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors R-HSA-8866910	1	0	0/9	1	
TFAP2 (AP-2) family regulates transcription of other transcription factors R-HSA-8866906	1	0	0/3	1	
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation R-HSA-8869496	1	0	0/4	1	
TGF-beta receptor signaling activates SMADs R-HSA-2173789	0.851668895633996	0.52491646278713	1/41	1	UBA52
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) R-HSA-2173791	0.501352035090244	1.50960242203817	1/15	1	UBA52
TGFBR1 KD Mutants in Cancer R-HSA-3656532	1	0	0/6	1	
TGFBR1 LBD Mutants in Cancer R-HSA-3656535	1	0	0/4	1	
TGFBR2 Kinase Domain Mutants in Cancer R-HSA-3645790	1	0	0/3	1	
TGFBR2 MSI Frameshift Mutants in Cancer R-HSA-3642279	1	0	0/2	1	
TICAM1 deficiency - HSE R-HSA-5602566	1	0	0/2	1	
TICAM1, RIP1-mediated IKK complex recruitment R-HSA-168927	0.585989544514493	1.17302584275925	1/19	1	UBA52
TICAM1,TRAF6-dependent induction of TAK1 complex R-HSA-9014325	0.37099061448409	2.35079399308912	1/10	1	UBA52
TICAM1-dependent activation of IRF3/IRF7 R-HSA-9013973	0.426772182116293	1.92268712388978	1/12	1	UBA52
TLR3 deficiency - HSE R-HSA-5602410	1	0	0/1	1	
TLR3-mediated TICAM1-dependent programmed cell death R-HSA-9013957	1	0	0/6	1	
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway R-HSA-5676594	1	0	0/9	1	
TNF signaling R-HSA-75893	0.546871130387055	1.11162888632792	2/40	1	UBA52;UBE2L3
TNFR1-induced NF-kappa-B signaling pathway R-HSA-5357956	0.63994378502192	1.00470864523097	1/22	1	UBA52
TNFR1-induced proapoptotic signaling R-HSA-5357786	1	0	0/14	1	
TNFR1-mediated ceramide production R-HSA-5626978	1	0	0/5	1	
TNFR2 non-canonical NF-kB pathway R-HSA-5668541	0.640323911535587	0.915960022126889	3/72	1	UBA52;PSMC5;SKP1
TNFs bind their physiological receptors R-HSA-5669034	1	0	0/7	1	
TP53 Regulates Transcription of Caspase Activators and Caspases R-HSA-6803207	0.341107769845094	2.6453817850105	1/9	1	TP53
TP53 Regulates Transcription of Cell Death Genes R-HSA-5633008	0.313579151415377	1.84339522129094	2/25	1	TP53;BAX
TP53 Regulates Transcription of Death Receptors and Ligands R-HSA-6803211	0.242721710581898	4.23445267568269	1/6	1	TP53
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release R-HSA-6803204	0.114567745590346	3.86533873346815	2/13	1	TP53;BAX
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain R-HSA-6804115	0.477631583419205	1.62611481395553	1/14	1	TP53
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain R-HSA-6803205	0.242721710581898	4.23445267568269	1/6	1	TP53
TRAF3 deficiency - HSE R-HSA-5602571	1	0	0/3	1	
TRAF3-dependent IRF activation pathway R-HSA-918233	1	0	0/13	1	
TRAF6 mediated IRF7 activation R-HSA-933541	1	0	0/27	1	
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling R-HSA-975110	0.426772182116293	1.92268712388978	1/12	1	UBA52
TRAF6 mediated NF-kB activation R-HSA-933542	0.27952948330592	2.02003720593716	2/23	1	NFKB1;RELA
TRAF6-mediated induction of TAK1 complex within TLR4 complex R-HSA-937072	0.426772182116293	1.92268712388978	1/12	1	UBA52
TRAIL  signaling R-HSA-75158	1	0	0/5	1	
TRIF-mediated programmed cell death R-HSA-2562578	1	0	0/7	1	
TRKA activation by NGF R-HSA-187042	1	0	0/1	1	
TRP channels R-HSA-3295583	1	0	0/8	1	
TWIK related potassium channel (TREK) R-HSA-1299503	1	0	0/0	1	
TWIK-related alkaline pH activated K+ channel (TALK) R-HSA-1299361	1	0	0/0	1	
TWIK-related spinal cord K+ channel (TRESK) R-HSA-1299344	1	0	0/0	1	
TWIK-releated acid-sensitive K+ channel (TASK) R-HSA-1299316	1	0	0/1	1	
TYSND1 cleaves peroxisomal proteins R-HSA-9033500	1	0	0/2	1	
Tachykinin receptors bind tachykinins R-HSA-380095	1	0	0/1	1	
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) R-HSA-1299308	1	0	0/1	1	
Tandem pore domain halothane-inhibited K+ channel (THIK) R-HSA-1299287	1	0	0/1	1	
Tandem pore domain potassium channels R-HSA-1296346	1	0	0/3	1	
Tat-mediated HIV elongation arrest and recovery R-HSA-167243	0.262447347130839	2.12165544098413	2/22	1	POLR2F;SUPT4H1
Tat-mediated elongation of the HIV-1 transcript R-HSA-167246	0.330484949669379	1.76624926591966	2/26	1	POLR2F;SUPT4H1
Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417	0.0721621680941335	5.31709371407414	2/10	1	RPA3;PCNA
Telomere C-strand synthesis initiation R-HSA-174430	1	0	0/2	1	
Terminal pathway of complement R-HSA-166665	1	0	0/4	1	
Termination of O-glycan biosynthesis R-HSA-977068	1	0	0/11	1	
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151	1	0	0/5	1	
The AIM2 inflammasome R-HSA-844615	1	0	0/2	1	
The IPAF inflammasome R-HSA-844623	1	0	0/2	1	
The NLRP1 inflammasome R-HSA-844455	1	0	0/2	1	
The NLRP3 inflammasome R-HSA-844456	0.161617941350537	3.03489390408789	2/16	1	NFKB1;RELA
The activation of arylsulfatases R-HSA-1663150	1	0	0/1	1	
The canonical retinoid cycle in rods (twilight vision) R-HSA-2453902	1	0	0/4	1	
The fatty acid cycling model R-HSA-167826	1	0	0/0	1	
The phototransduction cascade R-HSA-2514856	1	0	0/10	1	
The proton buffering model R-HSA-167827	1	0	0/0	1	
The retinoid cycle in cones (daylight vision) R-HSA-2187335	1	0	0/1	1	
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276	0.667815981669016	0.877107865593007	3/75	1	UBA52;PSMC5;TP53
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952	1	0	0/18	1	
Threonine catabolism R-HSA-8849175	1	0	0/3	1	
Thrombin signalling through proteinase activated receptors (PARs) R-HSA-456926	1	0	0/17	1	
Thromboxane signalling through TP receptor R-HSA-428930	1	0	0/12	1	
Thyroxine biosynthesis R-HSA-209968	1	0	0/3	1	
Tie2 Signaling R-HSA-210993	1	0	0/15	1	
Tight junction interactions R-HSA-420029	1	0	0/6	1	
Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016	0.123222811156315	1.68442717575286	8/110	1	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toll-like Receptor Cascades R-HSA-168898	0.163584965720725	1.55863280754988	8/118	1	UBA52;SKP1;TP53;JUN;NFKB1;RELA;FOS;ATF2
Toxicity of botulinum toxin type A (botA) R-HSA-5250968	1	0	0/0	1	
Toxicity of botulinum toxin type B (botB) R-HSA-5250958	1	0	0/3	1	
Toxicity of botulinum toxin type C (botC) R-HSA-5250971	1	0	0/0	1	
Toxicity of botulinum toxin type D (botD) R-HSA-5250955	1	0	0/1	1	
Toxicity of botulinum toxin type E (botE) R-HSA-5250992	1	0	0/0	1	
Toxicity of botulinum toxin type F (botF) R-HSA-5250981	1	0	0/1	1	
Toxicity of botulinum toxin type G (botG) R-HSA-5250989	1	0	0/2	1	
Toxicity of tetanus toxin (tetX) R-HSA-5250982	1	0	0/1	1	
Trafficking and processing of endosomal TLR R-HSA-1679131	1	0	0/4	1	
Trafficking of AMPA receptors R-HSA-399719	1	0	0/14	1	
Trafficking of GluR2-containing AMPA receptors R-HSA-416993	1	0	0/7	1	
Trafficking of myristoylated proteins to the cilium R-HSA-5624138	1	0	0/0	1	
Transcription from mitochondrial promoters R-HSA-75944	1	0	0/2	1	
Transcription of the HIV genome R-HSA-167172	0.112272858221699	2.30892720594353	4/41	1	POLR2F;SUPT4H1;TBP;TAF10
Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827	0.119950102934975	2.24753497535373	4/42	1	UBA52;POLR2F;RPA3;PCNA
Transcriptional  activation of  cell cycle inhibitor p21  R-HSA-69895	0.0884673733624665	21.1535855938183	1/2	1	TP53
Transcriptional Regulation by E2F6 R-HSA-8953750	0.330484949669379	1.76624926591966	2/26	1	TFDP1;E2F1
Transcriptional Regulation by MECP2 R-HSA-8986944	1	0	0/33	1	
Transcriptional Regulation by NPAS4 R-HSA-9634815	0.545626551046988	1.32029355805218	1/17	1	FOS
Transcriptional activation of mitochondrial biogenesis R-HSA-2151201	0.47500080445081	1.28167815488302	2/35	1	CYCS;ATF2
Transcriptional activation of p53 responsive genes   R-HSA-69560	0.0884673733624665	21.1535855938183	1/2	1	TP53
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer R-HSA-2173793	0.0787638138735221	2.32906019232505	5/51	1	UBA52;TFDP1;SP1;MYC;E2F4
Transcriptional and post-translational regulation of MITF-M expression and activity R-HSA-9856649	1	0	0/21	1	
Transcriptional regulation by RUNX1 R-HSA-8878171	0.872872989583921	0.673595122968224	6/191	1	UBA52;PSMC5;H2AX;H2BC8;H2BC3;DPY30
Transcriptional regulation by RUNX2 R-HSA-8878166	0.686235314443557	0.858081484982988	4/102	1	UBA52;PSMC5;SKP1;BAX
Transcriptional regulation by RUNX3 R-HSA-8878159	0.605259975903222	0.958110139156748	4/92	1	UBA52;PSMC5;TP53;MYC
Transcriptional regulation by small RNAs R-HSA-5578749	0.483423722019437	1.12800854842521	4/79	1	POLR2F;H2AX;H2BC8;H2BC3
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors R-HSA-8864260	0.622784856026871	1.05523077016551	1/21	1	MYC
Transcriptional regulation of brown and beige adipocyte differentiation R-HSA-9843743	1	0	0/19	1	
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 R-HSA-9844594	1	0	0/19	1	
Transcriptional regulation of granulopoiesis R-HSA-9616222	0.165111801020997	1.68794279040785	6/82	1	TFDP1;E2F1;H2AX;H2BC8;H2BC3;MYC
Transcriptional regulation of pluripotent stem cells R-HSA-452723	1	0	0/13	1	
Transcriptional regulation of testis differentiation R-HSA-9690406	1	0	0/7	1	
Transcriptional regulation of white adipocyte differentiation R-HSA-381340	0.710036374405601	0.809426910722397	2/54	1	NFKB1;RELA
Transfer of LPS from LBP carrier to CD14 R-HSA-166020	1	0	0/0	1	
Transferrin endocytosis and recycling R-HSA-917977	0.145545260024666	3.26902954467283	2/15	1	ATP6V1F;ATP6V0E1
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9679504	1	0	0/5	1	
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9694676	1	0	0/5	1	
Translation of Structural Proteins R-HSA-9683701	0.566274760919946	1.24232925880823	1/18	1	UBA52
Translation of Structural Proteins R-HSA-9694635	0.740166932123927	0.752200778598454	1/29	1	UBA52
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template R-HSA-110313	0.0665890602673162	3.55631952144581	3/21	1	UBA52;RPA3;PCNA
Translocation of SLC2A4 (GLUT4) to the plasma membrane R-HSA-1445148	1	0	0/47	1	
Translocation of ZAP-70 to Immunological synapse R-HSA-202430	1	0	0/16	1	
Transmission across Chemical Synapses R-HSA-112315	1	0	0/112	1	
Transmission across Electrical Synapses  R-HSA-112307	1	0	0/1	1	
Transport and synthesis of PAPS R-HSA-174362	1	0	0/5	1	
Transport of Mature Transcript to Cytoplasm R-HSA-72202	1	0	0/32	1	
Transport of Mature mRNA Derived from an Intronless Transcript R-HSA-159231	1	0	0/15	1	
Transport of Mature mRNA derived from an Intron-Containing Transcript R-HSA-159236	1	0	0/27	1	
Transport of Mature mRNAs Derived from Intronless Transcripts R-HSA-159234	1	0	0/16	1	
Transport of RCbl within the body R-HSA-9758890	1	0	0/3	1	
Transport of Ribonucleoproteins into the Host Nucleus R-HSA-168271	1	0	0/11	1	
Transport of bile salts and organic acids, metal ions and amine compounds R-HSA-425366	1	0	0/15	1	
Transport of connexins along the secretory pathway R-HSA-190827	1	0	0/2	1	
Transport of connexons to the plasma membrane R-HSA-190872	1	0	0/20	1	
Transport of fatty acids R-HSA-804914	1	0	0/4	1	
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159763	1	0	0/2	1	
Transport of glycerol from adipocytes to the liver by Aquaporins R-HSA-432030	1	0	0/1	1	
Transport of inorganic cations/anions and amino acids/oligopeptides R-HSA-425393	1	0	0/40	1	
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane R-HSA-83936	1	0	0/3	1	
Transport of nucleotide sugars R-HSA-727802	1	0	0/4	1	
Transport of organic anions R-HSA-879518	1	0	0/5	1	
Transport of small molecules R-HSA-382551	0.975189869885512	0.540739237796771	8/309	1	DERL2;UBA52;RNF5;PSMC5;EIF2S2;SKP1;ATP6V1F;ATP6V0E1
Transport of the SLBP Dependant Mature mRNA R-HSA-159230	1	0	0/13	1	
Transport of the SLBP independent Mature mRNA R-HSA-159227	1	0	0/12	1	
Transport of vitamins, nucleosides, and related molecules R-HSA-425397	1	0	0/17	1	
Transport to the Golgi and subsequent modification R-HSA-948021	0.990364670697713	0.211021338279319	1/99	1	DYNLL1
Triglyceride biosynthesis R-HSA-75109	1	0	0/6	1	
Triglyceride catabolism R-HSA-163560	1	0	0/14	1	
Triglyceride metabolism R-HSA-8979227	1	0	0/20	1	
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA R-HSA-450513	1	0	0/14	1	
Truncations of AMER1 destabilize the destruction complex R-HSA-5467348	1	0	0/10	1	
Tryptophan catabolism R-HSA-71240	1	0	0/5	1	
Type I hemidesmosome assembly R-HSA-446107	1	0	0/6	1	
Type II Na+/Pi cotransporters R-HSA-427589	1	0	0/1	1	
Tyrosine catabolism R-HSA-8963684	1	0	0/1	1	
UCH proteinases R-HSA-5689603	0.710189986609751	0.819079999712745	3/80	1	UBA52;PSMC5;UCHL3
UNC93B1 deficiency - HSE R-HSA-5602415	1	0	0/1	1	
Ub-specific processing proteases R-HSA-5689880	0.340298552545331	1.23322068207413	8/146	1	UBA52;PSMC5;CCNA2;H2BC8;H2BC3;TP53;MYC;TAF10
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A R-HSA-69601	0.669125016689837	0.877787349609299	2/50	1	UBA52;PSMC5
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815	0.679768317501771	0.859651180674065	2/51	1	UBA52;PSMC5
Unblocking of NMDA receptors, glutamate binding and activation R-HSA-438066	1	0	0/11	1	
Uncoating of the HIV Virion R-HSA-162585	1	0	0/1	1	
Unfolded Protein Response (UPR) R-HSA-381119	0.737889407951267	0.764680442221327	2/57	1	EIF2S2;CXCL8
Unwinding of DNA R-HSA-176974	1	0	0/6	1	
Uptake and actions of bacterial toxins R-HSA-5339562	1	0	0/16	1	
Uptake and function of anthrax toxins R-HSA-5210891	1	0	0/8	1	
Uptake and function of diphtheria toxin R-HSA-5336415	1	0	0/5	1	
Uptake of dietary cobalamins into enterocytes R-HSA-9758881	1	0	0/2	1	
Urea cycle R-HSA-70635	1	0	0/4	1	
Utilization of Ketone Bodies R-HSA-77108	1	0	0/0	1	
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399	1	0	0/4	1	
VEGF ligand-receptor interactions R-HSA-194313	1	0	0/4	1	
VEGFA-VEGFR2 Pathway R-HSA-4420097	1	0	0/73	1	
VEGFR2 mediated cell proliferation R-HSA-5218921	1	0	0/17	1	
VEGFR2 mediated vascular permeability R-HSA-5218920	1	0	0/21	1	
VLDL assembly R-HSA-8866423	1	0	0/3	1	
VLDL clearance R-HSA-8964046	1	0	0/4	1	
VLDLR internalisation and degradation R-HSA-8866427	0.426772182116293	1.92268712388978	1/12	1	UBA52
Variant SLC6A14 may confer susceptibility towards obesity R-HSA-5619094	1	0	0/0	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5619101	1	0	0/1	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5660686	1	0	0/1	1	
Vasopressin regulates renal water homeostasis via Aquaporins R-HSA-432040	1	0	0/19	1	
Vasopressin-like receptors R-HSA-388479	1	0	0/1	1	
Vesicle-mediated transport R-HSA-5653656	0.999682994475224	0.264348523726652	4/305	1	UBA52;DYNLL1;VAMP8;ARPC1A
Vif-mediated degradation of APOBEC3G R-HSA-180585	0.700220534921121	0.825511968611909	2/53	1	UBA52;PSMC5
Viral Messenger RNA Synthesis R-HSA-168325	0.656326253281738	0.958800817046349	1/23	1	POLR2F
Viral RNP Complexes in the Host Cell Nucleus R-HSA-168330	1	0	0/1	1	
Virus Assembly and Release R-HSA-168268	1	0	0/2	1	
Visual phototransduction R-HSA-2187338	1	0	0/26	1	
Vitamin B1 (thiamin) metabolism R-HSA-196819	1	0	0/0	1	
Vitamin B2 (riboflavin) metabolism R-HSA-196843	1	0	0/3	1	
Vitamin B5 (pantothenate) metabolism R-HSA-199220	1	0	0/5	1	
Vitamin B6 activation to pyridoxal phosphate R-HSA-964975	1	0	0/0	1	
Vitamin C (ascorbate) metabolism R-HSA-196836	1	0	0/2	1	
Vitamin D (calciferol) metabolism R-HSA-196791	1	0	0/3	1	
Vitamin E R-HSA-8877627	1	0	0/0	1	
Vitamins R-HSA-211916	1	0	0/0	1	
Voltage gated Potassium channels R-HSA-1296072	1	0	0/7	1	
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization R-HSA-180897	1	0	0/1	1	
Vpr-mediated nuclear import of PICs R-HSA-180910	1	0	0/13	1	
Vpu mediated degradation of CD4 R-HSA-180534	0.40836414679745	1.3238525111593	3/51	1	UBA52;PSMC5;SKP1
VxPx cargo-targeting to cilium R-HSA-5620916	1	0	0/10	1	
WNT ligand biogenesis and trafficking R-HSA-3238698	1	0	0/9	1	
WNT mediated activation of DVL R-HSA-201688	1	0	0/5	1	
WNT5:FZD7-mediated leishmania damping R-HSA-9673324	0.242721710581898	4.23445267568269	1/6	1	JUN
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 R-HSA-5140745	1	0	0/9	1	
WNT5A-dependent internalization of FZD4 R-HSA-5099900	1	0	0/8	1	
Wax and plasmalogen biosynthesis R-HSA-8848584	1	0	0/1	1	
Wax biosynthesis R-HSA-9640463	1	0	0/1	1	
XAV939 stabilizes AXIN R-HSA-5545619	1	0	0/1	1	
XBP1(S) activates chaperone genes R-HSA-381038	1	0	0/22	1	
Xenobiotics R-HSA-211981	1	0	0/7	1	
YAP1- and WWTR1 (TAZ)-stimulated gene expression R-HSA-2032785	1	0	0/10	1	
Z-decay: degradation of maternal mRNAs by zygotically expressed factors R-HSA-9820865	1	0	0/9	1	
ZBP1(DAI) mediated induction of type I IFNs R-HSA-1606322	0.211408656218083	2.49763475961611	2/19	1	NFKB1;RELA
Zinc efflux and compartmentalization by the SLC30 family R-HSA-435368	1	0	0/0	1	
Zinc influx into cells by the SLC39 gene family R-HSA-442380	1	0	0/0	1	
Zinc transporters R-HSA-435354	1	0	0/0	1	
Zygotic genome activation (ZGA) R-HSA-9819196	0.309813381545497	3.02371343760045	1/8	1	TP53
activated TAK1 mediates p38 MAPK activation R-HSA-450302	0.63994378502192	1.00470864523097	1/22	1	UBA52
alectinib-resistant ALK mutants R-HSA-9717316	1	0	0/0	1	
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism R-HSA-2046104	1	0	0/5	1	
alpha-linolenic acid (ALA) metabolism R-HSA-2046106	1	0	0/5	1	
betaKlotho-mediated ligand binding R-HSA-1307965	1	0	0/1	1	
brigatinib-resistant ALK mutants R-HSA-9717319	1	0	0/0	1	
cGMP effects R-HSA-418457	1	0	0/5	1	
ceritinib-resistant ALK mutants R-HSA-9717323	1	0	0/0	1	
crenolanib-resistant FLT3 mutants R-HSA-9702581	1	0	0/0	1	
crizotinib-resistant ALK mutants R-HSA-9717326	1	0	0/0	1	
eNOS activation R-HSA-203615	1	0	0/6	1	
gilteritinib-resistant FLT3 mutants R-HSA-9702590	1	0	0/0	1	
lestaurtinib-resistant FLT3 mutants R-HSA-9702596	1	0	0/0	1	
linifanib-resistant FLT3 mutants R-HSA-9702998	1	0	0/0	1	
lorlatinib-resistant ALK mutants R-HSA-9717329	1	0	0/0	1	
mRNA 3'-end processing R-HSA-72187	1	0	0/23	1	
mRNA Capping R-HSA-72086	0.604812877024766	1.11101589883285	1/20	1	POLR2F
mRNA Editing R-HSA-75072	1	0	0/0	1	
mRNA Editing: A to I Conversion R-HSA-75064	1	0	0/0	1	
mRNA Editing: C to U Conversion R-HSA-72200	1	0	0/0	1	
mRNA Splicing - Major Pathway R-HSA-72163	0.114055534645432	1.71901848191231	8/108	1	POLR2F;LSM3;LSM4;LSM5;SNRPE;SNRPG;SF3B5;SNRNP27
mRNA Splicing - Minor Pathway R-HSA-72165	0.0839238216544498	2.59107938836756	4/37	1	POLR2F;SNRPE;SNRPG;SF3B5
mRNA Splicing R-HSA-72172	0.142685003631542	1.61915792653022	8/114	1	POLR2F;LSM3;LSM4;LSM5;SNRPE;SNRPG;SF3B5;SNRNP27
mRNA decay by 3' to 5' exoribonuclease R-HSA-429958	1	0	0/10	1	
mTORC1-mediated signalling R-HSA-166208	0.63994378502192	1.00470864523097	1/22	1	RPS6
midostaurin-resistant FLT3 mutants R-HSA-9702600	1	0	0/0	1	
mitochondrial fatty acid beta-oxidation of saturated fatty acids R-HSA-77286	1	0	0/6	1	
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids R-HSA-77288	1	0	0/3	1	
p130Cas linkage to MAPK signaling for integrins R-HSA-372708	1	0	0/7	1	
p38MAPK events R-HSA-171007	1	0	0/10	1	
p53-Dependent G1 DNA Damage Response R-HSA-69563	0.318228079983844	1.43984505169485	4/63	1	UBA52;PSMC5;CCNA2;TP53
p53-Dependent G1/S DNA damage checkpoint R-HSA-69580	0.318228079983844	1.43984505169485	4/63	1	UBA52;PSMC5;CCNA2;TP53
p53-Independent DNA Damage Response R-HSA-69610	0.669125016689837	0.877787349609299	2/50	1	UBA52;PSMC5
p53-Independent G1/S DNA damage checkpoint R-HSA-69613	0.669125016689837	0.877787349609299	2/50	1	UBA52;PSMC5
p75 NTR receptor-mediated signalling R-HSA-193704	0.457031266610523	1.22076592574228	3/55	1	UBA52;NFKB1;RELA
p75NTR negatively regulates cell cycle via SC1 R-HSA-193670	1	0	0/4	1	
p75NTR recruits signalling complexes R-HSA-209543	0.426772182116293	1.92268712388978	1/12	1	UBA52
p75NTR regulates axonogenesis R-HSA-193697	1	0	0/2	1	
pexidartinib-resistant FLT3 mutants R-HSA-9702605	1	0	0/0	1	
phospho-PLA2 pathway R-HSA-111995	1	0	0/2	1	
ponatinib-resistant FLT3 mutants R-HSA-9702614	1	0	0/0	1	
quizartinib-resistant FLT3 mutants R-HSA-9702620	1	0	0/0	1	
rRNA modification in the mitochondrion R-HSA-6793080	1	0	0/0	1	
rRNA processing in the mitochondrion R-HSA-8868766	1	0	0/1	1	
semaxanib-resistant FLT3 mutants R-HSA-9702577	1	0	0/0	1	
snRNP Assembly R-HSA-191859	0.24537329698268	2.23374304689324	2/21	1	SNRPE;SNRPG
sorafenib-resistant FLT3 mutants R-HSA-9702624	1	0	0/0	1	
sunitinib-resistant FLT3 mutants R-HSA-9702632	1	0	0/0	1	
t(4;14) translocations of FGFR3 R-HSA-2033515	1	0	0/0	1	
tRNA Aminoacylation R-HSA-379724	1	0	0/11	1	
tRNA modification in the mitochondrion R-HSA-6787450	1	0	0/2	1	
tRNA modification in the nucleus and cytosol R-HSA-6782315	1	0	0/10	1	
tRNA processing R-HSA-72306	0.784412680894045	0.657501709845148	1/33	1	RPP30
tRNA processing in the mitochondrion R-HSA-6785470	1	0	0/1	1	
tRNA processing in the nucleus R-HSA-6784531	0.622784856026871	1.05523077016551	1/21	1	RPP30
tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis R-HSA-9708296	1	0	0/0	1	
tamatinib-resistant FLT3 mutants R-HSA-9703009	1	0	0/0	1	
tandutinib-resistant FLT3 mutants R-HSA-9702636	1	0	0/0	1	
trans-Golgi Network Vesicle Budding R-HSA-199992	0.837122498402455	0.552829745416831	1/39	1	VAMP8
vRNA Synthesis R-HSA-192814	1	0	0/1	1	
vRNP Assembly R-HSA-192905	1	0	0/1	1	
